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Cells of multicellular organisms, no matter how specialized they are, share the same genetic 
information, stored in their deoxyribonucleic acid (DNA) sequence. They obtain their identity during 
lineage commitment and differentiation, where specific gene expression patterns are established and 
subsequently maintained. This process does not involve the alteration of the DNA sequence itself; 
instead, it is achieved through mechanisms that modulate the accessibility of the DNA to the 
transcription machinery and thus control how the genetic code is read and applied. Faithful 
development and survival of complex multicellular organisms is thus not only depending on the genetic 
code but is also controlled by an additional layer of information called the epigenetic code. In 
mammals, the epigenetic information is stored mainly in two forms, posttranslational histone tail 
modifications and DNA methylation. DNA methylation of the fifth carbon of cytosines (C) yielding 5-
methylcytosine (5mC) is predominantly found in palindromic CpG dinucleotides affecting roughly 60 - 
80% of them (Bird 2002). Epigenetic memory that comprises both layers of epigenetic information is 
generally maintained during cell division and in particular DNA methylation poses a fundamental and 
heritable barrier that prevents regression into an undifferentiated state and loss of cellular identity 
(Messerschmidt et al. 2014; Seisenberger et al. 2013). DNA methylation is established by DNA 
methyltransferases (DNMTs) that, in our current understanding, either focus on the (de novo) 
establishment or the maintenance of DNA methylation across cell generations (Jurkowska et al. 2011; 
Law and Jacobsen 2010). Despite its crucial role, DNA methylation patterns are not only statically 
maintained but are also subject to dynamic regulation through active as well as passive mechanisms. 
DNA demethylation events have been observed locus-specifically in differentiated cells (Kangaspeska 
et al. 2008; M. S. Kim et al. 2009b; Metivier et al. 2008) as well as on a global scale during early 
development (Oswald et al. 2000; Seisenberger et al. 2012; Smith et al. 2014). Although global 
erasure of DNA methylation can be obtained efficiently through passive dilution by inhibiting the 
methylation maintenance machinery, a major caveat of this process is the dependence on repeated 
DNA replication, reducing the dynamic flexibility. In contrast, DNA demethylation also occurs in an 
active manner, involving enzymatic activities that can process 5mC and revert it back to unmodified C. 
While the catalytic mechanism of DNA methylation is well understood and established, the process of 
removing DNA methylation has puzzled researchers for a long time and a variety of mechanisms have 
been proposed (Ooi and Bestor 2008; S. C. Wu and Zhang 2010). Many of these pathways, however, 
have failed to find sufficient support, most often due to a lack of reproducibility or convincing 
biochemical as well as biological evidence. 
In recent years, major advances have been made in the understanding of DNA demethylation and 
some promising candidate mechanisms have emerged (H. Wu and Zhang 2014). Compelling 
biochemical as well as biological evidence points towards an involvement of the ten eleven-
translocation (TET) family of dioxygenases in the removal of DNA methylation (Pastor et al. 2013). 
The family consists of 3 members, TET1-3, that share a conserved catalytic core domain enabling 
iterative oxidation of 5mC to generate 5-hydroxymethylcytosine (5hmC), 5-formylcytosine (5fC), and 5-
carboxylcytosine (5caC), which could serve as intermediates in active or passive DNA demethylation 
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processes (He et al. 2011; Huang et al. 2014; Inoue et al. 2011; Ito et al. 2011). The thymine DNA 
glycosylase (TDG), originally identified as biochemical activity excising thymine (T) and uracil (U) 
when mispaired with guanine (G), is able to recognize and excise the TET-mediated 5mC oxidation 
products 5fC and 5caC (He et al. 2011; Maiti and Drohat 2011). A role for TDG in epigenetic 
programming and DNA demethylation has also been implicated by gene inactivation studies in animals 
(Cortazar et al. 2011; Cortellino et al. 2011; Saito et al. 2011) as well as in ES cells (Raiber et al. 2012; 
L. Shen et al. 2013; C. X. Song et al. 2013a). Together, these findings gave rise to a novel concept of 
active DNA demethylation (Kohli and Zhang 2013; H. Wu and Zhang 2014) involving TET-mediated 
5mC oxidation followed by TDG-initiated DNA repair to release the oxidized 5mC derivative and re-
establish the unmethylated state. Despite the fact that this mechanism is plausible and has been 
widely accepted, there is in fact little evidence supporting a direct link of TET with TDG and DNA 
repair and mechanistic details, coordination, regulation and targeting of this process remain to be 
clarified. 
In order to gain further insight into TET and TDG-mediated active DNA demethylation, I set out to 
address some of the imminent mechanistic questions by in vitro reconstitution of oxidative DNA 
demethylation along the TET-TDG axis in combination with base excision repair (BER). I first showed 
that TDG by itself has no detectable enzymatic activity on 5mC and 5hmC but efficiently recognizes 
and processes 5caC, a modification that does not affect regular Watson-Crick basepairing 
(Supplementary results 4.4.1) (He et al. 2011; Maiti and Drohat 2011). The proposed oxidative DNA 
demethylation mechanism implies a coupled action of TET and TDG to facilitate an efficient but 
coordinated removal of 5mC. To investigate the coupling mechanism, I tested a potential physical 
interaction of the two enzymes, through multiple experimental approaches. I could demonstrate that 
TET1 and TDG physically interact through domains located in the N-terminus as well as the catalytic 
domain (TET1CD) of TET1. Recombinant TET1CD/TDG complex, purified from Escherichia coli (E.coli) 
cells co-expressing both proteins, turned out to act as ‘demethylase’ by combining both enzymatic 
activities to remove 5mC and 5hmC from synthetic DNA oligonucleotides. After successful 
reconstitution of 5mC base release with purified recombinant proteins, I combined this activity with the 
BER machinery and showed complete reconstitution of active DNA demethylation via oxidized 
intermediates in vitro, providing the first experimental evidence that this process is functional in the 
proposed manner. Moreover, investigation of the process operating at symmetrically modified CpGs 
suggested that symmetric DNA demethylation is obtained through a processive mechanism that is 
highly coordinated and acts sequentially on both strands to protect the DNA from the formation of DNA 
double strand breaks (DSBs). However, the sequential and coordinated repair of two nearby 
substrates on opposite strands, beneficial in terms of avoiding the formation of DNA DSBs, could have 
an impact on mutagenesis of CpG dinucleotides. I could show that at fully methylated CpG sites, 
where spontaneous hydrolytic deamination may occur coincident with oxidative DNA demethylation, 
the repair of the resulting G/T mismatch is highly disfavored in presence of a G·5caC base pair. The 
preferential repair of 5caC can then occasionally create a C to T mutation and, hence, lead to the loss 
of the CpG dinucleotide (Appendix I). Additional experiments revealed that neither TET nor TDG 
activity is restricted to double-stranded DNA or a CpG context, suggesting that TET-TDG-mediated 
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DNA demethylation might also occur in other biologically relevant contexts including non-CpG 
methylation, single-stranded DNA or R-loops (Supplementary results 4.4.1). 
The process of active DNA demethylation by TET-TDG-BER has to occur in a tightly regulated and 
highly coordinated manner to ensure accuracy and genome integrity. TDG was previously described to 
be regulated by posttranslational modification and non-covalent interaction with the small ubiquitin-like 
modifiers (SUMO), SUMO1 and SUMO2/3 (Hardeland et al. 2002; Mohan et al. 2007; Steinacher and 
Schar 2005) and other BER factors are also amongst the increasing number of reported SUMO 
targets (Cremona et al. 2012; Weber et al. 2014). The biochemical investigation of the functional 
consequences of SUMO modification, however, has been lagging behind due to the difficulty to 
generate appreciable amounts of recombinant SUMOylated proteins. Therefore, I, in collaboration with 
David Schürmann, established a recombinant SUMOylation system, coupling efficient SUMO-
conjugation with affinity purification of modified target proteins, and present tools and strategies to 
generate SUMOylated proteins using versatile binary expression vector systems in protease-deficient 
E.coli. We successfully modified the BER factors TDG and XRCC1 and could show that purified 
SUMO-modified TDG had retained the expected biochemical properties (Appendix II). I was then also 
able to modify the N-terminus of TET1 with SUMO1 as well as SUMO3 using the recombinant 
SUMOylation system and identified SUMO interaction motifs (SIMs) in the TET1 sequence by in silico 
prediction. This indicates that SUMOylation might also be prominently involved in the coordination and 
regulation of TET-TDG mediated DNA demethylation processes (Supplementary results 4.4.2). 
We reasoned that other factors previously proposed to contribute to DNA demethylation might be 
involved in the concerted action of the TET and TDG enzymatic activities, exerting a regulatory or 
structural function. The growth arrest and DNA-damage-inducible protein 45 (Gadd45) family of 
proteins has previously been implicated in active DNA demethylation through Xeroderma 
pigmentosum group G (XPG)-dependent DNA repair (Barreto et al. 2007; Schmitz et al. 2009) or BER 
of activation-induced deaminase (AID)-based deamination products (Cortellino et al. 2011; Rai et al. 
2008). In collaboration with Zheng Li and Guoliang Xu at the Chinese Academy of Science in 
Shanghai, I set out to re-investigate a potential role of Gadd45a in the context of oxidative DNA 
demethylation and provide several lines of evidence that Gadd45a serves as a regulator in the TET-
TDG-mediated DNA demethylation pathway. Together, we showed that Gadd45a synergizes with TET 
and TDG to activate a methylated reporter gene in transfected cells. Moreover, Gadd45a physically 
interacted with TDG and potentiated TDG glycosylase activity to remove 5fC and 5caC from genomic 
DNA of transfected HEK293T cells. Finally, deletion of Gadd45a/b in mouse ES cells led to 
hypermethylation at specific genomic loci, which also gained increased DNA methylation levels and 
are enriched in 5fC in TDG-deficient cells. Despite the diverse molecular functions that have been 
attributed to Gadd45a, we were able to connect Gadd45 proteins with DNA demethylation along the 
TET-TDG axis and propose a regulatory function. My specific contribution to this work was the 
biochemical examination of Gadd45a on the enzymatic function of TET and TDG (Appendix III). 
Taken together, the work presented in my PhD thesis advances our understanding of TET-TDG-
mediated active DNA demethylation and the underlying mechanisms. I was able to show that TET 
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associates with BER by physically interacting with TDG and to provide proof of concept that DNA 
demethylation can be achieved through the coordinated action of an intricate network of enzymes 
consisting of TET, TDG and the core components of the DNA BER system. Without question, 
additional factors and regulatory mechanisms, like Gadd45a and SUMO modification, for which I was 
able to provide preliminary evidence, will turn out to contribute to coordination, targeting and regulation 
of this active DNA demethylation process. Additional findings that 5mC oxidation and repair by TET1 
and TDG is neither limited to CpG dinucleotides nor to double-stranded DNA suggest that this 





DNA is the carrier of the genetic information, stored in every cell and needed for proper development 
and functioning of all known living organisms. The genetic information is encoded by the sequential 
assembly of four building blocks, the nucleotides. The nucleotides are composed of a nucleobase, the 
purines adenine (A) and guanine (G) or the pyrimidines cytosine (C) and thymine (T), that are attached 
to a monosaccharide sugar called deoxyribose and a phosphate group. The DNA consists of two anti-
parallel complementary single-strands, coiled around each other to form a double-stranded α-helix. 
Complementarity is established through the Watson-Crick base pairing, where A pairs with T via two 
and G pairs with C via three hydrogen bonds.  
 
2.1 Genome Maintenance and DNA Repair 
DNA is a fragile chemical structure, susceptible to damage by reactive chemicals, by high energetic 
radiation and by spontaneous decay. DNA damaging agents can originate from exogenous sources 
like ionizing radiation, but are predominantly endogenously produced by cellular metabolic processes. 
DNA damage most frequently affects bases and includes various chemical modifications like 
methylation, oxidation, alkylation, deamination or even the hydrolytic loss of entire bases (Lindahl et al. 
1997). Repairing these often mutagenic or cytotoxic DNA alterations is important for cell survival and 
genome integrity. Unrepaired base damage can lead to genetic mutations or interfere with replication 
fork progression and replication associated chromatid breakage. To minimize the deleterious effects of 
DNA damage and maintain genome integrity, nature has evolved various repair systems, each of 
which tackling a specific class of DNA lesions (Dalhus et al. 2009; Germann et al. 2012; Scharer 
2003). 
I will now provide a very general overview on DNA damage and briefly introduce the most common 
DNA repair pathways, a more detailed introduction on the relevant repair mechanism for this thesis will 
follow in chapter 2.2.1. DNA DSBs represent the most severe form of DNA damage and are repaired 
either by non-homologous end joining (NHEJ) or by homologous recombination (HR). As the name 
implies, NHEJ repairs DSBs without using the information of homologous sequences and is therefore 
often error prone. After the DSB ends are processed to restore a ligatable configuration, they are 
simply re-ligated. Unlike in NHEJ, repair by HR uses sequence homology from the sister chromatid as 
a template for the repair of a broken chromatid. Frequent base modifications caused by alkylating 
agents can be repaired by direct damage reversal, employing a mechanism where the alkyl group is 
either transferred to a reactive cysteine group of the repair protein or oxidized and subsequently 
cleaved off. The majority of base lesions, DNA polymerase errors arising during DNA replication, UV-
light and chemical induced bulky DNA adducts and pyrimidine dimers are repaired by numerous 
excision repair pathways. Errors in DNA replication (misincorporation of nucleotides) are restored by 
the mismatch repair system (MMR) that recognizes and excises the mismatched base from the newly 
synthesized DNA strand, which is then re-synthesized at the original parental DNA strand. Lesions 
that cause more serious helix distortion but only affect one strand are dealt with by the nucleotide 
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excision repair pathway (NER). After the lesion is recognized and verified, the helix is unwound and an 
oligonucleotide of 24-32 nucleotides in length containing the damage is released. Finally, gap 
synthesis and strand re-ligation completes successful repair. Modifications of single bases are 
generally recognized and repaired by the BER machinery which can excise and replace single 
erroneous bases (chapter 2.2.1). 
Besides its role in maintaining genome integrity, DNA repair, in particular BER, has also been 
implicated a role in the maintenance of epigenetic DNA modifications (Schar and Fritsch 2010). The 
epigenome is referred to as the total of functionally relevant chemical modifications to DNA and 
histone tails, which together guide chromatin structuring and gene expression programs of individual 
cells at distinct developmental stages (Mohn and Schubeler 2009) (chapter 2.3). Potential repair-
mediated mechanisms that are involved in the shaping of the epigenome will be discussed in chapter 
2.5. 
 
2.2 DNA Base Modifications and Repair 
Nucleobases frequently engage in chemical reactions due to presence of DNA damaging agents, 
resulting in a variety of products of hydrolysis, deamination, alkylation and oxidation, which can lead to 
the loss of entire bases or the alteration of coding properties, both of which can be mutagenic or 
cytotoxic. Base damages are generally recognized and processed by the BER machinery. Besides 
these mutagenic or toxic base modifications, there are, however, also biologically relevant ones that 
are placed intentionally as part of the epigenetic code to instruct important biological processes, i.e. 
DNA methylation of the fifth carbon of C yielding 5mC (chapter 2.3.2). 5mC, which accounts for 
roughly 1% of total DNA bases is considered the 5th base and is itself a target for further modification. 
For example, through stepwise oxidation of the methyl group, generating 3 more chemically distinct C 
derivatives that are present in vertebrate DNA in comparably low amounts; 5hmC, 5fC and 5caC 
(Delatte et al. 2014). The biological function of these bases is only starting to be unveiled and the 
evidence available suggests that they have epigenetic functionality. To what extent they represent 
programmed modifications or oxidative lesions of 5mC, however, is currently unclear. Notably, the 
epigenetically relevant DNA base modifications, i.e. the methylation of C, is, from a structural point of 
view, not much different from base alkylations representing DNA damage. It is therefore not surprising 
that DNA repair mechanisms, and particularly DNA glycosylase-initiated BER, specialized in 
safeguarding DNA base integrity have been adopted for the control of epigenetic DNA methylation 
(see chapter 2.5). As this PhD thesis mainly focused on the role of said BER pathway and TDG in 
epigenetic maintenance, particularly in active DNA demethylation, this DNA repair pathway is 




 DNA Base Excision Repair (BER) 2.2.1
Substrate Recognition: DNA base modifications or damages are usually processed by the BER 
pathway (Baute and Depicker 2008; G. L. Dianov and Hubscher 2013; A. B. Robertson et al. 2009). 
BER is typically targeted and initiated by modification-specific DNA glycosylases that recognize and 
excise substrate bases from DNA. Most DNA glycosylases recognize base modifications that 
potentially compromise genome integrity like deaminated Cs or are known to be cytotoxic like 
oxidation products of all four bases and some types of alkylation damage. Still little is known about the 
mechanisms how modified bases are found in the vast quantity of undamaged bases in the genome. It 
is proposed that DNA glycosylases have different strategies of damage pre-selection by establishing 
loose base contacts through conserved residues close to the catalytic site without the need of fully 
inserting every base into the active pocket (Jacobs and Schar 2011). This scanning mode allows fast 
coverage of the genome with a minimized effort. Additionally, damage recognition by DNA 
glycosylases might also benefit from the fact that most lesions show reduced base pairing stability and 
helix distortion because of the mismatched context (Yang 2006). These sterical features, but often 
also specific interactions with the opposing base and strand must be important for the recognition of 
genuine DNA bases like T when mispaired with G but not when paired with A. For the final damage 
verification, the putative lesion is flipped out from the interior of the DNA helix and is inserted in the 
catalytic pocket of the DNA glycosylase, providing more room for molecular interactions. Specific 
molecular interactions in the catalytic pocket generally lead to a restriction of substrate tolerance but at 
the same time increases specificity, conferring high damage-specificity to DNA glycosylases. In 
contrast to DNA damages that predominantly occur in a stochastic way and are randomly distributed 
across the genome, epigenetic base modifications, i.e. DNA cytosine methylation is most often placed 
in a targeted way. For the recognition of these modifications, DNA glycosylases might need targeting 
to the respective loci and don’t need to scan the genome themselves. 
BER Mechanism: The mechanism of BER (Fig. 2.1) has initially been described and reconstituted with 
purified enzyme many years ago (G. Dianov and Lindahl 1994; G. L. Dianov and Hubscher 2013; 
Kubota et al. 1996). Core BER is initiated by a damage-specific DNA glycosylase which hydrolyzes the 
N-glycosidic bond that links the damaged base with the deoxyribose moiety of the nucleoside without 
cleaving the phosphodiester bond adjacent to the damaged base. Thereby, base removal from a DNA 
strand generates a repair intermediate, the so-called apurinic/apyrimidinic site (AP-site) or abasic site. 
AP-sites can give rise to DNA strand-breaks and impede the progression of RNA or DNA 
polymerases, resulting in cell toxicity or dysfunction (Wilson and Barsky 2001). Protection and 
coordinated processing of AP-sites is therefore crucial for cell survival and mutation avoidance and the 
initial hydrolysis of an irregular base must be tightly coupled to the subsequent incision and repair of 
the AP-site. 
Strand incision at the abasic site is exerted by the AP-endonuclease (APE1) which catalyzes the 
hydrolytic cleavage of the phosphodiester bond 5’ of the abasic site, generating a single-strand break 
(SSB) with a 5’-deoxyribose phosphate (5’-dRP) residue and a 3’-hydroxyl (3’-OH) end. The single-
strand break is recognized by Poly [ADP-ribose] polymerase 1 (PARP1), which then recruits X-ray 
repair cross-complementing protein 1 (XRCC1), DNA ligase 3 (LIG3) and DNA polymerase β (POLβ) 
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to insert a new nucleotide and seal the nick. The faithful repair of a SSB requires a 3’-OH and a 5’-
phosphate end that allows the downstream action of a DNA polymerase and DNA ligase to seal the 
nick. Removal of the 5’-dRP moiety and incorporation of a new nucleotide is performed simultaneously 
by the POLβ. Subsequently, strands are re-ligated by a heterodimer composed of the scaffold protein 
XRCC1 and LIG3. 
SSBs with unligatable ends can also arise spontaneously, by hydrolysis of AP-sites or by the action of 
bifunctional DNA glycosylases. In contrast to monofunctional DNA glycosylases, these enzymes have 
the capacity to convert an AP-site into a SSB by β- or β,δ-elimination through an associated DNA 
lyase activity, generating a 5’-phosphate (5’-P) and a 3’-polyunsaturated aldehyde (3’-PUA) or a 3’-
phosphate (3’-P) end, respectively. However, an AP-endonuclease with its intrinsic 3’ diesterase 
activity is then still required to remove the 3’ blocking α, β-unsaturated aldehyde, generated by AP 
lyases. After the conventional 3’ end has been restored, gap filling and re-ligation can continue. BER 
that only incorporates one nucleotide and subsequent re-ligation of the 3’-OH and 5’-P ends is referred 
to as short-patch BER (SP-BER).  
Fig. 2.1: Schematic short- and long patch BER pathways. BER is initiated by a DNA glycosylase to excise the 
damaged base. The DNA backbone is subsequently cleaved at the AP-site by APE1 or the lyase activity of a 
bifunctional DNA glycosylase. In the short-patch (SP) pathway, POLβ processes the free DNA ends and 
incorporates a new nucleotide. Finally the remaining nick is ligated by the XRCC1/LIG3 complex. The long-patch 
(LP) pathway is employed when the strand break produces ends that are refractory to processing by POLβ. 
Depending on the DNA ends one of the available endprocessors is employed. POLβ and/or POLδ/ε accomplish 
strand displacement by incorporation of multiple nucleotides. The DNA flap structure is cleaved by FEN1 followed 
by strand re-ligation by LIG1. Inspired by (Baute and Depicker 2008; Y. J. Kim and Wilson 2012; A. B. Robertson 
et al. 2009). 
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In case the 5’-end is blocked and cannot be processed by SP-BER, an alternative long-patch pathway 
(LP-BER) is engaged. During mammalian LP-BER, POLβ also incorporates the first nucleotide, 
elongation and strand displacement are then carried out by the replicative DNA polymerases δ or ε in 
presence of proliferating cell nuclear antigen (PCNA), replication factor C (RFC) and PARP1. The 
resulting 5' DNA “flap” structure of 2-12 nucleotides is then removed by the flap endonuclease 1 
(FEN1) and subsequently the nick is sealed by DNA ligase I (LIG1). 
Besides APE1 and POLβ other SSB end-processors were described, which may be needed 
downstream of the strand nicking reaction (G. L. Dianov and Hubscher 2013). Polynucleotide Kinase 
Phosphatase (PNKP) dephosphorylates 3’-ends and phosphorylates 5’-hydroxyl ends; Aprataxin 
processes 5’-termini blocked by abortive ligation reactions and tyrosyl DNA phosphodiesterase (TDP1) 
repairs SSBs generated by abortive DNA topoisomerase reactions. 
It is expected that the BER process occurs tightly regulated and orchestrated in cells, likely requiring 
regulatory processes such as posttranslational protein modifications, but it remains to be clarified how 
the individual steps are activated in a coordinated manner. Two popular models for the coordination of 
BER have been discussed in the literature, a stepwise ‘passing the baton’ model based on transient 
protein-protein interactions and a model suggesting a continuous process performed completely by 
preassembled DNA repair complexes (G. L. Dianov and Hubscher 2013). However, an emerging 
concept of how such complex processes can be coordinated is regulation of protein-protein 
interactions and protein conformations by SUMOylation that could feed into either of the two 
mentioned models (Jacobs and Schar 2011). 
 
 Thymine DNA Glycosylase (TDG) 2.2.2
Discovery and Classification: TDG was initially discovered in mammalian cells when looking for an 
activity capable of recognizing and processing a T when mispaired with G (Brown and Jiricny 1988; 
Wiebauer and Jiricny 1989), a situation that can occur through spontaneous hydrolytic deamination of 
5mC. Purification of the activity and subsequent molecular cloning of the gene led to the description of 
human TDG, which was the first reported mismatch-specific DNA glycosylase at that time 
(Neddermann and Jiricny 1993; Neddermann et al. 1996). TDG became the founding member of a 
protein family called mismatch-directed uracil-DNA glycosylases (MUG), a subgroup of monofunctional 
uracil-DNA glycosylases (UDGs) that share a common and characteristic α/β-fold structure (Aravind 
and Koonin 2000). All MUGs have a comparable and rather simple architecture; a conserved core 
domain containing the active site is flanked by less conserved N- and C-terminal domains of variable 
lengths. Within the core domain, the MUG orthologs share between 37-52% sequence identity at the 
amino acid level (Cortazar et al. 2007). A common structural feature of the MUG proteins is their large 
catalytic cavity which allows a rather broad spectrum of substrate bases for excision (Barrett et al. 
1999). A certain degree of substrate specificity is however granted due to specific interactions 
between residues in the active site and the G on the complementary strand, giving an evident 
preference for bases paired with G (Barrett et al. 1998). The human TDG is composed of 410 amino 
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acids, the mouse variant was found to occur in two splice variants, TDGa and TDGb, with a sequence 
length of 421 and 397 amino acids, respectively. TDGb is missing 25 amino acids from the N-
terminus, which doesn’t affect the catalytic domain, and it is currently not clear whether the two 
isoforms have distinct biological roles. 
Recognition and Repair of Base Modifications: Insight into the mechanism of base processing by MUG 
proteins came from structural studies of the E.coli Mug (eMug) (Barrett et al. 1999). The structure 
suggests an intercalation/nucleotide flipping mechanism; a conserved insertion loop intercalates into 
the DNA and flips out the substrate base into the catalytic pocket where it is processed. In this 
scenario the residues from the insertion loop mimic Watson-Crick base pairing with the opposite G 
through specific contacts to stabilize the enzyme/substrate complex (Maiti et al. 2008; Maiti et al. 
2009). In addition, specific contacts to the G positioned 3’ to the target nucleotide provide a structural 
basis for a potential lesions in a CpG context (Maiti et al. 2008). Owing to its name, TDG is best known 
for its ability to process T in a G/T mismatch, but like other members of the MUG family, it turned out 
to have a rather broad substrate spectrum including ethenoadducts, deaminated purines, oxidized 
pyrimidines and derivatives of U when paired with G, with U being the most common physiological one 
(Borys-Brzywczy et al. 2005; Cortazar et al. 2007; Hardeland et al. 2003). TDG is believed to 
associate with DNA through its flexible N-terminal domain that switches from an open to a clamp like 
conformation upon binding to DNA, thereby stabilizing the glycosylase on the DNA (Hardeland et al. 
2002; Steinacher and Schar 2005). This clamp structure may enable sliding along the DNA in order to 
detect substrate bases that are then flipped into the active site pocket upon encounter. A highly 
conserved asparagine residue (N151 in mouse, N140 in human TDG) in the active site promotes the 
hydrolysis of the N-glycosidic bond between the base and the deoxyribose-phosphate backbone 
through an activated water molecule (Barrett et al. 1998; Hardeland et al. 2000). TDG binds product 
AP-sites with high affinity and fails to dissociate (Hardeland et al. 2000; Waters et al. 1999); it is thus 
considered to be fully product inhibited and protects the hazardous repair intermediate from forming 
spontaneous SSBs or DSBs. Biochemical studies have shown that dissociation could be 
accomplished by either posttranslational modification of TDG with SUMO proteins (Hardeland et al. 
2002; Steinacher and Schar 2005) (see below) or in presence of an excess of downstream BER 
factors, which stimulate enzymatic turnover (Fitzgerald and Drohat 2008; Waters et al. 1999). 
SUMOylation of TDG: Posttranslational protein modifications, e.g. phosphorylation, acetylation, 
attachment of small polypeptides, are a rapid and energetically inexpensive means to reversibly 
modulate protein function. Enzymatic activity, subcellular localization, stability and also interaction with 
other proteins can be regulated by such modifications (Barry and Lock 2011). TDG was shown to be 
modified by SUMO1 and SUMO2/3 that are attached to an acceptor lysine (K341 in mouse TDGa, 
K330 in human TDG) within a SUMOylation consensus motif (VKEE) (Hardeland et al. 2002; Weber et 
al. 2014) (Appendix II). SUMO is conjugated to its substrates by an enzymatic cascade consisting of 
an activating enzyme (E1), a conjugating enzyme (E2) and, sometimes, a SUMO ligase (E3). In 
contrast to ubiquitylation, SUMOylation utilizes only a single conjugation enzyme, Ubc9, a single 
heterodimeric activating enzyme consisting of SAE1 and SAE2 (Aos1 and Uba2 in humans) and a 
limited number of E3-ligases (Weber et al. 2014) (Appendix II). SUMO1, conjugated to the C-terminus 
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of TDG, interacts functionally with the N-terminus and neutralizes its DNA binding capacity facilitating 
enzymatic turnover (Hardeland et al. 2002; Weber et al. 2014) (Appendix II). In addition to the 
SUMOylation site, TDG also contains two SIMs that mediate non-covalent SUMO-interactions with 
either SUMO alone or other SUMOylated proteins to induce complex formation (Mohan et al. 2007). In 
this regard, SUMOylation might also exert a regulatory function in the BER pathway, where XRCC1 
and APE1 have also been described as SUMO targets (Weber et al. 2014) (Appendix II), to ensure 
correct orchestration of the enzymatic cascade. The details of this potential regulation are, however, 
not yet fully understood. Besides SUMOylation, TDG was also reported to be modified by 
ubiquitylation (Hardeland et al. 2007), phosphorylation and acetylation (Mohan et al. 2010), which 
could play important roles in the regulation of TDG abundance, localization or enzymatic activity. 
Biological Roles: With its ability to process T from G/T mismatches, TDG was believed to 
predominantly counteract C to T transitions arising from hydrolytic deamination of 5mC at CpG sites. 
An increasing body of biochemical and genetic evidence, however, suggested that TDG could also be 
acting outside classical repair and play essential roles in various other biological processes such as 
embryonic development, regulation of gene expression and DNA demethylation (Cortazar et al. 2007; 
Sjolund et al. 2013). Over the years, numerous interactions with transcription factors, chromatin 
modifiers and DNA methyltransferases (DNMTs) have been described, proposing a functional role of 
TDG in gene regulation either as transcriptional co-factor or by modulating DNA methylation states 
itself. For example, TDG was shown to interact with the nuclear receptors retinoic acid receptor (RAR) 
and retinoid X receptor (RXR) (Um et al. 1998) stimulating receptor binding and activating of reporter 
genes. A similar effect was observed with estrogen receptor α (ERα) that was also shown to physically 
interact with TDG. There, TDG acted as a transcriptional co-activator for ERα-regulated genes (D. 
Chen et al. 2003a). Most convincing biological evidence for a role of TDG outside of DNA repair was 
then described in TDG knockout studies in mice, where it was found to be required for embryonic 
development (Cortazar et al. 2011; Cortellino et al. 2011; Saito et al. 2011). TDG knockout was shown 
to confer embryonic lethality and molecular studies pointed towards epigenetic and transcriptional 
dysregulation. Interestingly, TDG knockout mouse embryonic stem cells (ESCs) show largely normal 
gene expression patterns. Only upon differentiation into neuronal progenitor cells and mouse 
embryonic fibroblasts (MEFs), gene expression differences between TDG proficient and deficient cells 
arise and these are accompanied by epigenetic aberrations i.e. increased de novo DNA methylation of 
promoter CpG islands (CGIs) (Cortazar et al. 2011). This phenotype, not observed for any other DNA 
glycosylase so far, is most likely not arising from a DNA repair defect alone but is linked to a potential 
role of TDG in establishing and maintaining proper DNA methylation patterns as well as gene 
regulation during differentiation. Recent studies further substantiated an involvement of TDG in 
genome-wide methylation dynamics (L. Shen et al. 2013; C. X. Song et al. 2013a) and mechanistic 




2.3 Epigenetic Memory and DNA Methylation 
Every cell of an organism, no matter how specialized, contains an entire copy of the genome, 
representing an excess of unused genetic information for the majority of cells. Differentiation into and 
maintenance of specific cell types is not obtained by altering the genome itself but rather by controlling 
the readout and application of the genetic code. The mechanisms that have evolved to facilitate 
differential readouts of the genome are thought to modulate DNA accessibility for the transcription 
machinery. Thus, the information required for the growth, development and survival of a multicellular 
organism is not only stored genetically in the DNA sequence but also epigenetically as epigenetic 
memory in the superimposed code that determines gene expression patterns. Epigenetic memory is 
established by DNA cytosine methylation and a plethora of post-translational histone tail modifications 
(Fig. 2.2) and relies on faithful inheritance of these marks (Lee et al. 2014). These epigenetic 
modifications act in a concerted way to determine chromatin structure and regulate transcriptional 
activity at specific loci. As this thesis focuses mainly on DNA methylation I will only provide a very 
superficial view on histone modifications and their epigenetic function here. Detailed discussions about 
the expanding number of histone tail modifications and their implicated functions can be found in 
(Bannister and Kouzarides 2011; Kouzarides 2007). So-called repressive histone marks can induce a 
compaction of chromatin (heterochromatin), whereas activating histone marks decondense chromatin, 
resulting in a more open, accessible form (euchromatin) (Bannister and Kouzarides 2011). 
Heterochromatin is largely inaccessible for protein complexes involved in gene transcription and thus 
contains mostly transcriptionally inactive genes and repetitive sequences (Hubner et al. 2013). DNA 
methylation also contributes to chromatin compaction and can modulate transcriptional activity through 
other mechanisms, e.g. by recruiting repressive complexes (see chapter 2.3.2). These epigenetic 
instructions are needed to guide and control important biological processes including cell 
differentiation and cell lineage maintenance, cellular reprogramming and gametogenesis (Smith and 
Meissner 2013). A simplified model allows an allocation of biological processes to be regulated by 
either short- or long-term epigenetic memory. However, this is a very general view mainly applicable to 
vertebrates and there are likely to be exceptions to the rule. 
 
 Short- and Long-term Epigenetic Memory 2.3.1
Different mechanisms have evolved in cells to ensure long-term epigenetic stability and heritability but 
also to maintain plasticity in transcriptional programs, depending on the requirements of the cell (Mohn 
and Schubeler 2009; Reik 2007). Current knowledge suggests that the short-term epigenetic memory 
is mainly established by histone modifications and used to transiently repress or activate specific loci 
(Fig. 2.2 A). Dynamically regulated processes allow a rather fast adaptation of gene expression 
patterns in response to internal or external stimuli for example during cell differentiation. In pluripotent 
ESCs, for instance, genes that are required during development and differentiation are often held in a 
so-called bivalent chromatin state, which is characterized by both activating (histone 3 lysine 4 
methylation, H3K4me) as well as repressive (histone 3 lysine 27 methylation, H3K27me) marks 
around the transcription start site (TSS), whereas the DNA remains methylation free (Bernstein et al. 
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2006). Removal of the repressive or activating histone mark at the start of differentiation then leads to 
rapid gene activation or repression, respectively. How the epigenetic information encoded by histone 
modifications is maintained during DNA replication is not yet completely understood and subject to 
ongoing research. Putative models are discussed in (Probst et al. 2009). 
Long-term epigenetic memory, on the other hand, is sustained throughout the development and 
lifespan of an organism and is achieved by repressive histone marks in combination with DNA 
methylation (Fig. 2.2 B). The acquisition of these repressive marks leads to compaction of the 
genome, which in turn helps to keep it in a stably silenced state. The genomic DNA methylation 
patterns are established early in development and are generally statically maintained by the DNA 
methylation machinery during the lifespan of a cell (see chapter 2.3.2). These regions include 
imprinted genes, repeat regions, transposons and the inactivated X chromosome, where stable 
transcriptional silencing is crucial for proper development of an organism and genome integrity (Jones 
2012; K. D. Robertson 2005; Smith and Meissner 2013). Long-term silencing is also required for 
pluripotency and developmental genes that need to be shut down during cell lineage commitment to 
protect the cell from dedifferentiation and loss of identity. 
 
 DNA Cytosine Methylation 2.3.2
In mammals, enzymatic DNA methylation occurs almost entirely at the fifth carbon of Cs resulting in 
5mC predominantly in CpG dinucleotides (Bird 2002). These CpG dinucleotides are not evenly 
distributed across the genome and the CpG content is inversely correlated with the level of DNA 
methylation. Isolated DNA islands with a higher than average content of CpGs, hence called CGIs, are 
Fig. 2.2: The two main layers of epigenetic memory. (A) Short-term epigenetic memory mainly established by 
histone tail modifications. (B) Long-term epigenetic memory through DNA methylation in combination with histone 
tail modifications. Adapted from (Yan et al. 2010). 
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generally hypomethylated, the rest of the genome is mostly depleted of CpGs and hypermethylated 
(Cohen et al. 2011; Deaton and Bird 2011). The number of CGIs in mammalian genomes is estimated 
to be around 30’000; they frequently span gene regulatory elements and thus seem to be involved in 
gene regulation (Cohen et al. 2011; Illingworth and Bird 2009). DNA methylation at CpG rich gene 
regulatory elements is generally associated with gene repression. Mechanistically, transcriptional 
activity is repressed by directly inhibiting association of DNA binding factors or by recruiting methyl-
CpG binding proteins that administrate a repressive function through co-repressor molecules 
(Ballestar and Wolffe 2001; Bird 2002). Lately, most of the research on DNA methylation has focused 
on CGIs at promoter regions, however, 5mC also appears in gene bodies, enhancers and in non-CpG 
contexts (Lister et al. 2009). Non-CpG methylation has been described in plants and mammalian stem 
cells, but recent evidence indicated that it also occurs in somatic cells and could be involved in the 
regulation of gene expression, but its function in this context is only starting to be unraveled (Pinney 
2014). 
Methylation of Cs affects an organism on several levels, ranging from altering biochemical  and 
chemical properties down to consequences on the whole organism (Fig. 2.3) (Franchini et al. 2012). 
Starting from altering van der Waals radii around C5 of cytosine, base stacking, DNA structure and 
protein association by promoting or inhibiting protein-DNA interactions, DNA methylation also 
stimulates the compaction of chromatin and the subnuclear localization of gene loci, represses 
transposons, alters DNA replication efficacy or influences the rate of transcription and RNA 
processing. Altogether, DNA methylation substantially influences and regulates many important 
biological processes such as cellular proliferation and differentiation, pluripotency, genetic imprinting, 
and oncogenesis, hence ensuring proper development and long-term survival of an organism (Jones 
2012). DNA methylation in mammals is catalyzed by a group of proteins called the DNA 
methyltransferases (DNMTs) that classically either focus on the establishment or the maintenance of 
DNA methylation patterns. In the classical model the methylation system involving a maintenance 
methyltransferase DNMT1 and the de novo methyltransferases DNMT3A/B provides methylation 
fidelity at two levels: (1) De novo methylation, potentially guided by chromatin modifications, 
establishes and maintains DNA methylation states across genomic regions, which are then (2) 
maintained by faithful copying at hemimethylated CpGs of newly synthesized DNA to preserve 
previously established DNA methylation patterns. Notably, this traditional assignment of roles to 
DNMTs is not universally applicable and emerging concepts have pointed towards an involvement of 
the de novo DNMTs in DNA methylation maintenance at specific loci (Jones and Liang 2009). 
 
De Novo DNA Methylation 
The relatively well-established catalysis of de novo DNA methylation is carried out by the so-called de 
novo methyltransferases DNMT3A and DNMT3B in the presence of S-Adenosyl-L-methionine (SAM) 
(Hermann et al. 2004). A third member of the DNA methyltransferase family DNMT3L has no catalytic 
activity itself but acts as a regulatory factor in the process of DNA methylation and was shown to 
stimulate DNMT3A and DNMT3B both in vitro and in vivo (Ooi et al. 2007; Suetake et al. 2004). DNA 
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methylation patterns are mainly established during early embryogenesis, at around the time of 
implantation, through the activity of DNMT3A and DNMT3B (Law and Jacobsen 2010). The 
importance of this process was demonstrated when it was shown that a lack of de novo DNA 
methylation is incompatible with normal development and causes early embryonic lethality (Okano et 
al. 1999). Mechanistically, it is not yet fully understood how the methyltransferases are targeted and 
regulated to generate cell-type specific DNA methylation patterns during embryogenesis and germ cell 
development. It appears, however, that de novo DNA methylation can be directed by chromatin 
context and influenced by nucleosome positioning, histone modifications as well as chromatin-
associated repressor proteins (Denis et al. 2011). The hierarchical relationship between DNA 
methylation and histone modifications, however, is complex and still needs to be resolved. A current 
view is that transient downregulation of genes through histone modifications precedes induction of 
DNA methylation and, thus, that inactive genes are more susceptible to de novo DNA methylation than 
active ones (Smith and Meissner 2013). This idea is supported by studies showing that DNMT3L 
interacted with unmethylated H3K4 to enable de novo DNA methylation, but the interaction was 
strongly inhibited by the presence of the transcriptional activation mark H3K4 methylation (Ooi et al. 
2007; Y. Zhang et al. 2010b). On the other hand, the repressive chromatin mark H3K9 methylation, did 
not negatively affect de novo DNA methylation, indicating that the methylation machinery can 
discriminate between different chromatin states thus keeping transcriptionally active regions free of 
methylation. An induction of DNA methylation would then require coordinated action of a H3K4me3 
Fig. 2.3: The biological roles and consequences of DNA cytosine methylation. The methyl group on cytosine 
can induce direct as well as indirect biochemical changes to DNA that serve as molecular signals for biological 
functions via various means and determines development, physiology, and pathology of an organism. Inspired by 
(Franchini et al. 2012). 
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demethylase or nucleosome remodeler to provide a nucleosome at previously depleted regions (e.g. 
lymphoid-specific helicase (LSH) (H. Zhu et al. 2006)) and subsequent action of a H3K9 
methyltransferase (e.g. G9A) to initiate heterochromatin formation and recruitment of DNMT3A and 
DNMT3B to ensure long-term silencing (Dong et al. 2008). 
 
Maintenance DNA Methylation 
DNA methylation maintenance is a process that assures stable reproduction of DNA methylation 
patterns between cell generations. This is achieved by DNMT1 and its partner UHRF1, which copy the 
DNA methylation signature from the parental onto the daughter strand during DNA replication and 
repair. Consistently, it was found that the DNA methylation maintenance machinery prefers 
hemimethylated over unmethylated DNA (Bostick et al. 2007; Hermann et al. 2004). Intriguingly 
however, DNMT1 seems unable to maintain DNA methylation on its own as a gradual loss of 
methylation was observed in ESCs that lack DNMT3A and DNMT3B (T. Chen et al. 2003b). 
Furthermore, maintenance by DNMT1 alone might be challenging at regions with high frequency of 
5mC, possibly requiring a more complex maintenance system. In a newly emerging concept, the bulk 
of DNA methylation is still maintained by DNMT1 but at sites with higher CpG density it involves 
specific targeting and cooperation between the DNMTs. DNA methylation patterns at CGIs are 
proposed to be maintained by a template process involving DNMT1 and a stochastic process involving 
de novo methylation by DNMT3 methyltransferases (Jones and Liang 2009). Unlike DNMT1, which is 
regarded as a ‘reader’ of DNA sequences that places methyl groups at hemimethylated CpGs of newly 
synthesized DNA regardless of chromatin state, DNMT3 enzymes are anchored to nucleosomes and 
do not ‘read’ DNA but instead have a constitutive activity to methylate sites missed by DNMT1 in 
highly methylated regions (Jeong et al. 2009). The importance of proper establishment and 
maintenance of DNA methylation in embryonic development was demonstrated by studies showing 
that mice lacking either DNMT1 or DNMT3B are not viable and die during embryonic development and 
mice without DNMT3A die within a few weeks after birth (E. Li et al. 1992; Okano et al. 1999). 
 
 Biological Functions of DNA Methylation 2.3.3
Transcription control: CGIs are often associated with gene regulatory regions but nearly half of the 
identified CGIs are "orphans" that are not associated with annotated sequences (Illingworth et al. 
2010). These “orphans” behave like promoter CGIs but their function is not completely understood. 
The hypomethylated state of CGIs is believed to be mediated by transcription factor binding (Macleod 
et al. 1994). Furthermore, unmethylated CpG-rich regions are bound by CXXC finger protein 1 (CFP1), 
which recruits histone H3K4 methyltransferases to maintain these sites in an unmethylated and 
transcriptionally active state (Thomson et al. 2010). By contrast, DNA methylation at promoter regions 
has been linked to transcriptional repression. This is however not always the case and depends on the 
CpG density at gene regulatory elements. Promoters have thus been classified into three categories 
based on the CpG content; high CpG density promoters (HCPs), intermediate CpG density promoters 
(ICPs) and low CpG density promoters (LCPs) (Meissner et al. 2008). Whereas HCPs and ICPs are 
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downregulated upon methylation, LCPs remain transcriptionally active regardless of their methylation 
status (Meissner et al. 2008). Similarly to promoter regions, enhancers also have characteristic DNA 
methylation patterns and hypomethylation is associated with transcription factor binding and active 
gene expression (Stadler et al. 2011). However, as described above, dynamic gene expression 
patterns are often mediated by the short-term epigenetic memory and histone modifications. DNA 
methylation serves more to manifest and stabilize the transcriptionally silent state. 
Imprints: Genomic imprinting is a developmental process where parent-of-origin-specific gene 
expression is established. Manifestation of imprints, e.g. allele-specific DNA methylation, is 
coordinated by differential DNA methylation at cis-regulatory elements called imprinting control regions 
(ICRs). Methylation of ICRs guides downstream processes to maintain allele-specific gene clusters 
either repressed or active. Methylation at imprints is introduced during germ cell differentiation by the 
de novo DNMTs and relies on the enzymatically inactive DNMT3L (Kaneda et al. 2004). These 
established patterns are maintained throughout life; even in the zygote, where global erasure of DNA 
methylation is observed (see chapter 2.4.2), imprinted genes are protected and escape this epigenetic 
reprogramming process. Proper establishment of epigenetic imprinting patterns is crucial for 
embryogenesis and DNMT3L-deficient mice lacking maternal DNA methylation at ICRs die by 
embryonic day 10.5 (Henckel et al. 2009). 
Transposable elements: Roughly 40% of the mammalian genome is comprised of transposable 
elements of various classes (Lander et al. 2001). The three major classes are; long interspersed 
nuclear elements (LINEs), short interspersed nuclear elements (SINEs) and long terminal repeat- 
(LTRs) containing elements. LINE as well as LTR elements encode strong promoters that must be 
kept in a hypermethylated and thus repressed state because active transposable elements are highly 
mutagenic and recombinogenic; loss of DNA methylation may cause transcriptional activation and 
(retro)transposition. Furthermore, activation of retrotransposons can also deregulate the expression of 
neighboring genes by acting as enhancers or promoters (Girard and Freeling 1999). Mechanistically, 
the H3K9 methyltransferase SETDB1 appears to act prior to DNMT recruitment and DNA methylation 
is then established to reinforce and stabilize the repressed state (Karimi et al. 2011). 
Pericentromeric repeats: These elements are non-coding but show latent transcriptional activity, 
similar to transposable elements. Minor and major satellite elements extend from the centromere in 
thousands to tens of thousands of tandem copies (Lehnertz et al. 2003). Transcriptional repression 
and heterochromatization of these regions is essential for proper chromosome alignment and 
segregation during mitosis. Continued transcription of these repeats causes rearrangements in the 
vicinity of the centromeres likely due to chromosome misalignment during mitosis (Gopalakrishnan et 
al. 2009). Also this process appears to be orchestrated in a sequential manner, where H3K9 
methylation is deposited by SUV39H1, which in turn recruits DNMT3B to stably silence these regions 
(Lehnertz et al. 2003). 
X chromosome inactivation: Gene dosage control in females is obtained by random inactivation of one 
of the two X chromosomes. Early evidence suggested that DNA methylation plays a role in this 
process as treatment with the DNA demethylating agent 5-azadeoxycytidine resulted in reactivation of 
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several X-linked genes (Mohandas et al. 1981). It is, however, not entirely clear whether silencing 
precedes DNA methylation. Experimental evidence, however, indicated that de novo DNA methylation 
is again not the initiator of silencing but rather the long-term fixation of X inactivation (Lock et al. 1987). 
The current model suggests that inactivation is induced by the expression of a cis-acting non-coding 
RNA, Xist, which coats the X chromosome, followed by chromatin changes (repressive H3K9 and 
H3K27 methylation) and ultimately DNA methylation at promoter CGIs (Wutz 2011). 
 
2.4 Dynamics of DNA Methylation 
 DNA Methylation Stability/Fidelity 2.4.1
DNA methylation is an important component in the proper development of an organism and guides the 
differentiation of developmentally potent cells into any specific cell type. As development proceeds and 
cells progress in differentiation, they are directed towards their future lineages through the 
establishment of DNA methylation landscapes, which finally need to be stably maintained in the 
terminally differentiated cells. In our current understanding, bulk genomic DNA methylation is stably 
maintained within cell lineages, tissues and throughout life and includes regions that could cause 
genomic instability like repetitive elements and retrotransposons. Besides methylation of these bulk 
genomic regions, cells also need to dynamically establish specific gene expression patterns mediated 
in part by DNA methylation at gene regulatory elements. With increasing commitment, cells lose their 
plasticity and the pluripotency network is downregulated concomitant with an upregulation of cell line-
specific genes (Borgel et al. 2010). In this context, DNA methylation provides a framework and 
epigenetic barrier, which guides and restricts differentiation and prevents regression into an 
undifferentiated state (Messerschmidt et al. 2014; Seisenberger et al. 2013). Stability and heritability of 
these cell type-specific DNA methylation landscapes and gene expression patterns at given 
developmental stages is crucial for cell fate and errors could lead to aberrant cell function and a loss of 
cell identity. Regarding the extent of DNA methylation, it is likely that the fidelity of the DNA 
methylation patterns varies among different genomic regions, depending on their function reflected in 
CpG density and chromatin state. Bulk genomic regions might not need the same degree of fidelity 
and are more tolerant to stochastic errors than gene regulatory elements where even small errors 
could have a much larger impact (Schar and Fritsch 2010). In agreement with that, promoter-
associated CGIs were found to be more effectively protected from de novo DNA methylation than 
CGIs outside promoter regions (Ushijima et al. 2003). It appears that a constant methylation pressure 
sets and maintains the genome in a highly methylated state, at promoter-associated CGIs and other 
gene regulatory elements, however, supplementary mechanisms have evolved to keep them 
methylation free and in an active or transcription-poised state. Fidelity of DNA methylation patterns 
thus seems to be generally higher in regions that are more dynamically regulated and important for 
progression of development. 
Loss of methylation fidelity in somatic tissues leads to epigenetic instability, which is associated with 
disease development. Unscheduled epigenetic changes correlate with cellular ageing and alterations 
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in the distribution and levels of 5mC can be found in most, if not all, cancers. Cancer epigenomes are 
often characterized by genome-wide DNA hypomethylation accompanied by hypermethylation of CGI 
containing gene promoters (Jones and Baylin 2002). Extensive DNA hypomethylation leads to a loss 
of cell identity and can be associated with an increased developmental potency (see chapter 2.4.2), 
which is in part reflected in the renewing and growth potential of cancer cells and tumors. The range of 
diseases associated with epigenetic alterations and particularly with dysregulated DNA methylation 
expands beyond cancer as exemplified by imprinting disorders (e.g. loss of imprinting (LOI), Prader-
Willi syndrome (PWS)), repeat-instability diseases (e.g. fragile X syndrome (FRAXA), 
facioscapulohumeral muscular dystrophy) and others (K. D. Robertson 2005). 
 
 Resetting DNA Methylation Patterns 2.4.2
Despite the robust mechanisms of establishment and maintenance of DNA methylation patterns, DNA 
methylation does not under all circumstances represent a static epigenetic modification but is also 
subject to dynamic regulation. Dynamic regulation, however, implicates the existence of mechanisms 
of DNA demethylation. To what extent and under what conditions such mechanisms operate to 
dynamically regulate DNA methylation patterns is not yet fully understood. DNA demethylation has 
been observed to occur at specific loci in differentiated cells as well as on a global scale during early 
embryonic development (Fig. 2.4). It is believed that epigenetic reprogramming, including large scale 
erasure of DNA methylation, is closely associated with cell fate transition and restoration of 
developmental potency (Seisenberger et al. 2013). In the mouse model, widespread erasure of DNA 
methylation has been detected in the zygote immediately after fertilization and again in the 
establishment of the primordial germ cells (PGCs) which are the direct progenitors of sperm and 
oocytes (Messerschmidt et al. 2014; Seisenberger et al. 2013; Smith and Meissner 2013). 
DNA demethylation in PGCs: PGCs are derived from the epiblast, which is already directed towards 
somatic lineages. At early stages of mouse embryogenesis (E6.5), these progenitors show 
characteristics in DNA methylation, chromatin modification and gene expression profiles that are very 
similar to their somatic origin (i.e. pluripotency and germline-specific genes are tightly repressed by 
DNA methylation). Until E12.5-E13.5, however, DNA methylation virtually disappears in both parental 
genomes, imprints are erased and the X chromosome is reactivated in the female progenitors. Most 
recent studies have revealed that this global loss of DNA methylation occurs in two distinct phases 
involving both passive and active mechanisms (Seisenberger et al. 2012; Yamaguchi et al. 2013). In 
the first phase, beginning at around E8.0, bulk DNA methylation is lost indiscriminately, most likely 
through passive dilution due to a downregulation of the DNA methylation machinery (Kagiwada et al. 
2012; Seisenberger et al. 2012). Regions that escape this first wave of passive DNA demethylation 
including imprints, germline-specific genes and CGIs on the inactive X chromosome are then affected 
in the second phase of DNA demethylation. Demethylation at these sites appears to require active 
triggering by modifying 5mC (Hackett et al. 2013; Vincent et al. 2013; Yamaguchi et al. 2013) (putative 
mechanisms are discussed in detail in chapter 2.5). After the extensive loss of DNA methylation, both 
genomes undergo de novo DNA methylation. Interestingly, the extent of re-methylation seems to be 
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different for male and female germ cells, with sperm showing a highly methylated genome (~85% CpG 
methylation), while oocytes are only moderately methylated (~ 30% CpG methylation) (Seisenberger 
et al. 2013; Smallwood et al. 2011; Smith et al. 2012). 
DNA demethylation in early embryos: The newly established DNA methylation patterns in sperm and 
oocyte are reprogrammed again in the zygote shortly after fertilization. This second wave of global 
DNA demethylation is, however, not as widespread as in PGCs and at some regions, including 
imprinted loci, some retrotransposons and centromeres, DNA methylation patterns are retained. Here 
DNA demethylation includes genomic regions important for maintaining pluripotency, which are 
silenced in germ cells but needed in the early stages of development. Paternal and maternal genomes 
follow different DNA demethylation kinetics; whereas in the paternal pronucleus the methylation signal 
is lost rapidly after fertilization, the maternal genome undergoes a more gradual loss of DNA 
methylation (Santos et al. 2002; Santos and Dean 2004; Wossidlo et al. 2010) (mechanisms 
discussed in chapter 2.5). New methylation marks are acquired during and following implantation of 
the embryo when there is extensive de novo DNA methylation covering up to roughly 70% of all CpGs 
(Lepikhov et al. 2010; Morgan et al. 2005).  
For either of the DNA demethylation events, the biological reasons remain incompletely understood 
but for both situations the reprogramming assures that epigenetic traits from previous generations are 
not carried over onto newly developing organisms. An erasure of epigenetic memory may also 
increase epigenetic plasticity to facilitate the major changes in transcriptional programs that are 
associated with the reestablishment of developmental potency (Seisenberger et al. 2013). The 
extensive reprogramming could also serve as an opportunity to correct accumulated epimutations at 
the generational boundary and hence ensure that future phenotypes are not affected by events in the 
past. In the context of these reprogramming processes, recent evidence suggested that both passive 
Fig. 2.4: DNA methylation dynamics in the mammalian lifecycle. Two major waves of DNA demethylation are 
observed in the mouse germline. The first, in the early embryo until the blastocyst stage (E3.5), affects both the 
paternal (blue) and maternal (orange) genome. Methylation is lost again in the primordial germ cells (PGCs) 
between E6.5 and E13.5 as they emerge from the epiblast. dpc, days post coitum; PPN, paternal pronucleus; 
MPN, maternal pronucleus, TE, trophoectoderm; PE, primitive endoderm; ICM, inner cell mass; PGC, primordial 




and active DNA demethylation mechanisms are involved and different pathways may operate 
sequentially or in parallel in order to obtain such a widespread but controlled loss of DNA methylation 
(Guibert et al. 2012; Kawasaki et al. 2014; Seisenberger et al. 2012; Smith et al. 2012; Smith et al. 
2014) (see chapter 2.5). 
DNA demethylation in somatic cells: Dynamic epigenetic changes can also be observed post 
developmentally in somatic cells at specific loci, mostly upon nuclear- or hormone-receptor activation 
of gene promoters (Jost et al. 1991; Kangaspeska et al. 2008; M. S. Kim et al. 2009b; Kress et al. 
2006; Lucarelli et al. 2001; Metivier et al. 2008; Saluz et al. 1986; Thomassin et al. 2001; Wilks et al. 
1982). In contrast to global epigenetic reprogramming that occurs during early development, these 
rapid site-specific DNA demethylation events do not occur to erase parental marks but rather function 
in the dynamic regulation of gene transcription to allow rapid response to specific stimuli. Here, the 
DNA demethylation process occurs independent of cell division and is believed to be an active 
process. Considering this, the CpG methylation levels at such sites appear to reflect rather a steady-
state than a stable condition, a dynamic equilibrium that can shift depending on the requirements of 
the cell. The underlying mechanisms of active DNA demethylation are still a matter of debate but 
major advances have been made in this regard recently and will be discussed in chapter 2.5. 
 
 Breaking DNA Methylation Patterns 2.4.3
The epigenetic marks that are acquired during development and differentiation restrict the cell’s 
lineage potential and they become increasingly committed. This process is thought to be unidirectional 
in mammals, meaning that differentiated cells generally do not switch fates and epigenetic marks are 
stably passed on during mitosis, restricting cellular plasticity of the following cell generation. However, 
the remarkable epigenetic stability of differentiated cells in vivo can be circumvented and reversed in 
vitro by nuclear transfer (SCNT), cell fusion and induced pluripotent stem cell (iPSC) technology 
(Jullien et al. 2011; J. Xu et al. 2015; Yamanaka and Blau 2010). These approaches are capable of 
breaking the stable epigenetic state of differentiated cells by simulating the physiological processes of 
early development, leading to altered patterns of gene expression and to an induction of pluripotency. 
Apparently, it is sufficient to provide 4 key pluripotency factors Oct4, Sox2, Klf4 and Myc (OSKM) to 
reprogram a cell towards an induced pluripotent stem cell (iPSC) (Takahashi et al. 2007). Since the 
initial description of iPSCs, many cell types have been reprogrammed using a variety of 
reprogramming factors (J. Xu et al. 2015). This indicates that cells, no matter how committed, retain a 
certain degree of plasticity and established epigenetic barriers in terminally differentiated cells can be 
overcome. The fact that epigenetic reprogramming can be induced principally in any cell type indicates 
that potent processes capable of actively modulating the epigenome exist, particularly in early 
development and are strongly associated with pluripotency. These advances in epigenetic 
reprogramming provide a valuable opportunity to generate pluripotent stem cells from adult cells of the 
same individual that can be suitable for various applications. 
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So far the understanding of the molecular mechanisms underlying nuclear reprogramming are 
incomplete and it remains unclear to what degree it is a deterministic or stochastic process (Jullien et 
al. 2011). Although some parts of the epigenome can be deterministically and efficiently 
reprogrammed under the proposed conditions, other regions seem resistant to these programs and 
the epigenetic stability is sustained throughout the process. To break such a blockage and allow full 
reprogramming, stochastic processes may be required in addition that depend on random access of 
the involved factors to their targets spread throughout the genome. If and how DNA demethylation of 
target CGIs in promoter regions is mediated to reactivate gene expression is also still unclear, but 
evidence points towards an active DNA demethylation pathway (Simonsson and Gurdon 2004) and 
DNA demethylation seems to be a limiting step in reprogramming towards iPS cells (Mikkelsen et al. 
2008). 
 
2.5 DNA De-Methylation 
The most recent advances in DNA methylation dynamics suggest that different mechanisms operate 
sequentially or in parallel to achieve genome-wide as well as locus-specific DNA demethylation. In 
both genome-wide reprogramming events it is widely accepted that the bulk of the genomic DNA 
methylation is erased passively (Kohli and Zhang 2013; Lee et al. 2014; H. Wu and Zhang 2014). 
Active mechanisms however may still operate as rapid inducers of DNA demethylation at specific loci 
and the current evidence points towards a prominent involvement of DNA repair pathways like NER or 
the BER pathway in these processes. Several lines of experimentation revealed a generation and 
repair of DNA strand breaks in the course of DNA demethylation (Barreto et al. 2007; Hajkova et al. 
2010; Kress et al. 2006; Le May et al. 2012; Wossidlo et al. 2010), indicating a strand incision process 
potentially initiated by a DNA glycosylase or a repair associated endonuclease as discussed in detail 
in chapter 2.2.1. It is thus not surprising that proposed DNA demethylation pathways often, but not 
always, involve DNA repair. In the following section an overview of putative DNA demethylation 
scenarios will be given, ranging from very early observations to the most recent and promising 
pathways still being discussed today. 
 
 Scenarios of Active DNA Demethylation 2.5.1
Direct Reversal of DNA Methylation 
Probably the most direct way to achieve DNA demethylation is to directly remove the methyl group by 
an enzymatic activity capable of breaking the rather strong C-C bond (Fig. 2.5 A). This energetically 
unfavorable reaction involving no cofactors other than water was proposed to be carried out by MBD2, 
a methyl CpG-binding protein (Bhattacharya et al. 1999). So far, however, this activity could not be 
reproduced and the results have been contested (Bird 2002). Furthermore, MBD2 knockout mice are 
viable and fertile and show no abnormalities in the pattern of genomic DNA methylation (Hendrich et 
al. 2001). Another enzymatic activity potentially capable of directly reverting DNA methylation is the 
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repair machinery for alkylation damages. Reversal of alkylation damage (1-methyladenine, 1mA and 
3-methylcytosine, 3mC) in mammals is achieved by the AlkB homologs ABH2 and ABH3 employing an 
oxidative mechanism, where the methyl group is oxidized and subsequently released from the base as 
free formaldehyde (Duncan et al. 2002) (Fig. 2.5 B). Although the C-C bond in 5mC is energetically 
more difficult to break than the C-N bond in 1mA and 3mC, it still remains possible that a novel type of 
oxidase could directly demethylate 5mC by an oxidative mechanism. Recent studies identified 
structurally related dioxygenases, the TET proteins, which can directly act on 5mC. They however do 
not revert the DNA methylation directly but oxidize the methyl group to generate new 5mC derivatives 
(see chapter 2.5.2). 
 
Direct 5mC Removal by DNA Glycosylases 
More than 20 years ago, an enzymatic activity was discovered in extract of chicken embryos that was 
capable of excising 5mC from a DNA substrate (Jost 1993) (Fig. 2.5 C). At around the same time, the 
enzymatic removal of 5mC in HeLa cell nuclear extracts was reported and proposed to be mediated by 
a DNA glycosylase (Vairapandi and Duker 1993). A 5mC demethylation activity was also found in 
differentiating mouse myoblasts between the 3rd and 5th day of differentiation (Jost and Jost 1994) and 
an active, DNA glycosylase-initiated, demethylation mechanism was suggested (Jost et al. 1995). The 
5mC DNA glycosylase activity in developing chicken embryos was then attributed to TDG and 
recombinant protein showed 5mC glycosylase activity in vitro (B. Zhu et al. 2000b). The same activity 
was also shown to be present in recombinant human MBD4 glycosylase (B. Zhu et al. 2000a). 
However, recombinant TDG and MBD4 show 30-40 fold lower activity on G∙5mC than on G/T 
mismatch substrates in vitro (B. Zhu et al. 2000b; B. Zhu et al. 2000a) and this activity still remains to 
be reproduced independently. It is thus questionable whether TDG and MBD4 are reliable and efficient 
5mC DNA glycosylases. It could recently, however, be shown that a fusion of TDG with a sequence-
specific DNA binding domain can induce DNA demethylation and transcription of targeted genes 
(Gregory et al. 2012), though it is not clear if TDG was directly responsible for 5mC removal or if other 
factors were involved as well. Still, it is an interesting indication that targeting of DNA glycosylases to 
the right places might facilitate DNA demethylation. Knockout of the two DNA glycosylases MBD4 and 
TDG gave somewhat of a variable outcome. MBD4 knockout mice are viable and fertile and do not 
show aberrant DNA methylation but rather increased mutability (Millar et al. 2002). In agreement with 
that, global DNA demethylation of the paternal pronucleus in zygotes does not seem to rely specifically 
on MBD4 (Santos and Dean 2004). In contrast to MBD4, a TDG knockout in mouse causes embryonic 
lethality around E11.5, likely owing to developmental defects caused by epigenetic aberrations as 
discussed in chapter 2.2.2. In addition, there is indication that TDG plays a role in demethylation of 
imprinted genes in PGCs (Cortellino et al. 2011). Apparently, the catalytic functionality of TDG is 
required for its role in DNA demethylation as the knock-in of the catalytic mutant (N151A) has the 
same severe phenotype (Cortellino et al. 2011). Despite this strong experimental evidence, it remains 
doubtful that the role of TDG is to directly act as a DNA demethylase due to a lack of biochemical 
evidence supporting such a glycosylase activity. The existence of a DNA glycosylase initiated DNA 
demethylation mechanism is, however, well accepted and supported by strong genetic and 
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biochemical evidence in plants. In Arabidopsis thaliana active DNA demethylation is achieved by BER 
of 5mC initiated by the DNA glycosylases ROS1 and DEMETER (Choi et al. 2002; Gong et al. 2002). 
In mammals, the mechanism appears to be more sophisticated and relies on additional 5mC modifiers 
that render the base more susceptible to DNA damage repair and thereby triggering DNA 
demethylation. 
 
Deamination-coupled Removal of 5mC by Base Excision Repair 
An alternative mechanism to direct 5mC excision by DNA glycosylases is through deamination of 5mC 
to T, which generates a G/T mismatch (Fig. 2.5 D). In this case, TDG or MBD4 might again contribute 
to the DNA demethylation process. Both, cytidine deaminases and DNMTs have been proposed to 
catalyze the deamination step in this process. AID and apolipoprotein B mRNA editing enzyme, 
catalytic polypeptide 1 (APOBEC1) were shown to have weak 5mC deaminase activity in vitro, 
resulting in G/T mismatches, though these enzymes were shown to have a strong preference for 
single-stranded DNA (Morgan et al. 2004). More recent evidence, however, contested the deamination 
capacity of AID and APOBEC on 5mC and both enzymes showed a clear preference for unmodified C 
in vitro (Larijani et al. 2005; Nabel et al. 2012; Rangam et al. 2012). Still, studies in Zebrafish embryos 
suggested a potential coupling of a deaminase with a DNA glycosylase in the context of DNA 
demethylation (Rai et al. 2008); overexpression of AID and MBD4 together triggered demethylation of 
the bulk genome and injected methylated DNA fragments whereas overexpression of either protein 
alone had no effect. Thus, AID and MBD4 were suggested to be functionally coupled and their 
overexpression can demethylate DNA via a detectable G/T intermediate (Rai et al. 2008). 
It also appears noteworthy that the genes encoding AID and APOBEC1 are both located within a 
cluster of pluripotency genes including NANOG and STELLA and are expressed in mouse oocytes, 
embryonic germ cells and ESCs, in line with a function associated with a pluripotent cell state (Morgan 
et al. 2004). Consistently, AID was shown to contribute to genome-wide DNA demethylation in mouse 
PGCs, but DNA methylation levels are also drastically reduced to below 20% by E13.5 in the absence 
of AID (Popp et al. 2010) implicating a prominent involvement of other pathways as well. This is 
supported by studies showing that AID knockout mice do not show major developmental defects and 
are viable and fertile (Muramatsu et al. 2000); APOBEC1 knockout mice are also viable and fertile 
(Morrison et al. 1996). The deaminases might however have a functional overlap and only a double 
knockout could further elucidate the importance of a cytidine deaminase in active DNA demethylation 
and epigenetic reprogramming. In addition, deamination of a symmetrical CpG dinucleotide 
(methylated or not) could give rise to a double mismatch and biochemical evidence that either of TDG 
or MBD4 possesses such a processing activity is lacking so far. Most recent findings suggested that 
global DNA demethylation in PGCs occurs in two distinct phases (Seisenberger et al. 2012), where the 
first and more extensive one is believed to occur mostly passive by inactivation of the DNA 
methylation machinery. Specific sequences escaped this process until the beginning of the second 
wave of DNA demethylation that appeared to occur more targeted, and AID could possibly have a role 
in this second phase of active DNA demethylation. Additional evidence for a putative involvement of 
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AID in active DNA demethylation came from reprogramming studies, where somatic cells were fused 
to ESCs to induce nuclear reprogramming and restore pluripotency (Bhutani et al. 2009). In these non-
dividing heterokaryons, AID contributed to locus-specific active DNA demethylation of the OCT4 and 
NANOG promoter and was required for epigenetic reprogramming of somatic cell nuclei (Bhutani et al. 
2009). AID also appeared to stabilize reprogramming of somatic cells using the iPSC approach by 
aiding DNA demethylation of pluripotency genes (Kumar et al. 2013). Interestingly, it is now also 
hypothesized that AID-mediated DNA demethylation is not necessarily induced by the deamination of 
5mC but rather deamination of C to U in methylated regions, followed by subsequent LP-BER initiated 
by the Uracil-DNA glycosylase UNG2 instead of TDG (Franchini et al. 2014; Santos et al. 2013; D. Wu 
et al. 2014). This pathway could allow removal of several methylated CpG sites in close proximity 
using only a single repair event and thereby also reduce the genotoxic potential. Another non-
enzymatic factor, Gadd45a, was suggested to play a role and serve as a scaffold to couple AID and 
MBD4 (Rai et al. 2008), AID and TDG (Cortellino et al. 2011) or assist in a NER (see below) 
dependent DNA demethylation pathway (Barreto et al. 2007). However, a functional role of Gadd45a 
in DNA demethylation could not be substantiated upon overexpression in human cells (Jin et al. 2008) 
and global as well as locus-specific DNA hypermethylation was not observed in Gadd45a-deficient 
mice (Engel et al. 2009).  
Another DNA demethylation process coupling deamination with base excision has been proposed for 
DNMT3A/B and TDG. Initial evidence that methyltransferases could have deamination activity was 
found in bacteria, where they were shown to actively deaminate C and 5mC under suboptimal reaction 
conditions, i.e. when the concentration of their essential cofactor SAM is too low (J. C. Shen et al. 
1992; Yebra and Bhagwat 1995). The mammalian methyltransferases DNMT3A/B, which commonly 
catalyze de novo DNA methylation, have also been shown to deaminate C and 5mC to U and T, 
respectively, in the absence of SAM (Metivier et al. 2008). Consistent with a functional cooperation, 
DNMT3A or DNMT3B were also shown to interact physically with TDG and stimulate its enzymatic 
activity (Boland and Christman 2008; Y. Q. Li et al. 2007). Furthermore, the recruitment of DNMT3A/B 
together with TDG and other BER factors to transcriptionally stimulated gene promoters coincided with 
cyclical, replication-independent, DNA methylation and demethylation processes at these sites (e.g. 
pS2 gene) (Kangaspeska et al. 2008; Metivier et al. 2008). This indicates a potential functional liaison 
of the deamination activity of DNMTs and the G/T, G/U processing activity of TDG to achieve locus-
specific DNA demethylation. However, this mechanism would require that SAM levels also rapidly 
cycle in vivo to achieve 5mC deamination by DNMT3A/B. It is difficult to imagine that this is possible 
without biological consequences, given that SAM is also involved in many other essential biochemical 
processes. Alternatively, the TDG-DNMT3A/B interaction may simply ensure recruitment and targeting 
of the glycosylase to methylated DNA, where it exhibits a protective function by preventing C to T 
mutations caused by spontaneous deamination of 5mC (Boland and Christman 2008; Y. Q. Li et al. 
2007). The incorporated C could then quickly be re-methylated by the DNMT3s to maintain the 
methylated state. This would also enable and facilitate a dynamic regulation of methylation states, 




Nucleotide Excision Repair initiated 5mC Removal 
Another DNA repair pathway implicated in active DNA demethylation is NER that could erase 5mC by 
repairing short genomic regions containing methylated Cs (Fig. 2.5 E). In HeLa cells, NER factors 
have been shown to sequentially assemble at gene promoters upon gene activation even in absence 
of exogenous genotoxic attack (Le May et al. 2010). A differential role of the NER machinery present 
at gene promoters and at more distal gene regions has been proposed, where the former is 
functionally coupled to transcription and proper DNA demethylation. Consistently, it could be shown 
that transcriptional activation of RARβ2 leads to XPG-induced DNA breaks and DNA demethylation at 
the promoter region, suggesting an involvement of NER (Le May et al. 2012). NER was previously 
associated with active DNA demethylation in combination with Gadd45a as mentioned before. 
Gadd45a was identified in a screen for cDNAs, which activate expression of a methylation-silenced 
reporter gene, and proposed to directly interact with the NER endonuclease XPG (Barreto et al. 2007). 
Transfection of Gadd45a in cultured cells led to DNA demethylation by recruiting the DNA repair 
machinery to specific sites and a reduction in global DNA methylation, whereas knockdown of 
Gadd45a as well as XPG led to a global increase of 5mC (Barreto et al. 2007). These results were 
contested and a functional role of Gadd45a in DNA demethylation could not be substantiated upon 
overexpression in human cells as mentioned above (Jin et al. 2008). However, it has been shown that 
Fig. 2.5: Illustration of possible active DNA demethylation scenarios. (A) Hydrolytic release of the methyl 
group as methanol. (B) Direct reversal of methylation using an oxidative mechanism. (C) Release of 5mC by a 
DNA glycosylase, the predominant mechanism in plants. (D) 5mC deamination followed by G/T mismatch repair. 
(E) Excision of multiple nucleotides using NER. Details of these mechanisms can be found in the main text. 
Inspired by (J. K. Zhu 2009) 
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Gadd45a is associated with active rDNA repeats and knockdown of Gadd45a or components of the 
NER machinery led to increased promoter methylation (Schmitz et al. 2009). 
 
 TET-initiated DNA Demethylation 2.5.2
The search for a biological activity that could potentially trigger DNA demethylation by modifying 5mC 
was motivated by two pathways involved in oxidative modification of T. The first involves biosynthesis 
of the „Base J“ in the genome of the parasite Trypanosoma brucei and the other the conversion of free 
T to U in the pyrimidine salvage pathway. „Base J“, the trivial name for β-D-  glucosyl-
hydroxymethyluracil, is a modified T, functions in transcriptional regulation and is generated in a two-
step process. A T in the context of genomic DNA is first oxidized to 5hmU by the J-binding proteins 
(JBP) 1 or 2; the addition of a glucose to 5hmU by a glycosyltransferase then completes biosynthesis 
of Base J (Borst and Sabatini 2008). JBP1/2 are members of Fe(II)/α-ketoglutarate (α-KG)-dependent 
dioxygenase family of enzymes. Another member of this family, Thymine-7-hydroxylase (THase), also 
acts on T to generate 5hmU but rather on the free base and not in the context of DNA. 5hmU is then 
iteratively further oxidized to 5-formyluracil (5fU) and 5-carboxyluracil (5caU) (Liu et al. 1973). The 
isoorotate decarboxylase finally completes the T to U conversion through decarboxylation of 5caU 
(Smiley et al. 2005). 
A large bioinformatics screen for mammalian paralogues of JBP1/2 finally led to the discovery of the 
TET family of proteins (Tahiliani et al. 2009). The family consists of 3 members, TET1-3, sharing a 
conserved catalytic core comprised of a cysteine-rich region followed by a double-stranded β helix 
(DSβH) region (Tahiliani et al. 2009). TET1 and TET3 contain an N-terminal CXXC domain, enabling 
DNA binding and specific recognition of CpG dinucleotides. TET2 was separated from its CXXC 
domain during evolution (Ko et al. 2013). The IDAX protein that was originally encoded within an 
ancestral TET2 gene was then shown to physically and functionally interact with TET2 (Ko et al. 
2013). The three TET proteins display different expression patterns during development and across 
tissues (Ito et al. 2010). TET1 and TET2 are highly expressed in mouse ESCs and both are present in 
PGCs albeit not at the same level (Hackett et al. 2013; Wossidlo et al. 2011; Yamaguchi et al. 2012). 
TET3 appears neither in ESCs nor PGCs but is the only TET enzyme present in mouse oocytes and 
one-cell zygotes (Iqbal et al. 2011; Wossidlo et al. 2011). Moreover, TET3 but also TET2 are more 
broadly expressed in various tissues compared to TET1 (Ito et al. 2010). In contrast to the above 
described Fe(II)/α-KG-dependent dioxygenase family members, the TET proteins were suggested to 
act on 5mC rather than T bases in DNA. Indeed, it was found that overexpression of TET1 led to a 
reduction of 5mC in genomic DNA and purified TET enzymes converted 5mC in oligonucleotides to 
5hmC through oxidation (Ito et al. 2010; Tahiliani et al. 2009). The similarity between oxidation of T by 
the THase and oxidation of 5mC has raised the question if the TET proteins could also mediate 
iterative oxidation of 5mC beyond 5hmC. Although a first attempt to verify the presence of these 5mC 
oxidative derivatives in genomic DNA was unsuccessful (Globisch et al. 2011), they could eventually 
be detected in ESCs under physiological conditions (He et al. 2011; Ito et al. 2011; Pfaffeneder et al. 
2011) and the generation of 5fC and 5caC by TET was shown in vitro (He et al. 2011; Ito et al. 2011). 
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Recent structural studies provided first insight into the putative mechanism of 5mC oxidation. 
Seemingly, the enzyme flips the 5mC out of the DNA double helix into its catalytic pocket where it is 
stabilized by hydrogen bonds. Importantly, the cysteine-rich DNA binding domain of the human TET2 
catalytic domain also played a role in stabilizing the DSβH, forming a compact structure (Hashimoto et 
al. 2014; Hu et al. 2013). It is, however, still unclear if the TET enzymes operate in a continuous 
processive or a distributive way for the three successive oxidation steps. Notably, 5hmC, 5fC and 
5caC are chemically distinct cytosine modifications that pair normally with G, have no mutagenic 
potential and are found at different levels in the mammalian genome (Inoue et al. 2011; Ito et al. 2011; 
Pfaffeneder et al. 2011). Although little is known about the biological implications of these 
modifications, these oxidized 5mC derivatives extend the previously accepted bimodal state of 
cytosine modifications to five distinct states in the mammalian genome (H. Wu and Zhang 2014). 
Oxidation of the C5-substituent leads to altered steric as well as electron density properties, opening 
up new potential ways of TET-initiated DNA demethylation. Three main possibilities for DNA 
demethylation following 5mC oxidation were suggested and will be discussed in detail below; (i) 
passive dilution of 5mC oxidized derivatives, (ii) direct removal of the oxidized C5-substituent and (iii) 
excision of the modified nucleotide mediated by DNA repair (Fig. 2.4). 
Regulation of TET-initiated DNA demethylation could be provided on various levels, that remain 
incompletely understood. For example, little is known about the substrate preference of the TET 
proteins; interestingly, it appears that the rate of initial oxidation from 5mC to 5hmC is significantly 
higher than that of oxidizing 5hmC or 5fC (Hashimoto et al. 2014; Ito et al. 2011), indicating some 
discrimination between oxidative states. Notably, the methyl group of 5mC is not involved in the TET2-
DNA interaction and it remains to be clarified if TET proteins have distinct affinity for any of the C 
derivatives (Hu et al. 2013). For the catalysis of 5mC oxidation, TET enzymes require several 
supplements including oxygen, Fe(II) and α-KG and regulation of TET activity might also occur at the 
level of metabolites and cofactors. α-KG is produced primarily by the isocitrate dehydrogenases 
(IDHs) in the tricarboxylic acid (TCA) cycle. Mutations in IDH can result in accumulation of 2-
hydroxyglutarate (2-HG) at the expense of α-KG, which competitively inhibits the TET enzymes and 
leads to DNA hypermethylation (Figueroa et al. 2010; Kaelin and McKnight 2013). Furthermore, 
ascorbic acid was shown to stimulate the catalytic activity of TET proteins by directly interacting with 
the catalytic domain and facilitating conformational changes or by recycling the cofactor Fe(II) (Yin et 
al. 2013). In mouse ESCs, providing ascorbic acid greatly enhanced TET activity leading to 
significantly higher levels of 5mC oxidation and a blastocyst like methylome (Blaschke et al. 2013). 
Genomic targeting, probably mediated by the N-terminal domain (including the CXXC domain) of the 
protein, might also play an essential role in the regulation of TET activity. Genome-wide analysis 
revealed that TET1 preferentially localized to unmethylated CpG rich regions in ESCs (K. Williams et 
al. 2011; H. Wu et al. 2011) and also IDAX (and TET2 alongside) was shown to be enriched at 
unmethylated CpG sequences (Ko et al. 2013). The CXXC domains of the TET proteins, however, do 
not restrict the protein to localize to unmethylated regions (Y. Xu et al. 2011; Y. Xu et al. 2012; H. 
Zhang et al. 2010a) and may thus have increased flexibility in targeting the TET proteins to genomic 
loci to be regulated. Given the differential expression patterns of the TET proteins during development 
and across tissues, TET expression might also be regulated posttranscriptionally by microRNAs. 
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Indeed, the microRNA miR-22 was recently shown to negatively regulate TET protein levels in breast 
cancer development and hematopoietic stem cell transformation (S. J. Song et al. 2013b; S. J. Song et 
al. 2013c). Another microRNA miR-29 also appeared to directly regulate TET1-3 mRNA levels, thus 
indirectly affecting DNA methylation levels (P. Zhang et al. 2013). 
 
TET-mediated DNA Demethylation Pathways 
Passive dilution: Symmetrically modified CpG dinucleotides are generally maintained in the fully 
methylated state by the maintenance DNA methylation system (DNMT1/UHRF1), thus preserving DNA 
methylation patterns through cell divisions as discussed in chapter 2.3.2. A process similar to the 
passive dilution of 5mC might also be employed or even facilitated by TET-mediated oxidative 
modification. In vitro evidence supported such a scenario and UHRF1 was shown to bind hemi-5hmC 
ten-fold less efficiently than hemi-5mC modified DNA (Hashimoto et al. 2012b). In addition, the activity 
of recombinant DNMT1 was up to 50-fold reduced at these hemi-modified sites (Hashimoto et al. 
2012b). Whether hemi-modified CpGs carrying a 5fC or 5caC also impair DNMT1 activity is currently 
not known, but the low abundance of these modifications indicates that they are rather short-lived and 
passive dilution might only play a minor role in the removal of these modifications. Interestingly, in vitro 
methylase activity of DNMT3A/B on hemi-modified 5mC and hemi-modified 5hmC DNA was 
comparable (Hashimoto et al. 2012b) and DNMT3A/B could potentially take over a maintenance 
function in cells with high TET activity to prevent passive dilution of oxidized 5mC derivatives. In 
contrast to non-enzymatically induced passive loss of 5mC, preceding oxidation of 5mC followed by 
passive dilution might not be regarded as genuinely passive but rather active-passive (Kohli and 
Zhang 2013). This kind of passive dilution may be effective even in the presence of maintenance DNA 
methylation and provides an alternative way to reduce DNA methylation levels. 
Direct removal of C5-substituents: Whereas for 5mC the direct removal of the methyl group is 
energetically highly unfavorable, oxidation of the C5-substituent may render such a reaction more 
feasible. In bacteria for example, 5hmC is directly converted to C by bacterial methyltransferases 
(M.HpaII, M.SssI, M.AluI) (Liutkeviciute et al. 2009). Such an activity was also attributed to all three 
mammalian DNMTs, observed to directly convert 5hmC to unmodified C in vitro (C. C. Chen et al. 
2012). Apparently the function of DNMT3A can be regulated by the redox status; while reducing 
conditions favor the methyltransferase activity, the dehydroxymethylation is active under oxidizing 
conditions (C. C. Chen et al. 2012). The validity and physiological relevance of such a mechanism is 
currently not clear but it is an interesting observation. Analogous to the thymidine salvage pathway, 
the unmodified state might be obtained through deformylation of 5fC and decarboxylation of 5caC. 
There is in fact experimental evidence for a decarboxylase activity in ESC lysates (Schiesser et al. 
2012) but the protein responsible for 5caC decarboxylation needs yet to be identified. 
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Excision of the modified nucleotide: A likely and widely accepted scenario is the engagement of DNA 
repair downstream of 5mC oxidation to revert the base modification. An interesting side note here is 
that the plant 5mC glycosylases; DME and ROS1, also have a significant 5hmC excision activity in 
vitro, although 5hmC does not appear to be present in Arabidopsis (Jang et al. 2014). Early studies 
showing in vitro evidence of a mammalian 5hmC glycosylase activity in calf thymus extract (Cannon et 
al. 1988) were never reproduced substantiating that DNA glycosylase mediated DNA demethylation 
pathways differ between plants and animals. After the discovery of TET proteins and the oxidized C 
derivatives, the role of TDG in DNA demethylation was revisited and it could indeed be shown that 5fC 
as well as 5caC are specifically recognized and excised by TDG but not by UNG2, SMUG1 or MBD4 
in vivo and in vitro (He et al. 2011; Maiti and Drohat 2011; L. Zhang et al. 2012). The molecular basis 
for this unusual activity of TDG, which otherwise prefers mismatched bases, lies in the stability of the 
N-glycosidic bond, which was previously shown to have a major effect on the catalytic efficiency of 
TDG (Bennett et al. 2006; Hardeland et al. 2000). Oxidation of 5mC weakens the N-glycosidic bond 
and stabilizes the transition state of the glycosylase reaction (R. T. Williams and Wang 2012) thus 
enabling efficient base excision. In addition, it could be shown that residues in the active site of TDG 
engaged in additional molecular interactions with 5fC and particularly 5caC, mediating efficient 
recognition of these base modifications (Hashimoto et al. 2012a; L. Zhang et al. 2012). Seemingly, 5fC 
can also alter the structure of the DNA helix, an attribute that is usually related to faulty base 
modifications and thereby facilitate initial base recognition and initiation of BER (Raiber et al. 2015). 
Fig. 2.6: TET-initiated DNA demethylation. Three main possibilities for DNA demethylation following 5mC 
oxidation were suggested; (i) passive dilution of 5mC oxidized derivatives (ii) direct removal of the oxidized C5-
substituent by either dehydroxylation, deformylation or decarboxylation and (iii) excision of the modified nucleotide 
mediated by DNA repair. Another possibility is 5mC oxidation followed by deamination and DNA repair. Details in 
the main text. 
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Although there is yet no biochemical evidence that another DNA glycosylase acts on the TET-oxidized 
5mC derivatives, a recent study showed that in the absence of TDG the NEIL glycosylases could 
partially reactivate reporter gene expression in ES cells (Muller et al. 2014). They hypothesized but did 
not show that the NEIL glycosylases can also initiate DNA demethylation via BER after TET-mediated 
C oxidation by direct excision of 5fC and 5caC. 
5hmC could potentially also be deaminated to generate 5hmU, a base modification that is readily 
detected and excised by TDG as well as SMUG1 (Jacobs and Schar 2011), opening up the possibility 
of a coupled oxidation-deamination pathway with 5hmC as a key intermediate to remove 5mC. It could 
indeed be shown that AID/APOBEC deaminases specifically promoted 5hmC removal and did not 
have a significant effect on 5mC (Guo et al. 2011) and that expression of TET1 resulted in a significant 
amount of 5hmU in HEK293 cells (Guo et al. 2011). 5hmU, however, does not necessarily originate 
from deamination of 5hmC but might also be generated through oxidation of T by TET1 itself 
(Pfaffeneder et al. 2014) and could thus be an artefact or byproduct of TET1 overexpression. 
Furthermore, biochemical studies that evaluated the feasibility of AID/APOBEC mediated 5hmC 
deamination showed that this activity, if at all detectable, is extremely weak in several in vitro assays 
and in cells (Nabel et al. 2012; Rangam et al. 2012), arguing against a prominent role of such a 
pathway. Yet, 5mC deamination is still a feasible scenario for DNA demethylation as discussed above, 
but it more likely operates in parallel rather than in combination with the TET-mediated oxidation.  
With the discovery of the TET proteins came along a re-evaluation of the role of Gadd45a in DNA 
demethylation (chapter 2.5.1). Gadd45a was shown to interact with TDG and overexpression together 
with TET led to DNA demethylation and activation of a reporter gene in HEK293T (Appendix III). In 
addition, knockout of Gadd45a/b led to hypermethylation of specific loci that also display 5fC 
enrichment in the absence of TDG (Appendix III). Another study suggested a direct interaction of 
Gadd45a with TDG in long non-coding RNA (lncRNA)-mediated DNA demethylation, also requiring the 
TET but not the NER proteins (Arab et al. 2014). 
Finally, evidence starts to emerge for a direct interaction of TET proteins with TDG and components of 
the BER machinery and a DNA demethylation mechanism triggered by 5mC oxidation and subsequent 
processing by TDG and BER is now the first biologically and biochemically validated active DNA 
demethylation mechanism (Appendix I and III). This major breakthrough in DNA demethylation 
research has led to reevaluation of many biological processes that rely on DNA demethylation and it 
becomes more and more evident that TET but also TDG-initiated DNA repair contribute to active DNA 





3 Aim of the Thesis 
TDG was initially discovered as a DNA glycosylase that excises T when mispaired with G. Recent 
compelling evidence, however, suggests that the essential role of this DNA repair enzyme is the 
control of DNA methylation (Cortazar et al. 2011; Cortellino et al. 2011; Raiber et al. 2012; L. Shen et 
al. 2013; C. X. Song et al. 2013a). Current models supported by both biochemical as well as genetic 
evidence implicate TDG-initiated BER in active DNA demethylation following the step-wise oxidation of 
5mC to 5hmC, 5fC and 5caC by TET proteins (Inoue et al. 2011; Ito et al. 2011). 5fC and 5caC were 
shown to be efficiently excised from DNA by TDG (He et al. 2011; Maiti and Drohat 2011) and the 
phenotype of TDG deficient mice and cells is consistent with a dysregulation of DNA methylation 
patterning (Cortazar et al. 2011; Cortellino et al. 2011; Raiber et al. 2012; L. Shen et al. 2013; C. X. 
Song et al. 2013a). Although DNA demethylation through this pathway is a plausible and therefore 
widely accepted scenario, the actual evidence proofing the functionality of such a mechanism is 
scarce. A molecular and functional interaction between TET, TDG and BER has not been established 
and key mechanistic features and regulatory aspects of the complex multistep process have not been 
resolved. 
The overall aim of my PhD thesis was to provide a proof of functionality of a TET, TDG and BER 
based DNA demethylation system. By reconstituting an operational TET, TDG and BER system with 
purified proteins in vitro, I aimed to biochemically investigate the process of active DNA demethylation. 
Specifically, the interplay of TET and TDG and functional interactions with additional factors such as 
Gadd45a and the BER proteins was to be elucidated and characterized. Aside, I aimed to establish 
novel tools and biochemical assays, facilitating the functional investigation of implicated regulatory 
factors such as posttranslational SUMO modification or RNA interactions. 
A major part of my thesis project, thus, comprised the production and purification of highly active 
recombinant proteins. With the purified proteins it was then possible to study their enzymatic activities 
individually or in combination using biochemical assays to unravel the process of DNA demethylation. 
My work also comprised the establishment and successful application of protein expression systems 
facilitating the production of recombinant SUMO-modified proteins for mechanistic studies as well as 
of biochemical assays with RNA containing DNA demethylation substrates. 
To this end, I – in collaboration with others – was able to extend previous biochemical findings and 
provide a biochemically validated concept of TET-initiated and DNA repair-mediated active DNA 
demethylation involving TDG, BER and in part Gadd45a. I fully reconstituted the DNA demethylation 
process for the first time and my results revealed a highly coordinated and sequential mechanism to 





This chapter provides an overview and summary of the results obtained during my PhD thesis, which 
are attached as manuscripts in the appendix. Additional important results not contained in the 
manuscripts are presented here in chapter 4.4. 
 
4.1 Biochemical Reconstitution of TET1-TDG-BER Dependent Active 
DNA Demethylation Reveals a Highly Coordinated Mechanism 
(Appendix I) 
DNA methylation at the C5 position of Cs (5-methylcytosine, 5mC) is one of the best described 
epigenetic modifications and is found predominantly within CpG dinucleotides, affecting 60-90% of 
such sites (Bird 2002). Originally considered a static developmentally established and maintained 
epigenetic mark, recent advances have indicated that DNA methylation is subject to dynamic 
regulation through passive as well as active enzymatic processes. Mechanisms of DNA demethylation 
have long been under debate but recent findings have advanced our understanding of this process 
and some candidate pathways have received a lot of experimental support (H. Wu and Zhang 2014). 
A widely accepted model suggests an involvement of the TET family of dioxygenases and the DNA 
glycosylase TDG in the removal of DNA methylation (Kohli and Zhang 2013; Pastor et al. 2013). TET 
proteins catalyze the oxidation of 5mC to 5hmC, 5fC and 5caC (He et al. 2011; Inoue et al. 2011; Ito et 
al. 2011; Tahiliani et al. 2009). TDG, originally identified as a DNA glycosylase for the excision of T 
and U mispaired with guanine G, was then shown to recognize and excise the TET-mediated 5mC 
oxidation products 5fC and 5caC. These findings implicated an engagement of the BER pathway in 
the exchange of 5mC for an unmethylated C (He et al. 2011; Maiti and Drohat 2011). However, 
although plausible as a mechanism, there is yet only little evidence supporting a direct link of TET with 
BER and key features relating to the regulation, coordination and progression of oxidative DNA 
demethylation remain to be resolved. In this study, we set out to reconstitute the process of oxidative 
DNA demethylation with purified proteins in vitro and to address the biochemical features of this 
pathway. 
The mechanism of TET- and TDG-dependent DNA demethylation implies a coupled action of both 
enzymes and we reasoned that they might physically interact to facilitate an efficient but coordinated 
removal of 5mC. To this end, we provide evidence of a direct interaction between the two proteins 
following three complementary approaches (Appendix I, Fig. 1). Results obtained from gel filtration 
(Appendix I, Fig. 1 A), yeast two-hybrid (Y2H) (Appendix I, Fig. 1 B) and co-affinity purification 
(Appendix I, Fig. 1 C) supported a direct TET-TDG interaction and led us to conclude that TET1 and 
TDG physically interact through domains located in the TET1 N-terminus (TET1N) as well as the TET1 
catalytic domain (TET1CD). When measuring the catalytic activity of the complex formed between 
TET1CD and TDG by means of a standardized nicking assay (Hardeland et al. 2000), I detected 
efficient base release from oligonucleotide substrates containing 5mC or 5hmC modifications 
(Appendix I, Fig. 2 A). As both catalytic activities were required for the base release in these assays, 
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the results strongly indicate a concerted action of TET and TDG and, hence, the functionality of the 
TET and TDG complex. Evaluation of the enzymatic activity of the purified catalytic domain (TET1CD) 
by itself (Appendix I, Fig. 2 B) and reconstitution with purified TET1CD and TDG (Appendix I, Fig. 2 C) 
then provided proof for a successful cooperation of both enzymes in the oxidation and excision of 5mC 
and 5hmC from DNA to generate an abasic-site DNA repair intermediate. 
As TET1 and TDG were shown to physically interact, we reasoned that this interaction might also have 
functional consequences. I thus tested potential stimulatory effects on the partner’s enzymatic activity 
using different approaches (Appendix I, Fig. 3). To measure the effect of TDG on the ability of TET1CD 
to produce 5mC derivatives, I treated DNA substrates containing 5mC with TET1CD by itself or in 
complex with a catalytically inactive TDG (TDGΔcat). The abundance of 5mC derivatives in the DNA 
was then measured by the base release assay using active TDG (Appendix I, Fig. 3 A) or by 
LC/MS/MS analysis (Appendix I, Fig. 3 B). Neither analysis resulted in a significant difference between 
TET1CD by itself and in complex with TDGΔcat, indicating the TDG interaction did not stimulate TET1 
activity on either 5mC or 5hmC.  Interestingly, the presence of TET1CD had a stabilizing effect on TDG 
activity and increased the efficiency of 5caC processing (Appendix I, Fig. 3 C). From these results, we 
conclude that physical interaction of TET1 and TDG does not affect their catalytic efficiency but has a 
stabilizing effect, particularly on TDG. 
The initial steps of DNA demethylation, i.e. the release of the 5mC base, are suggested to be followed 
by BER to restore the DNA sequence with an unmodified C. To formally proof the validity of such a 
mechanism and to provide a tool to investigate its biochemical mode of action, I reconstituted the full 
DNA demethylation pathway with purified TET1CD, TDG and BER proteins. Analysis of individual steps 
of the process (Appendix I, Fig. 4 A) as well as of the end product (Appendix I, Fig. 4 B) showed not 
only that it is possible to release 5mC in a TET-TDG dependent manner but also that an unmodified C 
can be correctly incorporated in vitro, thus reestablishing the unmethylated state via the oxidative DNA 
demethylation pathway. 
It is known that DNA methylation is most often present at palindromic CpG dinucleotides, involving 
methylation of both strands. We therefore asked how the DNA demethylation process is coordinated in 
a context of symmetrical DNA methylation to avoid a deleterious formation of DSBs. The analysis of 
fully methylated CpGs processed by the TET1CD/TDG complex showed that the 5mCs in both strands 
are equal targets for demethylation, indicating an absence of DNA strand preference or a randomly 
distributed but coordinated action of the TET1CD/TDG complex (Appendix I, Fig. 5 A). To further 
examine the events at symmetrically modified CpGs, I separated the TDG from the TET1 activity and 
measured the kinetics of 5caC processing strand-specifically. As for the activity of the complex, there 
was no detectable strand specificity, but the processing of one strand apparently blocked the access 
to the other, indicating that TDG did not dissociate easily from the abasic site (Appendix I, Fig. 5 C). 
Complete reconstitution of DNA repair on a symmetrically modified substrate then showed that the 
unmethylated state was correctly reestablished on both strands (Appendix I, Fig. 5 D). Importantly, the 
repair process of symmetrically modified CpGs, that ultimately requires breaking of both strands, did 
not induce a detectable level of DSBs. Hence, full DNA demethylation and repair of the two strands 
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occurred in a processive but sequential manner, restoring the unmodified state and maintaining 
genome integrity during the DNA demethylation process. 
Having evidence that repair at symmetrically modified CpGs occurs sequentially, I set out to 
investigate potential interferences between oxidation-induced DNA demethylation and repair of 
mismatched DNA. Spontaneous or induced deamination of 5mC on one strand while the other strand 
is being actively demethylated could generate a G·5caC modification next to a G/T mismatch within 
the same CpG dinucleotide. Interestingly, when offered both substrates at the same time, TDG almost 
exclusively processed 5caC with largely unaffected rate, leaving the G/T mismatch completely 
unrepaired (Appendix I, Fig. 6 B). Sequential repair in this situation is of biological relevance, as it 
occasionally promoted C to T mutations when BER of the 5caC·G incorporated two (or more) instead 
of just one nucleotide, and thereby generated an A opposite T in the opposite strand (Appendix I, Fig. 
6 C). Such events may contribute to the depletion of CpG dinucleotides in the genome. 
In conclusion, we provide a proof of concept for the mechanism of repair-mediated oxidative DNA 
demethylation (Appendix I, Fig. 6 D). We showed in vitro that TET1 does indeed associate with TDG 
to release 5mC from DNA and together with the BER machinery productively demethylates DNA via 
oxidative intermediates. With the gained knowledge, some pending mechanistic questions could be 
addressed. In particular, my results provide evidence for a highly coordinated and sequential 
mechanism to achieve DNA demethylation even at symmetrically methylated CpGs (Appendix I, Fig. 6 
D middle path), which is important to avoid the formation of DNA DSBs and, hence, gross genomic 
instability (Appendix I, Fig. 6 D right path). The sequential repair of both lesions, however, turns into a 
disadvantage in situations of coincident deamination and oxidation at fully methylated CpGs. My 
results clearly showed that a strong preference for 5caC masks the nearby G/T mismatch to fix a C to 
T mutation and hence a loss of the CpG dinucleotide (Appendix I, Fig. 6 D left path). 
Contribution: I designed and cloned the bacterial TET1 expression constructs as well as the TDG-
GST construct. I performed the gel filtration and the co-affinity purifications that were used to study the 
interaction between TET1 and TDG. I purified TET1CD, TDG as well as the TET1CD/TDG complex that 
were used in the biochemical assays. I performed and established (where necessary) the biochemical 
assays (base release, oxidation, in vitro reconstitution). I wrote the manuscript and designed all the 
figures based on my own results. 
 
4.2 Versatile Recombinant SUMOylation System for the Production of 
SUMO-Modified Protein (Appendix II) 
Posttranslational modification by ubiquitin-like polypeptides, so-called UBLs, has been implicated in 
the regulation and coordination of a variety of vital biological processes, including DNA repair, cellular 
response to DNA replication stress, regulation of gene expression and epigenetic DNA and histone 
modifications (Cubenas-Potts and Matunis 2013; Flotho and Melchior 2013; Jackson and Durocher 
2013; Zhao 2007). Also, in the context of DNA repair-mediated DNA demethylation, SUMOylation is 
likely to have regulatory functions, given its well-documented ability to modulated TDG function. The 
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SUMO peptides represent a prominent subfamily of the UBLs and exist in four different isoforms 
(SUMO1, SUMO2, SUMO3 and SUMO4) in mammalian cells, all of them showing high 3D-structural 
resemblance (Dohmen 2004; Gareau and Lima 2010; Geiss-Friedlander and Melchior 2007; Jackson 
and Durocher 2013). The mechanism of SUMO conjugation appears to be the same for all SUMO 
isoforms; they are covalently attached to their target proteins by a cascade of enzymatic reactions 
resembling ubiquitin conjugation (Hay 2013; Schwartz and Hochstrasser 2003). These involve a 
heterodimeric activating enzyme E1 (SAE1/SAE2), a single conjugating enzyme E2 (Ubc9) and, in 
some cases, an E3 protein ligase (Appendix I, Fig. 1 A). The number of proteins identified as SUMO 
targets has been increasing over recent years, mechanistic insight into the impact of SUMO 
interactions and modifications on the respective molecular processes, however, is only slowly 
emerging. A main reason for this is the difficulty to generate appreciable amounts of recombinant 
SUMOylated proteins for biochemical and structural investigation. 
In this part of my PhD thesis, we set out to establish a versatile and potent SUMOylation system in 
E.coli, to facilitate the production of homogeneously SUMOylated recombinant proteins for subsequent 
biochemical and structural studies. We designed and experimentally validated two alternative two-
component vector systems for simultaneous expression of the complete SUMOylation machinery 
alongside a target protein of interest. The first, termed pSUMO-based system, expresses all essential 
components for SUMO modification from a single plasmid (pSUMO1-3) (Appendix II, Fig. 1 B) and can 
be combined with commonly used bacterial expression vectors (Appendix II, Fig. 1 C). The second 
was named SUMO-E2-fusion system and is composed of a SUMO-activating vector (pSA1-3), 
encoding the SUMO polypeptide and SUMO-E1 (Appendix II, Fig. 3 A), and a SUMO-conjugating 
vector (pSC) (Appendix II, Fig. 3 C and E), containing a TARGET-Ubc9-GST fusion expression 
cassette. Both systems are suitable for in-cell as well as in-extract SUMOylation (Appendix II, Fig. 6), 
thus providing versatility in respect to the experimental setup and requirements of a target protein. In 
this publication, we evaluated the newly developed vector systems with a well-established and a 
putative SUMO target, the DNA BER proteins TDG and XRCC1 (Bruderer et al. 2011; Gocke et al. 
2005; Jacobs and Schar 2011). 
Our systems differ from previously established ones (Lens et al. 2011; Mencia and de Lorenzo 2004; 
O'Brien and DeLisa 2012; Uchimura et al. 2004b), in that they consist of human components only, 
provide two different tags for affinity purification and avoid a fusion of the two subunits of SUMO-
activating enzyme E1 (SAE1 and SAE2), previously shown to reduce SUMO-E1 activity (Uchimura et 
al. 2004a)(Appendix II, Fig. 1 B). Evaluation of our pSUMO-based system consistently led to a faster 
appearance and higher yields of in-cell SUMOylated mouse TDG (mTDG) and human XRCC1 
(hXRCC1) protein when compared to the system by Saitoh and colleagues (Uchimura et al. 2004a) 
(Appendix II, Fig. 1 D and E). 
SUMOylation efficiency and specificity can be enhanced by SUMO-E3 ligases (O'Brien and DeLisa 
2012) that promote structural proximity between the substrate and the SUMO-conjugating enzyme 
Ubc9. To avoid co-expression of respective SUMO-E3 ligases, their function can be mimicked by 
fusing Ubc9 directly to SUMO1 or target proteins of interest (Jakobs et al. 2007; E. T. Kim et al. 
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2009a). To provide such opportunity, we used a TARGET-Ubc9 fusion approach in our SUMO-E2-
fusion system. The generation of SUMO-conjugated protein was efficiently obtained in-cell using this 
fusion approach with human (hTDG) as well as mouse TDG (mTDG) (Appendix II, Fig. 3 D, F, G) and 
appeared to be affected by the configuration of the TARGET-Ubc9 construct that was designed in two 
variants (Appendix II, Fig. 3 D compared to F). 
In contrast to TDG, in-cell modification of the hXRCC1 SUMO-E2-fusion was not satisfactory due to 
inefficient protein expression. To circumvent such barriers, we developed a strategy where SUMO-
modification can be obtained in crude E.coli extracts without prior enrichment of the SUMOylation and 
target factors (Appendix II, Fig. 4 A). Using this approach, fast and efficient SUMOylation of hXRCC1 
was detected (Appendix II, Fig. 4 B and E) that turned out to completely rely on the Ubc9 fusion 
(Appendix II, Fig. 4 C). This indicated that the TARGET-Ubc9 fusion efficiently mimicked SUMO-E3 
ligase functionality and enhanced SUMOylation of hXRCC1 in mixed lysates (Appendix II, Fig. 4 D). 
This in-extract approach can be employed using lysates from pSA or pSUMO expressing cells 
(Appendix II, Fig. 4 A); particularly pSUMO offers high combinatorial flexibility and can be combined 
with lysates from virtually any potential SUMO target (Appendix II, Fig. 6). 
The generation of homogeneously SUMO-modified target proteins was finally achieved by purification 
and separation from unmodified isoforms by sequential GST and Ni-NTA affinity chromatography or 
vice versa. We could show that purification following both routes work in principle and result in a clear 
enrichment of SUMO-modified target protein (Appendix II, Fig. 2). Treatment of purified mTDG-
SUMO1 with recombinant SUMO protease SenP2 then generated the unmodified isoform 
demonstrating that the detected high molecular bands are indeed SUMO1-modified mTDG protein 
(Appendix II, Fig. 5 A and B compare lanes 3 and 4). Moreover, we showed that the purified in-cell 
SUMOylated mTDG displays previously described modification-dependent enzymatic features 
(Hardeland et al. 2002), when we evaluated its capacity to release uracil from G/U mismatched DNA 
substrates in a base release assay (Appendix II, Fig. 5 C and D). 
In conclusion, we developed tools and strategies to produce SUMO-modified proteins using versatile 
binary expression vector systems in protease-deficient E.coli (Appendix II, Fig. 6). They are designed 
to be applied for biochemical and structural studies of proteins and biological pathways potentially 
regulated by SUMOylation, i.e. the coordination of active repair-mediated DNA demethylation. Using 
this system I could already successfully SUMOylate TET1 (see chapter 4.4.1) corroborating a potential 
involvement of this regulatory pathway in oxidative DNA demethylation. 
Contribution: I cloned cDNAs of target proteins into the pSC constructs that were assembled by 
David Schürmann. Together with David Schürmann, I designed and conducted in-cell as well as in-
extract SUMOylation of TDG and XRCC1 and performed immunoblot analysis (Appendix II, Fig. 1 – 4). 
I purified in-cell SUMOylated mTDG and made the biochemical evaluation (Appendix II, Fig. 5). I 




4.3 Gadd45a promotes DNA demethylation through TDG (Appendix III) 
In vertebrates, cytosine methylation in CpG-rich regulatory gene promoters and enhancers inversely 
correlates with transcriptional activity of associated genes by mechanisms involving recruitment of 
transcriptional repressors and chromatin condensation. Reversal of DNA methylation is subject of 
ongoing research and a widely accepted model suggests that active DNA demethylation can be 
obtained by a concerted action of TET proteins and TDG-initiated BER (Kohli and Zhang 2013). 
Results obtained during my PhD project have provided a proof of the mechanistic concept of this 
pathway (Appendix I), it is however likely that auxiliary factors also contribute to DNA demethylation by 
modulating TET and TDG activities and coordinating these with BER processes. Gadd45 family 
proteins are multi-faceted nuclear factors that have been implicated in active DNA demethylation, 
potentially through XPG-dependent DNA repair (Barreto et al. 2007; Schmitz et al. 2009) or BER of 
AID-based deamination products (Cortellino et al. 2011; Rai et al. 2008). However, despite the 
connection of Gadd45 proteins with DNA demethylation, their role in the process has remained 
unsolved and controversial (Jin et al. 2008; Niehrs and Schafer 2012). This collaborative study 
initiated by Li Zheng and Guoliang Xu at the Chinese Academy of Science in Shanghai, aimed to 
investigate the role of Gadd45a in TET-TDG-dependent oxidative DNA demethylation and activation of 
methylation-silenced genes. 
Candidate factors (Appendix III, Table S2) were first tested in combination with TET and TDG in a 
HEK293T cell-based firefly luciferase reporter assay for their capabilities to promote reactivation of a 
methylated reporter gene. Seemingly, the presence of Gadd45a stimulated the re-expression of the 
silenced reporter and co-expression of Gadd45a with Tet2CD and TDG increased the luciferase 
activity by 35-fold (Appendix III, Fig. 1 A). The effect was strongly dependent on the enzymatic 
activities of both Tet2CD and TDG and gene activation was lost upon co-expression with the 
catalytically inactive mutants (Appendix III, Fig. 1 A), suggesting that Gadd45a cooperated with TET 
and TDG in the activation of a methylation-silenced reporter gene. 
To further evaluate the role of Gadd45a in TET and TDG-mediated DNA demethylation, the 
occurrence of genomic 5caC was monitored in HEK293T cells. Interestingly, a substantial reduction of 
the genomic 5caC level (30% reduction) was detected upon co-transfection of Gadd45a with TET2 
(Appendix III, Fig. 2 A) and selective removal of 5fC and 5caC but not 5mC or 5hmC was measured 
(Appendix III, Fig. 2 B), suggesting that Gadd45a potentially cooperated with endogenous TDG in the 
removal of genomic 5fC and 5caC. Consistently, in TDG knockout HEK293T cells (TDG KO) 
(Appendix III, Fig. 4 A and B and Fig. S3), overexpression of Gadd45a had no effect on the TET2-
generated genomic 5caC levels (Appendix III, Fig. 4 C). It thus appears that the role of Gadd45a in 
oxidative DNA demethylation relies on the presence of TDG and its enzymatic function. 
To further elucidate a potential interplay between Gadd45a and TDG in DNA demethylation, their 
potential to engage in physical interaction with each other was tested. Findings from co-affinity 
purification (Appendix III, Fig. 3 A), co-immunoprecipitation (Co-IP) (Appendix III, Fig. 3 B) as well as 
Y2H (Appendix III, Fig. 3 C) assays supported the existence of physical interactions between the two. 
Interaction domain mapping then corroborated that the interaction is mediated by the N-terminal 
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domain of Gadd45a (amino acids 1-137) and the N- (amino acids 1-132) as well as C-terminus (amino 
acids 178-397) of TDG (Appendix III, Figure 3 D). 
The effect of Gadd45a on TDG-mediated removal of 5fC/5caC was then evaluated by co-transfecting 
an in vitro generated 5fC/5caC-containing reporter plasmid (Appendix III, Fig. 5 A) with the Gadd45a 
expression vector into HEK293T cells. M.SssI-assisted bisulfite sequencing (MAB-seq) of the 
recovered plasmid revealed a substantially reduced level of 5fC/5caC (58% vs. 89%) (Appendix III, 
Fig. 5 B), whereas 5fC/5caC was largely retained without Gadd45a (84% vs. 89%) (Appendix III, Fig. 5 
B). Consistent with the idea of TDG activity mediating the Gadd45a effect, there was no significant 
reduction of 5fC/5caC in TDG KO cells upon expression of Gadd45a (89.5% vs. 89.2%) (Appendix III, 
Fig. 5 B). 
We next evaluated the biological relevance of Gadd45a in TET-TDG-mediated modulation of 
epigenetic states in ES cells. Interestingly, in cells lacking both Gadd45a and Gadd45b 
(Gadd45a/Gadd45b double knockout, DKO), no obvious difference in global methylation was 
observed at the genomic scale (Appendix III, Fig. S6). However, locus-specific hypermethylation but 
not hypomethylation was detectable (Appendix III, Table S3) as exemplified by the two genomic loci, 
the Plagl1 and Cilp2 genes (Appendix III, Fig. 6 A). Overall, the hypermethylated regions in Gadd45 
deficient cells significantly overlapped with regions showing enrichment of 5hmC and 5fC in TDG 
deficient mouse ES cells (C. X. Song et al. 2013a; Yu et al. 2012) (Appendix III, Fig. 6 C). In these 
regions epigenetic states are considered to be dynamically maintained involving TET and TDG and 
the results presented here support the hypothesis that Gadd45 proteins functionally cooperate with the 
TET and TDG enzymes in the dynamic regulation of genomic targets in mouse ES cells. 
It remains yet unclear how Gadd45a exactly regulates TDG activity in cells. From the direct interaction 
and the stimulation of TDG-dependent DNA demethylation by Gadd45a in cells, we reasoned that 
Gadd45a might impact on the enzymatic activity of TDG. I contributed to this study by examining this 
hypothesis in vitro using purified proteins. Evaluation of 5caC base release under single turnover 
conditions showed that Gadd45a did not stimulate the processing rate of TDG (Appendix III, Fig. S8 C 
and D). In presence of a large excess of substrate, however, Gadd45a increased the overall 
processing, albeit this effect was not specific compared to a BSA control (Appendix III, Fig. S8 A and 
B). Finally, EMSAs indicated that Gadd45a increased TDG DNA binding, thus exerting a stabilizing 
function, but again this effect turned out to be largely unspecific (data not included in the publication). 
In conclusion, several lines of evidence provided in this study suggest that Gadd45a serves as a 
regulator in the TET-TDG-mediated DNA demethylation pathway: (i) Gadd45a enhanced TET and 
TDG-dependent reactivation of a methylated reporter gene in transfected cells (Appendix III, Fig. 1), 
(ii) Gadd45a interacted physically with TDG both in vitro and in vivo (Appendix III, Fig. 3), (iii) 
overexpression of Gadd45a enhanced TDG-dependent removal of 5fC and 5caC from genomic or 
transfected plasmid DNA in HEK293T cells (Appendix III, Fig. 2, 4, 5), (iv) deletion of Gadd45a/b in 
mouse ES cells led to locus-specific hypermethylation (Appendix III, Fig. 6). As Gadd45a did not 
stimulate TDG activity when examined biochemically, we propose a model where Gadd45a (and 
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Gadd45b) acts as a scaffold protein and promote TET-TDG-mediated DNA demethylation by 
coordinating the assembly of demethylation complexes at specific loci. 
Contribution: My contribution started at a later stage of the project and consistent in the evaluation of 
the stimulatory effect of Gadd45a on TDG activity in vitro. I purified Gadd45a and TDG protein used in 
the base release assays. I performed the base release assays shown in Figure S8 as well as a series 
electrophoretic mobility shift assays (EMSA), results of which were not included in the final version of 
the manuscript. I wrote the relevant parts in the methods section and integrated my results in the 
discussion. 
 
4.4 Supplementary Results 
 Biochemistry of TDG and TET1 suggests function in RNA-containing structures 4.4.1
The discovery of the TET proteins and the products of TET-mediated 5mC oxidation has greatly 
advanced our understanding of active DNA demethylation and led to reevaluation of previous 
mechanistic hypotheses regarding globally as well as locally observed DNA demethylation events 
(Kohli and Zhang 2013; Lee et al. 2014; Seisenberger et al. 2013; H. Wu and Zhang 2014). Also the 
DNA glycosylase TDG has received a great deal of attention and a role in TET-mediated DNA 
demethylation was soon suggested, particularly after the TET-mediated 5mC oxidation products 5fC 
and 5caC were identified to be readily recognized and excised by TDG (Hashimoto et al. 2012a; He et 
al. 2011; Maiti and Drohat 2011; L. Zhang et al. 2012) (chapter 4.1 and 4.3, Appendix I and III). 
TDG has previously been implicated in active DNA demethylation in different contexts: in analogy to 
the glycosylase-initiated DNA demethylation mechanism in plants, it has formerly been suggested to 
be a 5mC-specific glycosylase by JP Jost (Jost 1993; Jost et al. 1995; B. Zhu et al. 2000b). It was also 
JP Jost and colleagues who first suggested that the glycosylase requires an RNA moiety for efficient 
DNA demethylation and that the RNA might exert a targeting function (Fremont et al. 1997; Jost et al. 
1997). Careful biochemical evaluation of TDG interactions with RNA in our lab has confirmed that TDG 
does have affinity for RNA and that RNA can stimulate the TDG catalytic activity in certain contexts, 
not to the extent however that the enzyme would become proficient in 5mC excision (Christophe Kunz, 
unpublished results). Preliminary analysis of TDG cross-linking immunoprecipitation (CLIP) data as 
well as RNA immunoprecipitation (RIP) performed with mouse ES cells confirmed that TDG interacts 
with RNA in vivo (Christophe Kunz, unpublished results). To date, the biological role of this interaction 
is not entirely clear and the mechanistic implications of such interactions have not been addressed. 
Inside cells RNAs are present in multiple forms, they can be single- and double-stranded, highly 
structured, and present in RNA/DNA hybrids and R-loops. R-loops are generally formed during gene 
transcription at the transcription bubble where they have been suggested to play a role in 
transcriptional regulation as well as in other processes, e.g. recombination (Aguilera and Garcia-Muse 
2012). TDG was also attributed a role in transcriptional regulation (Cortazar et al. 2007; Dalton and 




Here, I wanted to combine the latest insight in oxidative DNA demethylation with previous 
observations on the biochemical properties of TDG. First, I evaluated TDG's affinity for 5mC and TET-
mediated DNA demethylation intermediates as well as its activity on these bases in regular DNA 
duplex contexts. I then verified if oxidative DNA demethylation could occur in other substrate contexts, 
i.e. RNA/DNA hybrids or R-loops by testing the enzymatic activities of TDG and TET in newly 
generated assays with such hybrid substrates in vitro. 
RESULTS 
TDG binds to and processes 5caC but not 5mC or 5hmC 
Following the discovery of the TET-mediated 5mC oxidation, I first set out to evaluate the affinity and 
activity of TDG for 5mC and its oxidized DNA demethylation intermediates. Binding affinity of TDG was 
measured by a standardized electrophoretic mobility shift assay (EMSA) (Fig. 4.1 A). TDG was 
incubated with labeled synthetic 60 bp DNA substrates containing one modified C in a CpG context 
(5mC, 5hmC, 5caC or T), alone as well as in the presence of unlabeled unspecific (60 bp homoduplex) 
or specific (60 bp G·5caC containing) competitor DNA. In the absence of competitor DNA, all the 
substrates were bound with high affinity using a two-fold molar excess of enzyme over substrate (100 
nM DNA, 200 nM enzyme) (Fig. 4.1 A). In the presence of 10- and 20-fold molar excess of unspecific 
competitor DNA (1 µM and 2 µM), 5mC and 5hmC binding was reduced 10- to 20-fold, suggesting that 
Fig. 4.1: TDG binds and processes 5caC specifically but not 5mC and 5hmC. (A) 1 pmol of 5’ fluorescein 
labeled DNA substrate containing one modified C (5mC, 5hmC or 5caC) or a G/T mismatch were incubated with 2 
pmol of TDG and 10 or 20 pmol unlabeled competitor DNA as indicated at 37°C for 15 min. The formation of 
DNA/protein complexes was examined by EMSA. (B) The ability to generate alkaline-sensitive abasic sites on the 
indicated substrates was assayed with a base release assay using equimolar enzyme and substrate 
concentrations at 37°C for 15 min. Products were separated by denaturing gel electrophoresis, visualized with 
fluorescent scanning and quantified. The 60mer substrate DNA and the 23mer product fragment are indicated by 
arrow heads. (n = 3; mean values with standard deviations). 
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a high degree of unspecific DNA binding was occurring under the assay conditions applied (Fig. 4.1 A, 
panel 1 and 2). In contrast, 57% of G·5caC and 20% of G/T containing DNA remained specifically 
bound in presence of a 20-fold molar excess of competitor DNA, indicating a strong preference and 
high affinity for these substrates (Fig. 4.1 A, panel 3 and 4). This result is interesting because unlike 
G/T, which represents a mismatch, 5caC forms regular Watson-Crick base pairs and cannot be 
recognized by mismatching characteristics. To directly compare the affinities of TDG for these two 
substrates, an unlabeled 5caC-containing DNA was used as competitor. Presence of the specific 
competitor DNA completely abolished binding to 5mC and 5hmC containing substrates (Fig. 4.1 A, 
panel 1 and 2) but also binding to a G/T mismatch was almost completely lost (Fig. 4.1 A, panel 4). As 
in this experimental setup TDG most likely generated AP-sites and DNA binding thus also reflected 
binding to these, the assay was repeated with a catalytically inactive TDG (TDGΔcat N151A).  The 
result was virtually the same using TDGΔcat (data not shown) indicating that TDG has a higher affinity 
for the normally paired 5caC than for G/T mismatches. I then tested the ability of TDG to release the 
modified bases in a standardized base release assay (Hardeland et al. 2000). Incubation of equimolar 
concentrations (25 nM)  of  5mC and 5hmC containing substrates with TDG at 37°C for 15 minutes did 
not produce any detectable base release products (Fig. 4.1 B). In contrast, 5caC and a G/T control 
substrate were well processed (38% and 50% respectively) and despite the lower binding efficiency for 
G/T as compared to 5caC (~1/3 in presence of a 20-fold molar excess of competitor DNA) (Fig. 4.1 A), 
processing of the mismatch was more efficient. Taken together, I could confirm more quantitatively 
previous findings that TDG has neither a specific binding affinity nor activity towards 5mC- and 5hmC- 
containing substrates. I could furthermore show the activity of TDG on 5caC, a TET-mediated 5mC 
oxidation product, and that TDG binds 5caC with higher affinity than a T mispaired with G. 
TDG processes 5caC in RNA/DNA hybrids as well as in R-loops 
Since TDG associated with RNAs in vivo, we hypothesized that its engagement in active DNA 
demethylation may rely on the presence of an RNA. I therefore evaluated the ability of TDG to process 
5caC in RNA/DNA hybrid- as well as in R-loop substrates. I first tested TDG activity on various 
substrate bases in RNA/DNA hybrids (Fig. 4.2 A, schematic view) under single turnover conditions 
(10-fold molar excess of enzyme over substrate) (Fig. 4.2 A). The results suggested that TDG is active 
on U and to a lower extent on T in these hybrids but not on 5mC and 5hmC substrates (Fig. 4.2 A, 
lanes 2 - 5). Interestingly, in comparison to processing in dsDNA, the excision was more efficient for 
5caC than for T in this context (Fig. 4.2 A, compare lanes 2 and 6). To compare the TDG activity on 
G·5caC and G/T in the hybrid substrates, we followed base release over time using equimolar enzyme 
and substrate concentrations (Fig. 4.2 B). Quantification of the reaction products revealed that 
processing of G·5caC in the context of a RNA/DNA hybrid is not much different than processing in 
dsDNA (Appendix I, Fig. 5 B). However, excision of T from a G/T mismatch was drastically reduced in 
this context (Fig. 4.2 B, right panel). Using the same experimental setup, base release was then 
monitored in the context of R-loop substrates (Fig. 4.2 C). Here, the difference appeared even more 
evident than in the hybrid substrates - albeit 5caC processing was slightly reduced when compared to 
excision in RNA/DNA hybrids, removal of T from a G/T mismatch was barely detectable in R-loops 
(Fig. 4.2 C).  Here, the difference appeared even more evident than in the hybrid substrates - albeit 
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5caC processing was slightly reduced when compared to excision in RNA/DNA hybrids, removal of T 
from a G/T mismatch was barely detectable in R-loops (Fig. 4.2 C).  
 Altogether, these experiments establish that purified TDG is active on RNA/DNA hybrids excising U 
as well as T in the DNA strand when mispaired with G in the RNA strand. Testing of 5mC and the DNA 
demethylation intermediates 5hmC and 5caC revealed no activity towards 5mC and 5hmC, whereas 
5caC was well recognized and excised in these hybrid substrates. Comparing TDG kinetics on hybrid 
substrates containing either G·5caC or G/T, excision of 5caC occurred  faster and with a higher overall 
efficiency than for T. Similar findings apply to processing of these bases in an R-loop context, where 
removal of T was almost not detectable while 5caC was readily recognized and released. 
Fig. 4.2: TDG processes 5caC in RNA/DNA hybrids and in R-loops. (A) Schematic illustration of RNA/DNA 
hybrid substrate used in the base release assay, an unlabeled 25 nt RNA strand was annealed to complementary 
labeled 60 nt DNA strand. Shown are the results obtained with substrates containing G·C, G/T, G/U, G·5mC, 
G·5hmC or G·5caC base pairs. Products were separated by denaturing gel electrophoresis, visualized and 
quantified. Positions of the 60mer substrate DNA and product fragments are indicated. (B) Time-course base 
release assay on an RNA/DNA hybrid substrate containing G·5caC or G/T. Reactions were stopped after 
indicated timepoints by the addition of NaOH and separated by denaturing gel electrophoresis. Strands were then 
visualized by fluorescent scanning and quantified. (n = 3, mean values with standard deviations). (C) Schematic 
illustration of an R-loop substrate used in the base release assay, an unlabeled 25 nt RNA strand was annealed 
within the bubble structure of an unlabeled and a labeled 60 nt DNA strand. Release of 5caC or T was again 
monitored over time in a time-course base release assay. (n = 3, mean values with standard deviations). 
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TET1CD is active on single-stranded DNA, RNA/DNA hybrids and in a non-CpG context 
I next evaluated if the TET proteins are also enzymatically active in RNA/DNA hybrids as well as in R-
loop substrates. Furthermore, I tested if 5mC can be released in a non-CpG context by the activity of 
TET1CD and TDG in a 60 bp substrate containing two methylated Cs in a CpA context. Substrates 
were first incubated with TET1CD alone at 37°C for 30 min before adding TDG to excise the TET-
mediated 5mC oxidation products. The reactions were carried out using a 10-fold (ss, hybrid, R-loop) 
or five-fold (non-CpG) molar excess of TET1CD and TDG over substrate and equimolar end 
concentrations of TET1CD and TDG. Since TDG was highly active in ssDNA (Appendix I, Fig. 5 B), 
RNA/DNA hybrid and R-loop context (see Fig. 4.2), we reasoned that TDG activity was not limiting in 
these reactions and the efficiency of base release largely reflected the activity of the TET protein. The 
results showed that TET1CD was highly active on ssDNA (Fig. 4.3 A, lanes 2 and 6). In the presence of 
TDG both 5mC and 5hmC were released via an oxidized 5mC derivative at the same efficiency (Fig. 
4.3 A, lanes 2 and 6). The activity was then found to be greatly reduced on hybrids and even more 
pronounced on R-loop substrates. Whereas substantial base release was detected from 5mC and 
5hmC containing RNA/DNA hybrid substrates (Fig. 4.3 A, lanes 3 and 7), the amounts of products 
formed in R-loop substrates was strongly reduced (Fig. 4.3 A, lanes 4 and 8). In the non-CpG 
methylated substrate both 5mCs were targeted by TET1CD and TDG and subsequently released 
roughly to the same amounts (Fig. 4.3 B, lane 3). Taken together, the results suggested that the 
activity of TET1CD is neither restricted to double-stranded DNA nor to a CpG context since a 
substantial amount of oxidation followed by TDG-dependent base release could also be detected in 
single-stranded DNA as well as in RNA/DNA hybrids. In contrast to TDG, TET1CD did not appear to be 
active on R-loop substrates. 
CONCLUSION & OUTLOOK 
TDG has been associated with DNA demethylation and transcriptional regulation through multiple 
Fig. 4.3: TET1CD can convert 5mC in single-stranded DNA and in a non-CpG context. (A) The activity of 
TET1CD was analyzed by base release assays in combination with TDG. After incubating substrates at 37°C for 
30 min with TET1CD, an equimolar amount of TDG was added and incubated for another 30 min. Shown are the 
results obtained with substrates containing either 5mC or 5hmC in single-stranded DNA (ss), RNA/DNA hybrids or 
R-loops. Products were separated by denaturing gel electrophoresis, visualized and quantified. Positions of the 
60mer substrate DNA and product fragments are indicated by arrow heads. (B) Combined TET1CD and TDG base 
release assay on duplex DNA containing two 5mC modifications in a CpA context. Arrows indicate the 60mer 
substrate and the two product fragments. 
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pathways (Dalton and Bellacosa 2012). But the most convincing biological as well as biochemical 
evidence has now pointed towards a mechanism where 5mC is first modified by the TET 
dioxygenases followed by TDG-mediated excision of the oxidized 5mC derivatives and BER to restore 
the unmodified state (He et al. 2011; Inoue et al. 2011; Ito et al. 2011; Maiti and Drohat 2011) 
(Appendix I). Shortly after the discovery of the TET proteins and its oxidation products, I could show 
that TDG binds and processes 5caC with high specificity but not 5mC or 5hmC. These results 
furthermore revealed that TDG binds 5caC with even higher affinity than a G/T mismatch, despite the 
fact that 5caC forms a normal base pair with G. Structural studies support these results and suggested 
that of all TDG substrates analyzed so far, 5caC established the most specific and strong hydrogen 
bonding interactions within the TDG active site, making it a high affinity and specificity substrate for 
TDG (Hashimoto et al. 2012a; L. Zhang et al. 2012). Despite the higher affinity for 5caC, the excision 
rate appeared to be lower than for G/T, indicating that the rate limiting step for 5caC processing was 
the cleavage of the N-glycosidic bond of the base. Cleavage efficiency of TDG was previously shown 
to depend on the stability of the N-glycosidic bond (Bennett et al. 2006; Hardeland et al. 2000), which 
is weakened for 5caC as well as T. However, 5caC excision may require a slightly higher activation 
energy than T excision (R. T. Williams and Wang 2012). 
TDG has previously been shown to associate with RNA and it was hypothesized that the RNA might 
target or stimulate the DNA demethylation activity (Fremont et al. 1997; Jost et al. 1997). Results 
obtained in our lab also showed a stimulating effect of a complementary RNA on the catalysis of TDG; 
processing of G/T and G/U mismatches was enhanced but also excision of T and U from single-
stranded DNA could be detected if the RNA induced a mismatch. Direct processing of 5mC by TDG, 
however, was not detected neither in single- nor double-stranded DNA in presence of the RNA 
(Christophe Kunz, unpublished results). I now evaluated processing of RNA/DNA hybrids (25mer RNA 
paired with complementary 60mer DNA) containing the TET-mediated oxidation products 5hmC and 
5caC in the DNA moiety to see if oxidative DNA demethylation could occur in such a context. 
RNA/DNA hybrids are transient structures that can occur during transcription, when a newly 
synthesized RNA strand anneals to its complementary DNA strand. Not surprisingly, direct excision of 
5mC and 5hmC by TDG alone could not be detected in such substrates but 5caC was found to be well 
processed and, unlike in duplex DNA, excised more efficiently than a T from a G/T mismatch. This 
difference in processing efficiency is even more pronounced in R-loop substrates, where the excision 
of T was almost completely abolished but 5caC was still well processed. Hence, 5caC processing of 
TDG in RNA/DNA hybrids and R-loops is biochemically evident but the biological relevance of this 
activity remains yet speculative. The activity on RNA-containing structures might be ascribed to the 
role of TDG in transcriptional regulation that has previously been suggested to occur either through 
interactions with transcription factors or by direct modulation of epigenetic states (D. Chen et al. 
2003a; Dalton and Bellacosa 2012; Sjolund et al. 2013; Um et al. 1998). Furthermore, R-loops, 
typically present at or shortly behind transcription bubbles, were suggested to exert, besides others, 
DNA methylation-related functions (Aguilera and Garcia-Muse 2012) such as the protection of CGIs 
against DNA hypermethylation (Ginno et al. 2012). In this regard, R-loops may function as a signal to 
recruit DNA demethylation factors, including TDG, to keep CGI promoters in a hypomethylated state. 
Data from TDG chromatin immunoprecipitation sequencing (ChIPseq) indicated that TDG indeed 
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associated with gene regulatory elements, but was not restricted to these regions (Annika Wirz, 
unpublished results). The induction of DNA nicks through DNA demethylation at gene regulatory 
elements, triggered by short (jump-start) transcripts forming hybrid and R-loop structures, could also 
induce chromatin reorganization around TSSs that can ultimately lead to gene activation at silenced or 
transcriptionally poised loci. The potential biological roles of TDG together with RNA are manifold but 
convincing evidence if and how TDG might be involved in such processes is yet scarce and the 
subject still needs further investigation. Arguing against a model of oxidative DNA demethylation 
directly on hybrid and R-loop structures is the observation that TET1CD had reduced activity on 5mC 
and 5hmC in RNA/DNA hybrids and almost no detectable activity on 5mC and 5hmC in R-loops 
compared to single-strand context. It might however still be possible that TET and TDG act in an 
uncoupled way to obtain DNA demethylation at certain loci. Seemingly, in contrast to TDG, RNA had 
an inhibitory effect on the TET1CD catalytic activity in this experimental setup. However, since there 
was substantial processing in ssDNA, it can be hypothesized that TET1CD might still be recruited to R-
loops but acts on the looped DNA single-strand rather than the one paired with the RNA. Together 
with TDG, DNA methylation could be actively removed, but also here more data is needed to support 
such a concept. Moreover, the role of the TET1 N-terminus is largely unknown but might be necessary 
for specific targeting and/or stability on particular substrates, i.e. hybrids or R-loops, thus also affecting 
its enzymatic efficiency. Interestingly, methylation of C does not exclusively occur in the context of 
DNA but can also be detected in various RNAs as 5-methyl-ribo-cytosine (5mrC). Yet, not much is 
known about its biological function (Motorin et al. 2010). Recently, it has been shown that TET1CD 
actively converts 5mrC to 5-hydroxymethyl-ribo-cytosine (5hmrC) in single-stranded RNA in vitro and 
5hmrC could also be detected in total RNA of ES cells (Fu et al. 2014). Binding of TDG to RNA could 
be connected to the ability of TET to oxidize 5mrC in RNA and oxidative DNA demethylation might 
also be occurring in RNA or other RNA structures. However, it still needs to be clarified if TET is 
capable of performing more than the initial oxidation step, thus, if potential TDG substrates can be 
generated. In addition, TDG activity and downstream BER on an RNA substrate could not yet be 
shown and as there is yet no described biological function of RNA methylation it needs to be clarified if 
reversal of RNA methylation is biologically relevant at all. 
Another noteworthy observation is that oxidative DNA demethylation is not only restricted to a CpG 
context and base release can also be detected in a non-CpG methylated substrate (Fig. 4.3 B). 
Although CpG dinucleotides remain the primary site for DNA methylation in mammals, there is good 
evidence that DNA methylation also occurs in non-CpG contexts (CpA, CpT and CpC) in mammalian 
cells (Lister et al. 2009). The function of non-CpG methylation is, however, just starting to be defined 
(Pinney 2014).The efficient release of a 5mC in a CpA context indicates that both TET1CD and TDG do 
not require a G 3’ to the 5mC for specific recognition and processing. Altogether, the activities of 
TET1CD on 5mC and TDG on the TET-mediated 5mC oxidation product 5caC are robust. Interestingly, 
neither a double-stranded context nor a CpG sequence is required for efficient processing indicating 
that there is still plenty to be explored to relate these activities to biologically relevant processes. 
MATERIALS AND METHODS 
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TDG and TET1CD expression constructs 
For expression of an N-terminally His6-tagged mouse TDG, the murine TDGa cDNA was cloned into 
pET28c (Novagen-Merck). The TDG catalytic mutant (N151A) was generated by site-directed 
mutagenesis on the pET28-mTDGa vector using the QuickChange Site-directed Mutagenesis Kit 
(Stratagene) with primers mmTdg-N151A-s (5’-
TATTGTGATCATTGGCATTGCCCCGGGATTAATGGCTGC-3’) and mmTdg-N151A-as (5’-
GCAGCCATTAATCCCGGGGCAATGCCAATGATCACAATA-3’) according to the manufacturer’s 
instructions. For the N-terminally His6-tagged TET1 catalytic domain (TET1CD aa 1367 - 2057) 
expression construct the cDNA of the mouse TET1 protein was amplified by adaptor PCR from an 
expression vector kindly provided by H. Leonhardt and introduced into the NotI and PacI sites of the 
pCDFDuet-1 vector (Novagen). 
Recombinant protein expression and purification 
The expression vectors were introduced into E.coli BL21(DE3) cells by electroporation. Overnight pre-
cultures were diluted with fresh pre-warmed LB medium and grown at 30°C to an OD600 level of 0.6 - 
0.8. Cultures were grown under selective pressure using either 50 mg/L of Kanamycin (TDG) or 50 
mg/L of Streptomycin (TET1CD). Protein expression was induced by the addition of the isopropyl-β-D-
thiogalactose (IPTG) to a final concentration of 250 µM and cultures were further incubated at 25°C for 
3 h (TET1CD) or at 15°C for 16 h (TDG). 
TDG was then purified as described previously (Kunz et al. 2009). Briefly, mTDG wt and Δcat were 
expressed from vectors pET28c-mTDGa.0 and pET28c-mTDGa.1, respectively, as described above. 
Cell lysis was carried out in Ni-NTA lysis buffer (50 mM Na-phosphate pH 7.5, 500 mM NaCl, 20% 
glycerol, 0.1% Tween-20, 20 mM imidazole, 20 mM β-mercaptoethanol, 0.1 mM PMSF) by sonication 
followed by extract clarification. The cleared supernatant was loaded onto a 5 mL HisTrap FF crude 
column (GE Healthcare) and bound protein was eluted with 400 mM imidazole. Eluted protein was 
dialyzed against Heparin buffer (25 mM Na-phosphate pH 7.0, 250 mM NaCl, 20% glycerol, 20 mM β-
mercaptoethanol, 0.1 mM PMSF), loaded onto a 5 mL HiTrap Heparin HP column (GE Healthcare) 
and bound protein was eluted with a linear gradient of 250 mM – 1.5 M NaCl. For ion exchange, 
relevant fractions were pooled, dialyzed against AIEX buffer (50mM Bicine pH 8.8, 25 mM NaCl, 20% 
glycerol, 20 mM β-mercaptoethanol, 0.1 mM PMSF) and loaded onto a 1 mL Resource Q column (GE 
Healthcare). Bound protein was eluted with a linear salt gradient of 25 mM – 1 M NaCl and the purest 
fractions were finally dialyzed against storage buffer (50 mM Tris-HCl pH 8.0, 50 mM NaCl, 10% 
glycerol, 1 mM DTT), frozen on dry-ice and stored at -80 °C. 
TET1CD was purified as described in Appendix I. The cleared lysate was loaded onto a 1 mL HisTrap 
FF crude column (GE Healthcare), bound protein was eluted with 400 mM imidazole and relevant 
fractions dialyzed against CIEX buffer (50 mM HEPES pH 7.2, 25 mM NaCl, 20% glycerol, 5 mM DTT 
and 0.1 mM PMSF). Dialyzed fractions were then loaded onto a 1 mL Resource S column (GE 
Healthcare) and bound protein was eluted with a linear salt gradient of 25 mM – 1 M NaCl and the 
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purest fractions were finally dialyzed against storage buffer (50 mM HEPES pH 7.2, 100 mM NaCl, 
20% glycerol, 5 mM DTT), frozen on dry-ice and stored at -80 °C. 
Oligonucleotides and substrate annealing 
The oligonucleotides were synthesized by Microsynth or supplied from Adam Robertson (5mC, 5hmC 
and 5caC containing oligonucleotides). Typically a 5’ fluorescein labeled upper strand was paired with 
its complementary lower strand. RNA/DNA hybrids were generated in annealing buffer (10 mM Tris-Cl 
pH 8, 50 mM NaCl) containing an unlabeled 25mer RNA (Subs25uG_RNA) and a complementary 5’-
fluorescein labeled 60mer DNA (Subs60lx-F) by heating at 95°C for 5 min and ramping to 4°C at a 
rate of 0.02°C/s. The R-loop substrates were generated in a two-step process in annealing buffer (10 
mM Tris-Cl pH 7.5, 2 mM MgCl2, 1 mM DTT). First, an unlabeled 25mer RNA (Subs25uG-RNA) and a 
5’-fluorescein labeled DNA (Subs60lx-F) were heated at 90°C for 1 min and the reaction was ramped 
to 71°C at a rate of 0.02°C/s before the unlabeled 60mer DNA (Subs60u_R-loop) was added and the 
reaction was ramped to 4°C. 
Name Sequence Description 











5’-fluorescein labeled 60mer, 










Unlabeled 60mer non-CG 




5’-fluorescein labeled 60mer, 
non-CG methylation, lower 
strand, x: 5mC 
Table 4.1:  List of oligonucleotides used to generate substrates for in vitro assays. 
Electrophoretic mobility shift assay 
EMSAs were performed using the double-stranded oligonucleotide substrates described above. 
Standard EMSAs were carried out in a total reaction volume of 10 µl containing 2 pmol of recombinant 
protein and 1 pmol of labeled DNA substrate with varying amounts of unlabeled competitor DNA in 1x 
reaction buffer (50 mM Tris-HCl pH 8.0, 1 mM DTT, 5% glycerol, and 1 mM EDTA). After incubation at 
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37 °C for 15 min, the reactions were loaded immediately onto 6% (19:1) native polyacrylamide gels 
and separated in 0.5x TBE for 50 min at 12 V/cm at room temperature. The fluorescein-labeled DNA 
was also visualized with a Typhoon 9400 (GE Healthcare) and quantified using the ImageQuant TL 
software (GE Healthcare). 
Base release assay 
The catalytic activity of the TDG and TET1CD in combination with TDG was monitored by means of a 
standardized nicking assay (Hardeland et al. 2000). TDG reactions were carried out in a reaction 
volume of 20 µL containing nicking buffer (50 mM Tris-HCl pH 8.0, 1 mM EDTA, 1 mM DTT, 1 mg/ml 
BSA), 0.5 pmol of substrate and 5 pmol purified TDG at 37°C for 15 min. The reactions for combined 
TET1CD and TDG were carried out in 40 µL reaction volume containing TET reaction buffer (50 mM 
HEPES pH 8, 50 mM NaCl, 1 mM Di-Sodium-Ketoglutarate, 2 mM Ascorbic acid, 75 µM Fe(II), 1 mM 
ATP), 0.5 pmol of substrate and 5 pmol purified TET1CD at 37°C for 30 min before addition of 5 pmol 
purified TDG and incubation for another 30 min. Reactions were stopped by addition of 1 M NaOH to a 
final concentration of 100 mM and heating at 99°C for 10 min. After EtOH precipitation at -20°C 
overnight, the products were separated in a 15% denaturing polyacrylamide gel and labeled DNA was 
detected using the red or blue fluorescence mode of the Typhoon 9400 (GE Healthcare) and analyzed 
quantitatively by ImageQuant TL software (v7.0, GE Healthcare). 
TDG time-course reactions were carried out in 200 µL reaction volume containing nicking buffer (50 
mM Tris-HCl pH 8, 1 mM DTT, 0.1 mg/mL BSA, 1 mM EDTA), 5 pmol of labeled substrate DNA and 5 
pmol of purified TDG. After the indicated times of incubation at 37°C, 20 µL aliquots were withdrawn 
and the reactions were stopped by the addition of 1 M NaOH to an end concentration of 100 mM and 
heating at 99°C for 10 min. Reaction products were analyzed by denaturing polyacrylamide gel 
electrophoresis and analyzed as described above. 
 
 TET proteins as potential SUMO targets 4.4.2
Posttranslational protein modifications, such as phosphorylation, acetylation, attachment of small 
polypeptides, are fast and energetically inexpensive ways to reversibly modulate stability, enzymatic 
activity and interaction dynamics of proteins. Modification by the SUMO proteins has turned out to be a 
widely applied regulatory mechanism; the number of SUMO substrates is still expanding alongside the 
number of mechanisms/pathways that are known to be regulated by SUMO. Molecular pathways 
affected by SUMO-modified proteins include most fundamental cellular transactions such as signal 
transduction, transcriptional regulation and DNA repair (Zhao 2007), and genome maintenance in 
general (Gill 2004). Notably SUMOylation plays a crucial role in developmental processes; depletion of 
non-redundant components of the SUMO pathway result in embryonic lethality (Lomeli and Vazquez 
2011). 
Previous biochemical studies have shown that SUMOylation of TDG provides an important regulatory 
function in the process of BER, facilitating the controlled dissociation of the glycosylase from the AP-
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site and passing the repair intermediate onto APE1 for further processing (Hardeland et al. 2002). 
SUMOylation might not only be important for modulating DNA affinity of TDG but could also play an 
essential role in the coordination and regulation of the entire repair process by orchestrating the 
assembly of proper function of downstream BER factors to the damaged site (Roland Steinacher, 
unpublished results). Given that a SUMOylation deficient variant of TDG causes a cell differentiation 
defect in mouse ESCs similar to that of a catalytic deficient TDG (Roland Steinacher, unpuslished 
data) we wondered whether SUMOylation could have a regulatory function in DNA demethylation and 
coordinate processes upstream of TDG. As a beginning, I therefore tested if TET1 or any of the other 
TET proteins are themselves targets of SUMO modification, making use of the newly established 
SUMOylation tools (see chapter 4.2, Appendix II). 
RESULTS 
I first conducted an in silico screen for potential SUMO conjugation consensus motifs (ψKxE, where ψ 
is a large hydrophobic residue, generally isoleucine, leucine or valine and x can be any residue 
(Sampson et al. 2001) in the TET1 sequence using various available SUMOylation prediction tools 
(SUMOsp 2.0, SUMOplot, SUMOFI). Owing to its large size, multiple SUMO sites were predicted and 
the number varies slightly depending on the used tool (Fig. 4.4 A). The number of potential sites was 
reduced by overlapping the results with the highest score and examination of the conservation of the 
Fig. 4.4: In silico screening for SUMO sites in mouse TET1. (A) The protein sequence of TET1 was analyzed 
for potential SUMO modification consensus motifs using three different prediction tools (SUMOsp 2.0, SUMOplot 
and SUMOFI, see Materials and Methods). Displayed are outputs with respective sequence context and score as 
received from the analysis tool, target lysine residues are highlighted in red. (B) The list of predicted TET1 
SUMOylation sites in mouse was aligned with a list containing predicted sites for human TET1 (not shown). 
Conserved sites between mouse and human TET proteins are displayed in red. (C) Scheme of the expression 
constructs used for the validation of the predicted SUMO sites. The positions of the predicted SUMO acceptor 
sites are K1208, K1221 and K1783. His6-tagged TET1N (aa 301 - 1366) containing two and His6-tagged TET1CD 
(aa 1367 - 2057) containing one predicted SUMO site, respectively, were used in combination with pSUMO1 and 
pSUOM3. Abbreviations; CXXC, CXXC zinc finger domain (aa 568 – 607); Cat, TET1 catalytic domain (aa 1367 – 
2057); C, Cys-rich region; DSβH, double-stranded beta helix. 
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predicted sites between mouse and human TET1, which then gave a final list of candidate sites (Fig. 
4.4 B). Two of the resulting candidate SUMOylation sites of mouse TET1 are located outside the 
catalytic domain in close proximity to each other (K1208 and K1221) and one site is within the catalytic 
domain (K1783) (Fig. 4.4 C). 
To evaluate the potential SUMOylation of TET1, I used the newly established in-cell and in-extract 
SUMOylation system for protein modification in E.coli (Weber et al. 2014) (Appendix II). TET1 was 
split into two expression constructs either containing the N-terminally His6-tagged TET1 N-terminal 
fragment (TET1N aa 301 - 1366) or the N-terminally His6-tagged TET1 catalytic domain (TET1CD aa 
1367 - 2057) (Fig. 4.4 C). SUMOylation was then induced either in-cell by co-expressing the TET1 
target constructs with pSUMO1 or pSUMO3 or in-extract by expressing the target and SUMOylation 
vectors separately followed by mixing of the cell lysates (for detailed methods see below and Appendix 
II). 
Following the in-extract approach first, I thus prepared crude lysates from E.coli cultures expressing 
separately the pSUMO1 and pSUMO3 components (250 µM IPTG at 30°C, 3 hours induction) and 
TET1N (250 µM IPTG at 25°C, 3 hours induction) as well as TET1CD (250 µM IPTG at 25°C, 3 hours 
induction) mixed the extracts at different volume ratios and incubated the combined lysates at 30°C in 
the presence of ATP for 1 hour. As a positive control, I used bacterial lysates of cells expressing TDG, 
which was previously shown to be efficiently modified in this procedure. Under these conditions, I 
could not detect TET1N by immunoblotting, indicating an insufficient production of soluble protein due 
Fig. 4.5: TET1N but not TET1CD is SUMO-modified. Extracts from E.coli BL21(DE3) cells expressing the 
SUMO1 or the SUMO3 system (250 µM IPTG at 30°C for 3 h) were mixed with extracts from cells expressing 
TET1CD (A) or TDG (B) (250 µM IPTG at 25°C for 3 h) with the indicated volume (V) ratios and analyzed using 
immunoblot with respective antibodies. (C) Immunoblot analysis of TET1N SUMOylation in E.coli cells, expressing 
the TET1N from pACYC-mTET1-N and the SUMO system from either the pSUMO1 or the pSUMO3 plasmid (250 
µM IPTG at 25°C for 3 h). a, b, c, d; different E.coli clones expressing the respective plasmids. 
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to codon-usage or folding issues (data not shown). However, TET1CD was readily detectable but did 
not seem to be SUMO-modified, neither by SUMO1 nor by SUMO3 (Fig. 4.5 A, lanes 2-7). Even the 
presence of a large excess of SUMOylation-potent extract did not produce any detectable SUMO-
modified TET1CD (Fig. 4.5 A, lanes 3, 4, 6 and 7). By contrast, a substantial amount of SUMO1- as 
well as SUMO3-modified TDG was produced using the same procedures (Fig. 4.5 B, lanes 2-7), 
confirming the activity of the SUMO extracts in the TET experiment. 
Next, I evaluated SUMOylation of the TET1N protein (Fig. 4.4 C) by co-expression with the 
recombinant SUMO system (pSUMO1 and pSUMO3) in E.coli. Two co-expressing E.coli clones each 
(SUMO1: a, b; SUMO3: c, d; Fig. 4.5 C) were analyzed for SUMOylation of TET1N under the applied 
expression conditions (250 µM IPTG at 25°C, 3 hours induction). I observed an additional prominent 
band in TET1 immunoblots migrating around 170 kDa, possibly corresponding to SUMO-modified 
protein, as compared to the negative control (TET1N expression alone) (Fig. 4.5 C). Seemingly, in-cell 
SUMOylation of TET1N could be achieved when it was co-expressed with the SUMOylation machinery 
from the pSUMO1 as well as pSUMO3 vector under these experimental conditions, albeit the 
efficiency was lower using pSUMO3.  
CONCLUSION AND OUTLOOK 
To investigate potential regulatory mechanisms in the process of DNA demethylation, I tested TET1 as 
a potential target for SUMO modification. Profound in silico analysis revealed that TET1 has several 
predicted SUMO conjugation consensus motifs, three of which are conserved between mouse and 
men, suggesting that these could represent genuine sites of modification. To establish a proof of 
concept I examined modification of mouse TET1, using the newly established SUMOylation system 
(Weber et al. 2014) (Appendix II). This revealed that only the N-terminus but not the catalytic domain 
of TET1 can be modified by SUMO1 as well as SUMO3. Notably, these results were obtained from a 
single experiment, but as the outcome was clearly positive, they can be taken as a strong indication 
for that TET1 being a SUMO-modified protein. From the observed pattern by immunoblot analysis, it 
appears that TET1N is modified at a single site. It can, however, not be concluded which of the two 
sites in the N-terminus is the target and further mapping studies, including site-directed mutagenesis 
of the predicted SUMO motifs, are required to ultimately identify the SUMO site. It will then be 
interesting to investigate the functional as well as structural consequences of the SUMO modification, 
particularly in the process of DNA demethylation in cooperation with TDG and BER. TDG has been 
described as SUMO target before affecting its structure and DNA binding properties to facilitate 
enzymatic turnover (Hardeland et al. 2002). Besides being covalently SUMO-modified, TDG also 
contains two SIMs, one in the N- and one in the C-terminal domain (Mohan et al. 2007), that could 
promote an interaction with TET or downstream BER factors. In silico analysis also predicted two 
conserved SIMs in the TET1 sequence (data not shown), further substantiating a potential involvement 
of SUMO in the coordination of TET-mediated processes. There are also multiple predicted 
SUMOylation sites for the other TET proteins TET2 and TET3 that are conserved between species 
(Fig. 4.6 A and B).  As more of the DNA demethylation factors are being identified as SUMO targets 
and interactors, it will be of great interest to explore the role of SUMO interactions, modifications, and 
transfer in the orchestration of the DNA repair mediated DNA demethylation. 
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MATERIALS AND METHODS 
In silico analysis for the prediction of SUMOylation sites 
For prediction of SUMOylation sites, online tools were used that are freely available on the internet. 
SUMOsp can be downloaded or used in an online version under http://sumosp.biocuckoo.org/. The 
SUMOplot analysis program is also an online tool that can be reached under 
http://www.abgent.com/sumoplot/. The SUmo MOtif FInder (SUMOFI) tool can be found under 
http://cbg.garvan.unsw.edu.au/sumofi/form.do. 
Fig. 4.6: In silico screening for SUMO sites in mouse TET2 and TET3. The protein sequence of (A) TET2 and 
(B) TET3 was analyzed for potential SUMOylation motifs (SUMOsp 2.0, SUMOplot and SUMOFI see Materials 
and Methods for details) which were then overlapped with a list containing predicted sites for human TET1 (not 
shown). Displayed are output sites with respective sequence context and score as received from the analysis tool 





The plasmids with the complete SUMO system (pSUMO1 and pSUMO3) were assembled by standard 
cloning methods as described in Appendix II and the plasmids, vector sequences and maps are 
available from Addgene (http://www.addgene.org/), plasmid ID 52258 and 52260. The cDNA of the 
mouse TET1 protein was amplified by adaptor PCR from an expression vector kindly provided by H. 
Leonhardt. For TET1N (aa 301 – 1366) the amplified fragment was introduced into the BamHI and 
PacI sites of pACYC-Duet1 vector (Novagen) and for TET1CD (aa 1367 – 2057) the fragment was 
introduced into the NotI and PacI sites of the pCDF-Duet1 vector (Novagen). 
Recombinant protein expression, in-cell and in-extract SUMOylation 
Detailed methods for in-cell and in-extract SUMOylation can be found in Appendix II. Briefly, 
expression vectors were introduced into E.coli BL21(DE3) cells by electroporation. Overnight pre-
cultures were diluted 20 times, grown at 30°C to an OD600 of ~ 0.8 and protein expression was 
induced by the addition of the isopropyl-β-D-thiogalactose (IPTG) and incubated at indicated 
temperatures for the indicated times. Cells were harvested by centrifugation and soluble protein 
fractions were extracted by sonication in lysis buffer for in-cell modification (50 mM Na-phosphate 
buffer pH 7.5, 300 mM NaCl, 10% glycerol, 0.1% Tween-20, 1 mM DTT, 1 mM PMSF) or in 
SUMOylation buffer for in-extract modification (50 mM Tris-HCl pH 8, 50 mM NaCl, 10% glycerol, 0.5 
mM DTT, 5 mM MgCl2, 5 mM ATP). Crude lysates were then cleared by centrifugation with >20’000 g 
at 4°C for 30 min. For in-extract SUMOylation the lysates were mixed at indicated volume ratios, 
SUMOylation was triggered by the addition of ATP to a final concentration of 5 mM and reaction 
mixtures were incubated at 30°C for 1 h. 
Analytical gel electrophoresis, western blotting and protein detection 
Protein fractions were analyzed by standard SDS-polyacrylamide gel electrophoresis (SDS-PAGE) 
followed by immunoblotting using chemiluminescence (WesternBright ECL, Advansta) according to 
the provider’s protocol. Antibodies were diluted in 5% non-fat dry milk TBS (100 mM Tris-HCl pH 8, 
150 mM NaCl) supplemented with 0.2% Tween-20: TDG, rabbit polyclonal ab 141, 1:20’000; TET1CD, 





5 Concluding Discussion and Outlook 
DNA cytosine methylation represents a key DNA modification throughout many phylogenies of life, 
which gained an important epigenetic function in multicellular organisms. Originally regarded as a 
rather static and rigid DNA mark, recent research has revealed unexpected dynamic features; the 
reversibility of DNA methylation was shown to be at the center of programming the genome function in 
mammalian development and life. Experimental evidence implicates the co-operation of both active 
and passive DNA demethylation processes to erase epigenetic marks. The search for candidate 
factors and mechanisms capable of actively reversing DNA methylation has been accompanied by 
controversy and uncertainty and led to the description of a variety of potential pathways (Ooi and 
Bestor 2008; S. C. Wu and Zhang 2010). Although still debated, the currently most plausible 
mechanisms involve DNA repair and are triggered by enzymatic activities that modify 5mC in order to 
make it visible for the repair machinery. Deamination of 5mC is one of them and would introduce a 
mismatch lesion to initiate DNA repair; several potential deaminases have been proposed to carry out 
the initial step in such a pathway (Fritz and Papavasiliou 2010). DNA demethylation triggered by 
oxidation of 5mC has also emerged as a plausible mechanism. Here, proteins of the TET family of 
DNA dioxygenases were suggested as candidates, owing to their ability to oxidize the methyl group of 
5mC (Inoue et al. 2011; Ito et al. 2011). Already the initial conversion of 5mC to 5hmC might facilitate 
passive DNA demethylation through replicative dilution, but further oxidation to 5fC and 5caC 
generates substrates for the DNA glycosylase TDG (He et al. 2011; Maiti and Drohat 2011), thereby 
initiating an active process to remove 5mC and restore an unmodified C. TDG was previously 
implicated in the control of DNA methylation (Dalton and Bellacosa 2012) but a clear mechanistic 
concept supported by both biological as well as biochemical evidence has not been established until 
now. 
During my PhD thesis, major advances were made in the field of active DNA demethylation and 
compelling evidence supporting an involvement of TDG in DNA demethylation has accumulated. In the 
proposed mechanisms TDG acts downstream of either 5mC oxidation by the TET dioxygenases or 
5mC deamination by the AID deaminases, but many mechanistic details remain unresolved. My work 
focused on the establishment of a reconstituted in vitro DNA demethylation system consisting of TET, 
TDG, BER and auxiliary factors to proof the functionality of a DNA oxidation and repair mediated 
demethylation. This system can then be employed to study mechanisms of coordination and regulation 
of the process and to address pertinent questions regarding its impact on genome stability. According 
to the generally accepted model of oxidative DNA demethylation, 5mC is iteratively oxidized to 5hmC, 
5fC and 5caC by the TET proteins followed by TDG-initiated DNA repair. This mechanism postulates a 
coupled action of TET and TDG to facilitate an efficient but coordinated removal of 5mC. The result of 
my work provides conclusive evidence for a direct physical interaction of TDG with TET1, mediated by 
domains located in the N- as well as C-terminus, linking TET1 to DNA repair. These results are also 
supported by recent findings in ES cells that showed co-localization of the two factors at sites 
undergoing dynamic epigenetic changes (L. Shen et al. 2013; C. X. Song et al. 2013a) (Annika Wirz, 
unpublished results). Moreover, the purified recombinant protein complex turned out to be highly 
active and capable of removing 5mC and 5hmC from a synthetic DNA substrate. Subsequent 
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biochemical experiments established a coupled action of both enzymes and showed for the first time 
that 5mC can be released via an oxidative intermediate using the combined activities of TET1CD and 
TDG. In the additional presence of the purified components of the core BER pathway, a methylated 
piece of DNA could for the first time be fully demethylated through a cascade of defined and 
coordinated enzymatic reactions. Hence, I was able to establish biochemical proof of functionality of 
TET-TDG-BER mediated active DNA demethylation. 
To what extent, where and under what conditions oxidative DNA demethylation occurs in cells still 
needs more clarification. DNA repair-mediated demethylation processes harbor a certain genotoxic 
potential, raising concerns about how genome stability is maintained at developmental stages 
requiring a great number of such repair events. I used the in vitro reconstitution system to study the 
repair process at fully methylated CpG sites, where complete DNA demethylation by BER inevitably 
involves nicking of both strands and thereby generates an evident risk of DNA DSB formation. 
Therefore, tight regulation and coordination of the repair process in this delicate situation is crucial to 
avoid gross genomic instability. Indeed, the omission of DNA POLβ and XRCC1/LIG3 from the 
reconstituted DNA demethylation assay gave rise to the formation of substantial amount of detectable 
DSBs whereas faithful symmetrical 5caC repair could be reconstituted in the presence of all the 
required repair factors. My data suggests that the repair processes at both DNA strands occurs in an 
arbitrary but sequential manner, where the initially attacked strand is completely repaired prior to 
processing of the opposite strand. I propose that the unusual high affinity of TDG to its product 
(Hardeland et al. 2000; Waters et al. 1999) provides for a highly coordinated progression through the 
BER steps, altogether preventing an unscheduled processing of 5caC on the opposite strand and 
facilitating efficient replacement of symmetrical 5mC with unmodified C. Such a mode of action would 
resolve a main conceptual caveat associated with excision repair-mediated active DNA demethylation, 
namely the destabilization of the genome through excessive DNA repair. 5mC is prone to deaminate 
with a higher rate than C, yielding a T (J. C. Shen et al. 1994), and this was used to explain the 
underrepresentation of CpG dinucleotides in the mammalian genome. As cells have evolved efficient 
repair mechanisms to counter the mutability of 5mC deamination, however, this concept always 
appeared to be somewhat incomplete. We reasoned that 5mC deamination could coincide with 
oxidative DNA demethylation and generated a substrate reflecting such a situation by placing a 5caC 
next to a G/T mismatch within a CpG dinucleotide. Here, base release by TDG did not occur in a 
random manner but with high preference at the 5caC, leaving the G/T mismatch unrepaired. Given 
this, the observed sequential action of the TDG-BER system at symmetrically modified CpGs, which 
avoids the induction of deleterious DNA DSBs, could have mutagenic consequences. My results show 
that in case the repair synthesis associated with the replacement of 5caC incorporates two (or more) 
instead of only one nucleotide, the G/T mismatch is resolved to an A·T base pair and, hence, the CpG 
dinucleotide mutated into a TpG. My data thus provide strong evidence that C to T mutations at 
methylated CpGs can arise when deamination clashes with oxidative DNA demethylation. In this case 
the repair system itself prevents G/T correction and favors mutation giving a possible explanation for 
the observed underrepresentation of CpG dinucleotides in the genome. 
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Interestingly, the initial oxidation step by TET appeared to be much more efficient than the oxidation of 
5hmC and 5fC in our in vitro experiments, resulting in higher amounts of 5hmC compared to 5fC and 
5caC, which correlates with their levels in cells (Ito et al. 2011; Pfaffeneder et al. 2011). 5hmC is 
considered to have a distinct biological function as it attracts a specific set of “reader” proteins (Spruijt 
et al. 2013). This raised the question how TET activity could be regulated in cells to ensure that 5hmC 
is sustained and further oxidation is only induced in presence of the right signals. To this end, I tested 
whether the presence of TDG or Gadd45a, another factor implicated in DNA demethylation, could 
stimulate TET1CD enzymatic activity and thus exert a regulatory function in the demethylation process. 
However, neither TDG nor Gadd45a did modulate any of the TET1CD-mediated oxidation steps. In 
contrast, presence of TET1CD stabilized the enzymatic activity of TDG, substantiating a functional 
interaction of them. Yet, little is known about the biological function and relevance of 5hmC and further 
studies regarding its impact on epigenetically regulated processes will contribute to the understanding 
of its catalysis and/or removal. 5fC and particularly 5caC occur at levels comparable to regular 
oxidative damage and might thus also be regarded as such, the role of TDG could then again be 
considered as classical repair enzyme. The low abundance of 5fC and 5caC might, however, simply 
reflect the high excision rate of these modifications and high dynamics of the demethylation process. 
This idea is supported by the observation of an accumulation of these demethylation intermediates in 
the absence of TDG (L. Shen et al. 2013; C. X. Song et al. 2013a)(Annika Wirz, Angelika Jacobs, 
unpublished results). 
Notably, I could establish some additional biochemical features of TET1CD and TDG. The enzymatic 
activity of both proteins is neither restricted to CpGs nor to double stranded DNA, suggesting that 
oxidative DNA demethylation might also occur in other contexts. TDG has previously been associated 
with RNA and was shown to process RNA/DNA hybrid structures (Christophe Kunz, unpublished 
results). I evaluated this activity in the light of oxidative DNA demethylation and demonstrated 5caC 
processing in RNA/DNA hybrids as well as in R-loops. Yet the biological relevance of this activity 
remains speculative. R-loops are typically found at the transcription bubble and suggested to exert 
various specific functions (Aguilera and Garcia-Muse 2012), e.g. the protection of CpG islands from 
hypermethylation and, thereby, the regulation of genes (Ginno et al. 2012). In this regard, R-loops 
might function as signal to recruit DNA demethylation factors including TDG to keep CGI promoters in 
a hypomethylated state. Indeed, data from our group showed that TDG is recruited to CpG-rich gene 
regulatory elements together with TET proteins (Annika Wirz, unpublished results). Whether this 
recruitment is targeted by R-loops or other RNA/DNA hybrids, however is not yet known. Although 
TDG was previously described to be involved in the regulation of gene expression (Cortazar et al. 
2011; Dalton and Bellacosa 2012; Sjolund et al. 2013), the underlying mechanism are not completely 
understood. Implicating a role of TET-TDG and BER in gene regulation, one could speculate that base 
release and subsequent nicking of the DNA might facilitate chromatin transactions at transcription start 
sites, which could contribute to gene activation. 
The biochemically investigated and here described sophisticated cascade of enzymatic events leading 
to DNA demethylation needs to be tightly regulated and orchestrated in cells, and is likely to involve 
regulatory processes such as posttranslational protein modifications. Given that SUMO-modification 
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and interaction is prominent in the regulation of TDG, SUMOylation and SUMO-binding might have 
coordinative and regulatory functions at specific stages of active DNA demethylation as well. 
Biochemical studies have previously implicated SUMOylation in modulating TDG activity (Hardeland et 
al. 2002; Steinacher and Schar 2005) and also in the coordination of the downstream BER process by 
mediating protein-protein interactions (Roland Steinacher, unpublished results). To investigate a 
function of SUMOylation in DNA demethylation, we developed a versatile SUMOylation system to 
generate recombinant SUMOylated proteins in E.coli. Using this system, we efficiently modified and 
purified the BER factors TDG and XRCC1. In addition, preliminary results indicated that TET1 is also a 
SUMOylation target and is modified in its N-terminal domain. This and the presence of SIMs in both 
TDG and TET1 might hint to a potential contribution of SUMO in the process of DNA demethylation. 
The inclusion of a dynamic SUMOylation system in the reconstituted DNA demethylation assay could 
facilitate the investigation of the regulation of individual steps in this process. Future studies will 
provide additional insight into the structural as well as functional implications of SUMO-modification on 
individual targets but also more globally on the coordination of the DNA demethylation process. 
In collaboration with Li Zheng and Guoliang Xu at the Chinese Academy of Science in Shanghai, we 
also explored other putative regulators of the DNA demethylation process by the TET-TDG cascade 
including those previously implicated. Among them is the multifunctional Gadd45a that was proposed 
to promote demethylation through XPG-dependent DNA repair (Barreto et al. 2007; Schmitz et al. 
2009) or BER of AID-based deamination products (Cortellino et al. 2011; Rai et al. 2008). Notably, 
Gadd45a has no described enzymatic activity itself but based on our results several lines of evidence 
point towards a regulatory role in the TET-TDG oxidative DNA demethylation pathway. We could show 
that Gadd45a enhanced the activation of a methylated reporter gene in HEK293T cells when co-
expressed with catalytically active TDG and TET. Furthermore, Gadd45a physically interacted with 
TDG and overexpression of Gadd45a increased the TDG-dependent removal of 5fC and 5caC from 
genomic and transfected plasmid DNA. Gadd45a and Gadd45b double knockout mouse ES cells were 
found to be hypermethylated at specific genomic loci that were described to be targets of TDG and 
show 5fC enrichment in TDG-deficient cells. Despite the diverse molecular functions that have been 
attributed to Gadd45a (Niehrs and Schafer 2012), our data indicate that DNA demethylation and 
activation of repressed genes is promoted specifically through TDG. Interestingly, Gadd45a does not 
appear to stimulate TDG in substrate binding, processing, or turnover in a specific manner when 
evaluated biochemically. We therefore favor a model whereby Gadd45a promotes TET-TDG mediated 
DNA demethylation by coordinating the recruitment of TDG into a demethylation complex. Gadd45a 
(and Gadd45b) could act as a scaffold protein which interacts with other epigenetic regulators and 
directs TDG to the target loci to efficiently excise 5fC and 5caC. 
In conclusion, my mechanistic investigations provided novel insight into individual steps of the active 
DNA demethylation process and thereby extend our current understanding of this aspect of epigenetic 
reorganization occurring in cells undergoing differentiation. The most conclusive active DNA 
demethylation scenarios comprise an initial triggering event by modifying 5mC either through 
deamination or oxidation to make it susceptible for DNA repair. My work has focused on the oxidative 
DNA demethylation and I provide functional evidence that DNA demethylation along the TET-TDG 
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axis is biochemically valid in various contexts. I, in collaboration with others, also suggest additional 
regulatory mechanisms and factors that could feed into this pathway, i.e. SUMOylation and Gadd45a, 
but the exact regulation and targeting of these processes in vivo still needs to be resolved. In contrast 
to the TET-initiated pathway, the deamination-triggered process is in many cases disfavored by the 
biochemical properties of the suggested deaminases that mainly function in epigenetically unrelated 
processes. In addition, deamination of bases in the genome, even programmed ones, harbors a 
certain mutagenic potential that needs to be counteracted immediately. It is possible that AID-
mediated DNA demethylation occurs under certain conditions at specific loci but other mechanisms, 
like oxidative DNA demethylation, are likely to operate in parallel and play a more prominent role. 
Biochemical as well as biological evidence has been accumulating, corroborating that the TET-TDG-
mediated DNA demethylation pathway is a frequently implicated epigenetic mechanism at different 
stages of the mammalian lifecycle (Kohli and Zhang 2013; Pastor et al. 2013; H. Wu and Zhang 2014). 
My data on the interaction of TET1 and TDG, their combined activity on 5mC as well as the 
reconstitution of the DNA demethylation process including downstream BER further supports this 
pathway, rendering it biochemically valid throughout. The fact that both proteins are also able to act 
outside CpG and double stranded DNA contexts makes it all the more versatile and likely to be 
involved in so far unexplored situations. In contrast to deamination-induced DNA demethylation, the 
oxidative pathway does not generate mutagenic intermediates. Instead, the TET-mediated C 
modifications appear to be truly epigenetic marks in the sense that they do not alter the DNA 
sequence but may be recognized by specific reader proteins. Through oxidation of 5mC, the genome 
can retain the necessary flexibility without directly affecting its integrity and coding information. Still, as 
I have shown, oxidative DNA demethylation may harbor a mutagenic potential under conditions where 
active DNA demethylation clashes with deamination of 5mC within a CpG dinucleotide. Nevertheless, 
active DNA demethylation events seemingly only make up a minor part in global methylation dynamics 
and TET proteins can also contribute to DNA demethylation in a targeted and repair-independent way 
by masking the methylation mark for passive dilution through oxidation without the need to excise the 
base. 
One could now ask whether active repair-mediated DNA demethylation is required at all. The answer 
is likely yes, but further studies are needed to evaluate where and under what circumstances DNA 
methylation states need to be maintained by or targeted for active DNA demethylation. Considering 
the iterative modification of C-5mC-5hmC-5fC-5caC-C as an ongoing cycle at certain loci under certain 
conditions, TET, TDG, BER and the DNMTs might operate as mediators of a dynamic equilibrium of 
DNA methylation and demethylation, establishing a steady-state rather than a stable methylation state 
at individual CpGs. Other factors like Gadd45a potentially also feed into this cycle and the purpose of 
the DNA repair mediated cycling may not be to regulate methylation in the first place but to maintain 
certain loci in a respective state of epigenetic plasticity. Most likely, this process of active epigenetic 
maintenance does not occur genome-wide but rather targeted and might be particularly important 
during phases where epigenetic patterns and transcriptional programs need to be correctly 
established, i.e. during cell differentiation or reprogramming of developmental potency. Disrupting this 
DNA methylation-demethylation cycle at any point, e.g. by depletion of TDG, would then lead to a 
locus-specific manifestations of aberrant epigenetic states. 
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With the results presented in my PhD thesis we are able to advance our understanding of the 
mechanism of active DNA demethylation. I, in collaboration with others, provide a biochemically 
validated concept for the coordinated and productive demethylation of DNA and additionally suggest 
potential regulatory mechanisms. Still much is to learn about the regulation, targeting and the 
sequence of events of this dynamic process but we are closer than ever to finally settle the debate 
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Cytosine methylation in CpG dinucleotides is an epigenetic DNA modification established and 
maintained by DNA methyltransferases. Recent research has substantiated the coexistence of active 
DNA demethylation processes, facilitating dynamic regulation of methylation states. One postulated 
pathway of active demethylation operates through TET hydroxylases that oxidize 5-methylcytosine 
(5mC) to generate substrates for TDG dependent base excision repair (BER), which then replaces 
5mC with C. Although mechanistically plausible, direct evidence for a functional and productive 
coupling of TET with BER has never been presented. Here, we show that TET1 and TDG interact to 
constitute a 5mC demethylase and proof by biochemical reconstitution that the TET/TDG-BER system 
is capable of productive DNA demethylation. We also show that intrinsic features of this mechanism 
assure a sequential demethylation of symmetrically methylated CpGs, thereby avoiding DNA double-
strand break formation, but can mutate CpGs if 5mC oxidation in one strand coincides with 5mC 




DNA methylation in mammals occurs almost entirely at the C5 position of cytosines (5-methylcytosine, 
5mC) and is found predominantly within CpG dinucleotides, affecting 60-90% of such sites1. 
Modulating chromatin states and thereby transcriptional activity and genome stability, DNA 
methylation plays an important epigenetic role in various biological processes2. It was long viewed as 
a largely static DNA base modification but recent research has shown that, under specific 
circumstances, DNA methylation undergoes dynamic regulation. This is best illustrated by its genome-
wide erasure during early embryonic development3-5 or in maturing primordial germ cells6. Locus 
directed DNA demethylation has also been observed in somatic cells upon triggering transcriptional 
activation in various ways7-9. Both passive and active pathways of DNA demethylation were proposed 
to operate in these contexts but the mechanisms underlying active demethylation, in particular, have 
remained controversial10. 
Recent evidence strengthens the case for an involvement of the ten eleven-translocation (TET) family 
of dioxygenases11. TET proteins oxidize 5mC to 5-hydroxymethylcytosine (5hmC), 5-formylcytosine 
(5fC), and 5-carboxylcytosine (5caC), all of which have been implicated as intermediates of DNA 
demethylation12-15. Considering active mechanisms, 5fC and 5caC appear of particular relevance as 
these bases are substrates for the thymine DNA glycosylase (TDG), a DNA repair protein previously 
characterized as an enzyme excising a variety of cytosine and 5mC base derivatives from DNA12,16-18. 
TET and TDG together thus constitute catalytic activities capable of oxidation and removal of 5mC in 
DNA. This biochemical reasoning is supported by the phenotype of TET19-21 and TDG knockout mice22-
24 as well as embryonic stem cells (ESCs), all showing aberrations in DNA methylation22,25-28. 
The evident mechanistic view is thus that TET and TDG cooperate to initiate active DNA 
demethylation by sequential oxidation and excision of 5mC in DNA. The resulting baseless site (AP-
site) is then repaired by the DNA base excision repair (BER) system to restore the original 
unmethylated DNA sequence. An engagement of the core BER pathway would imply that the AP-site 
is first recognized and incised by an AP endonuclease (i.e. APE1), which generates a DNA single-
strand break (SSB) that attracts and activates Poly [ADP-ribose] polymerase 1 (PARP1). PARP1 then 
facilitates the engagement of X-ray repair cross-complementing protein 1 (XRCC1), DNA ligase 3 
(LIG3) and DNA polymerase β (POLβ) for insertion of a new nucleotide and ligation of the DNA nick29. 
Although this mechanism is plausible and widely anticipated, there is in fact little evidence supporting 
a direct link between TET and BER; a productive action of TET with the BER system on a 5mC 
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substrate has not been shown, nor have the basic mechanistic features of such a process been 
addressed. 
The aim of this study was therefore to reconstitute the full DNA demethylation system in vitro and to 
address specific properties of the DNA transactions involved. We investigated physical and functional 
interactions between TET1 and TDG and tested the hypothesis that methylated DNA substrates can 
be fully converted to unmethylated DNA through oxidation and BER of 5mC. With the in vitro DNA 
demethylation system established, we addressed the strand-specificity of the reaction, whether 
symmetrically modified CpGs can be demethylated without DNA fragmentation, and how complex 
lesions such as the simultaneous deamination of a symmetrically opposite 5mC within a CpG 
dinucleotide do affect the demethylation outcome. The data proof full functionality of a TET1-TDG-
BER based DNA demethylation system on hemi- and fully methylated DNA and show that the 
molecular transactions involved are coordinated in a manner that avoids DNA DSB formation but can 
generate mutations if deamination and demethylation events coincide within a CpG. 
 
RESULTS 
TET1 and TDG interact physically 
The model of TET-TDG mediated oxidative DNA demethylation anticipates a coupled action of TET 
and TDG to facilitate an efficient but coordinated removal of 5mC. To address the mode of cooperation 
of TET and TDG, we examined a potential physical interaction of the two enzymes. We first co-
expressed a full length C-terminally 6His-tagged TET1 (TET1-His6) with a C-terminally GST-tagged 
TDG (TDG-GST). Although co-expression with TDG positively affected full-length TET1 expression, 
enrichment of TET1-His6 via Ni-NTA chromatography yielded prominent fragments migrating at sizes 
corresponding to 140 – 150 kDa, 90 kDa and 60 – 70 kDa. Size-fractionation of the eluate by gel 
filtration (Fig. 1a) showed that specific fragments of TET1-His6 (140 – 150 kDa, 60 – 70 kDa) co-
eluted with full-length TDG-GST in high molecular weight fractions (200 – 600 kDa). This occurred at 
high ionic strength (500 mM NaCl), indicating that the two proteins form a stable complex. Given the 
enrichment on the Ni-NTA resin, we concluded that the TET1 fragments isolated correspond to the C-
terminus of TET1 comprising the catalytic domain (Fig. 1a). A prominent 90 kDa fragment of TET1-
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His6, however, eluted in lower molecular weight fractions (90 – 200 kDa) showing only a partial 
overlap with TDG-GST, suggesting a weak interaction with TDG. 
To confirm and further characterize the TET1-TDG interaction, we used the yeast two-hybrid system. 
The TET1 protein was split into 4 fragments spanning the entire protein sequence (Fig. 1b) and fused 
to the Gal4 binding domain (bait). The TET1 constructs were then co-expressed separately with TDG 
fused to the Gal4 activation domain (prey). Growth on selective medium, allowing colony formation 
only if the reporter gene is activated by direct interaction of bait and prey proteins, indicated an 
interaction between TDG and the TET1 fragments 2 and 4, the former harboring the CXXC domain in 
the N-terminus, the latter spanning the C-terminal catalytic domain. These results indicate that the 
interaction between TET1 and TDG is mediated by domains located in the TET1 N-terminus (amino 
acids (aa) 397 – 931) as well as the catalytic domain (aa 1367 – 2057) (Fig. 1b). We next performed 
co-precipitations from lysates of E.coli cells co-expressing TDG-GST with either a His6-labeled TET1 
N-terminal fragment (TET1N; aa 301 – 1366) or the TET1 catalytic domain (TET1CD; aa 1367 – 2057) 
(Fig. 1c). After enrichment of His6-TET1N and His6-TET1CD using a Ni-NTA resin, TDG-GST was 
clearly co-eluting in the bound fraction of both TET1 fragments (Fig. 1c Ni-NTA). The outcome was the 
same when we enriched for TDG-GST, both TET1 fragments could be detected in the bound fraction 
after GST affinity purification (Fig. 1c, GST). The results of all protein interaction assays are consistent 
and lead us to conclude that TET1 and TDG physically interact through domains located in the TET1 
N-terminus (aa 397 – 931) as well as the TET1 catalytic domain (aa 1367 – 2057). 
 
A TET1CD/TDG protein complex releases 5mC and 5hmC via oxidized intermediates 
To examine the catalytic activity of the TET/TDG complex, we decided to work with TET1CD, which 
forms a complex with TDG as described above. We thus co-expressed the catalytic domain of TET1 
(His6-TET1CD) and TDG-GST as well as combinations of the respective catalytic-dead variants (His6-
TET1CD∆cat (H1652Y; D1654A) with TDG-GST; His6-TET1CD with TDG∆cat-GST (N151A)) in E.coli 
and enriched the complexes by Ni-NTA chromatography (Supplementary Fig. S1). The catalytic 
activities were then measured by means of a standardized base release assay30 with 2 fluorescein 
labeled synthetic 60 bp substrates containing a single 5mC or 5hmC. Incubation of the enriched His6-
TET1CD/TDG-GST with both these DNA substrates (1 h at 37°C) generated a substantial amount of 
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DNA incisions at the position of the modified cytosines (Fig. 2a). This 5mC/5hmC excision activity was 
not detectable when either of the two proteins was mutated at its catalytic site. Hence, the excision of 
5mC and 5hmC from DNA was dependent on the catalytic activities of both TET1 and TDG. 
To confirm that the base released in this assay was indeed oxidized 5mC or 5hmC, we examined the 
5mC oxidation products generated by His6-TET1CD purified in the absence of TDG. Purification of 
His6-TET1CD by Ni-NTA and ion exchange chromatography yielded two prominent protein fragments, 
both corresponding to TET1CD (Supplementary Fig. S2). Mass spectrometric analysis identified the 
smaller fragment as an N-terminal truncation lacking ~240 amino acids comprising the highly 
conserved Cys-rich domain, which was shown to be essential for the catalytic activity31. We tested the 
catalytic activity of this His6-TET1CD preparation in a plasmid based DNA oxidation assay (Fig. 2b). To 
this end, we in vitro methylated highly pure plasmid DNA using the M.SssI CpG methyltransferase, 
creating fully CpG methylated plasmids (200 pmol mCpG sites / µg DNA) and then reacted the 
methylated DNA (200 ng; 40 pmol mCpGs) with purified His6-TET1CD (500 ng; 6 pmol) at 37°C for 1 
hour. Immunoblot analyses with specific antibodies against 5mC, 5hmC, 5fC, and 5caC then showed 
that all detectable 5mC was fully oxidized to 5hmC, 5fC, and 5caC under these conditions. Hence, the 
His6-TET1CD efficiently carried out the predicted 5mC oxidation steps in vitro with the conversion of 
5mC to 5hmC representing the most efficient step (Fig. 2b). 
We next used separately purified TET and TDG proteins to reconstitute the 5mC release. To allow for 
preformation of the TET/TDG complex, we mixed His6-TET1CD with His6-TDG (Supplementary Fig. 
S2) at a molar ration of 2:1 (most active ratio as evaluated by titration) before addition of DNA 
substrates. A two-fold molar excess of TET/TDG (50 nM) over substrate DNA (25 nM) and incubation 
of 60 min at 37°C resulted in efficient release of both 5mC and 5hmC (Fig. 2c). Notably, 5mC was 
nearly as efficiently excised as 5hmC, indicating that TDG turnover32 rather than 5mC oxidation was 
rate limiting in this setup. As expected, 5caC was processed most efficiently. While it is fair to assume 
that TET1 was not required for 5caC release, it is noteworthy that its presence did not appear to 
interfere with TDG activity. 
Together, these results establish that TET1CD and TDG activities cooperate to efficiently excise 5mC 




TET stabilizes TDG activity 
To address whether TET1 and TDG cooperate at the level of their catalytic activities, we examined the 
effect of TDG on the efficiency of 5mC oxidation by TET1CD. In this setup, we used purified, catalysis 
deficient TDG to limit excision of TET-generated 5fC and 5caC. We thus pre-incubated His6-TET1CD 
(50 nM) with or without His6-TDG∆cat (25 nM), then added 5mC substrate (25 nM), stopped the 
reactions at different time points, and monitored the presence of 5fC and 5caC in the recovered 
product DNA by digestion with purified catalytic proficient TDG (250 nM). This showed that the 
presence of TDG∆cat had a minor but not statistically significant effect on 5mC oxidation by His6-
TETCD (Fig. 3a). Further evaluation of a potential effect of TDG on TET1 in a plasmid oxidation assay 
followed by LC/MS/MS analysis essentially supported this finding. We did, however, observe a slightly 
reduced conversion of 5hmC to 5fC and 5caC in presence of TDG∆cat under these multiple turnover 
conditions (Fig. 3b). This may indicate that TDG is rate limiting in the turnover of the TET1CD/TDG 
complex. Notably, the lack of detectable 5caC in the reactions with TDG∆cat is explained by the 
residual activity of the TDG catalytic mutant towards optimally suited substrates such as 5caC (see 
Fig. 2c)30. From these results, we conclude that, under single turnover conditions, purified His6-
TET1CD carries out all three 5mC oxidation steps equally efficiently irrespective of whether it is in a 
complex with TDG or not, while its efficiency in 5hmC oxidation is slightly reduced under multiple 
turnover conditions. Vice versa, the presence of a two-fold molar excess of TET1CD had a positive 
effect on TDG activity when compared to BSA added to the same molarity. The overall efficiency of 
base excision from 5caC•G (equimolar enzyme/substrate) and T•G substrates (five-fold excess of 
substrate) was enhanced, whereas the initial rate of excision by TDG was not affected (Fig. 3c). 
Hence, the interaction of TET1CD and TDG does not significantly impact on the TET1CD catalysis, but 
the presence of the TET1CD stabilized the activity of TDG. 
 
In vitro reconstitution of TET/TDG-BER mediated active DNA demethylation 
The current model TET1/TDG mediated active DNA demethylation postulates the engagement BER in 
the accurate restoration of the unmethylated DNA sequence following 5fC or 5caC excision. To 
formally proof the functionality of such a pathway and to provide a tool to investigate mechanistic 
features, we aimed to reconstitute the entire process of active DNA demethylation with defined 
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components. In addition to TET1CD and TDG, we thus purified to near homogeneity the enzymes of 
the core BER pathway33, APE1, POLβ and XRCC1/LIG3 (Supplementary Fig. S2). Using a 60 bp 
substrate containing a single 5mC, we first performed demethylation in step-by-step reactions to 
monitor the DNA intermediates generated. The combined action of His6-TET1CD and His6-TDG 
generated an AP-site cleavable either chemically by NaOH or enzymatically by APE1 to generate a 23 
nt oligonucleotide with or without a 3'-phosphate, respectively (Fig. 4a, lanes 3, 4). Following strand 
incision by APE1, POLβ was able to insert a dCMP, thus generating a 24 nt oligonucleotide as the 
main product (Fig. 4a, lane 5). Addition of either T4 ligase or an XRCC1/LIG3 complex then efficiently 
ligated the nicked intermediate, restoring a continuous 60mer DNA fragment (Fig. 4a, lanes 6 and 7). 
The nearly complete re-ligation confirmed the efficient removal of the 5’-dRP remains of the cleaved 
AP-site by POLβ. The results establish that TET1 and TDG convert 5mC to DNA repair intermediates 
amenable to processing by the core BER system. 
To test the accuracy of the reconstituted DNA demethylation process, we performed the reaction with 
a 5’-fluorescein labeled 59 bp DNA substrate presenting a hemi-methylated CpG dinucleotide within a 
recognition site for the HpaII endonuclease (CCGG) (Fig. 4b). Due to its methylation sensitivity, HpaII 
will not be able to cleave this substrate unless it undergoes successful and complete demethylation. 
We thus subjected the hemi-methylated substrate to demethylation by the reconstituted TET/TDG-
BER system and examined the generation of a cleavable restriction site by digestion with HpaII (Fig. 
4b). As expected, the asymmetrically methylated substrate was fully resistant to HpaII cleavage (Fig. 
4b, lane 2). Incubation in the presence of the reconstituted DNA demethylation system, however, 
generated HpaII digestible DNA products, indicating that the methylated DNA fragment was converted 
into an intact unmethylated fragment (Fig. 4b, lane 3). Together, these results proof that TET1/TDG 
mediated oxidation and excision of 5mC generates intermediates for BER, which then acts to 
efficiently restore the original DNA sequence in an unmethylated configuration. 
 
Coordinated operation of TET/TDG-BER prevents DNA DSB formation during demethylation of 
symmetrically methylated CpGs 
CpGs in mammalian DNA are mostly symmetrically methylated, generating a potential conflict for 
excision-repair mediated DNA demethylation; i.e. once started, a DNA demethylation event in one 
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DNA strand would have to be completed before another event starts at the symmetrically opposite 
5mC, which would otherwise lead to the formation of a DNA DSB. We therefore asked if in a 
symmetrically methylated CpG dinucleotide, demethylation events would generate DSBs or be 
confined to one strand at a time. For this purpose, we generated three 60 bp DNA substrates with 
either a fluorescein labeled bottom strand containing a single 5mC, a TexasRed labeled top strand 
containing a single 5mC, or both strands labeled and presenting a symmetrically methylated CpG (Fig. 
5a). Incubation of all these substrates with a two-fold molar excess of TET1CD/TDG produced a solid 
5mC release from both the bottom and the top strands, irrespective of whether the CpG was hemi- or 
symmetrically methylated (Fig. 5a). Activities on top and bottom strands in hemi-methylated substrates 
were similar, indicating the absence of sequence context effects in this setup (Fig. 5a, lanes 2, 4). 
Notably, the same reaction conditions applied to the substrate with 5mC modifications on both strands 
produced approximately half the amount of incised product on each DNA strand with the total activity 
remaining constant (Fig. 5a, lane 6). These results show that TET1CD/TDG can act on both strands on 
a substrate containing a symmetrically methylated CpG. 
To further investigate the demethylation events at symmetrically modified CpGs, we separated TDG 
from TET1 activities and measured the kinetics of 5caC processing in the context of potentially arising 
DNA demethylation intermediates. Using equimolar substrate and enzyme concentrations34, we 
evaluated substrates containing a 5caC on the labeled DNA strand opposite an unmodified C, a 5mC 
or a 5hmC within the same CpG (Fig. 5b). Under the conditions applied, both initial rate and overall 
5caC excision by TDG was not notably affected by the modification status of the symmetrically 
opposite C (Fig. 5b). 5caC was processed with appreciable efficiency even in single-stranded DNA, 
corroborating the high affinity of TDG for this substrate. The situation when 5caC arises in both 
strands simultaneously is of particular interest as it raises the possibility that TDG initiated BER will 
induce DNA DSBs. We thus evaluated the behavior of TDG in such a context, monitoring the release 
of 5caC from both strands in a time course base release assay with a substrate carrying labels on both 
strands. Similar to the combined activity of TET1/TDG on 5mC, the activity of TDG alone was 
distributed evenly to both strands carrying the 5caC (Fig. 5c), amounting to approximately 50% 
processing for each strand. The plateauing of single strand incision at 50% indicated that the 
processing of one DNA strand by TDG inhibited base release from the other strand. This is a likely 
consequence of TDGs tight interaction with AP-sites30,35, the coordinated dissociation of which32,36 
may favor completion of the repair process to initiation of an additional repair event at the opposite 
10 
 
strand. To test whether repair of a symmetrical demethylation intermediate is at all possible and can 
be achieved without the generation of DSBs, we used a substrate with a symmetrically 5caC modified 
HpaII site in a reconstituted TDG-BER assay and analyzed the generation of cleavable HpaII sites. 
Controls showed that both hemi- and symmetrically 5caC modified substrates were fully resistant to 
HpaII cleavage (Fig. 5d, lane 4, 6). Incubation of the symmetrically 5caC modified DNA with the TDG-
BER system, however, generated an appreciable amount of HpaII cleavable product. Thus, the 5caCs 
in both DNA strands were promptly replaced with unmodified Cs (Fig. 5d, lane 8). Notably, 
symmetrical repair, which essentially requires the breaking of both strands in the process, was not 
associated with the generation of detectable levels of DSBs (Fig. 5d, lane 7), indicating that repair 
events at both strands proceeded in a sequential manner. 
From these results, we conclude that DNA demethylation in vitro has no apparent strand and, hence 
sequence context preference. TET1/TDG is capable of initiating active DNA demethylation in both 
strands of a fully methylated CpG but the repair of symmetrically positioned 5caC modifications does 
not generate DNA DSBs. Once initiated in one strand, BER is completed before it restarts on the other 
strand, indicating that demethylation of symmetrically methylated CpGs occurs in a sequential manner 
protecting genome integrity. 
 
Active DNA demethylation inhibits G•T repair at methylated CpGs 
Another issue of BER mediated demethylation at symmetrically methylated CpGs is the potential 
collision with 5mC deamination. 5mC in genomic DNA is susceptible to spontaneous hydrolytic 
deamination37 generating in a thymine paired with a guanine. Such G•T mismatches are recognized 
and excised also by TDG. Enzymatic deamination coupled to BER has also been considered as a 
mechanism of active DNA demethylation7,23,38; it would replace a 5mC with an unmodified C through a 
mutagenic intermediate. To investigate potential interferences between deamination and oxidation-
induced DNA demethylation pathways, we evaluated G•T and G•5caC processing efficiencies in 
kinetic base release assays, using equimolar substrate/enzyme (His6-TDG) concentrations (25 nM). 
When provided on separate DNA molecules, TDG processed the G•T mismatch more efficiently than 
the 5caC substrate (Fig. 6a), showing that the mismatch is a preferred substrate as reported 
previously16. In a substrate where the G•5caC modification is next to a G•T mismatch within the same 
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CpG dinucleotide, reflecting a spontaneous deamination event on one strand while the other is being 
actively demethylated, however, TDG processes almost exclusively the 5caC, leaving the G•T 
mismatch untouched (Fig. 6b). Furthermore, the processing rate of 5caC was largely unaffected by the 
presence of the G•T mismatch, indicating that in this configuration 5caC is clearly the preferred 
substrate. The result was essentially the same when the modifications were inversed within the same 
double-stranded substrate (Supplementary Fig. S5), thus excluding DNA strand- or sequence context 
effects as an explanation for the preference for 5caC. 
This strong preference of TDG for the non-mutagenic 5caC next to a pre-mutagenic G•T mismatch 
implies that TET/TDG mediated active DNA demethylation has a potential to mutate CpG 
dinucleotides if it coincides with a deamination event. To test this possibility, we used our fully 
reconstituted BER setup on a 59 bp substrate containing a G•5caC next to a G•T mismatch within an 
MscI recognition site and analyzed the generation of mutant demethylation products by endonuclease 
digestion. 5caC directed sequential BER of this substrate would generate C to T mutations and thus 
create an MscI restriction site if two or more nucleotides were incorporated during the DNA re-
synthesis step (Fig. 6c). In the absence of the TDG-BER machinery, no MscI cleavage products were 
detectable (Fig. 6c, lane 3). Full reconstitution of TDG-BER, however, generated a cleavable product, 
indicating that the 5caC was correctly replaced with a C but an A was incorporated opposite of T, thus 
manifesting the C to T transition and a loss of a CpG dinucleotide (Fig. 6c, lane 4). 
 
DISCUSSION 
Recent biochemical as well as biological evidence points towards an active DNA demethylation 
mechanism involving TET proteins as well as the DNA glycosylase TDG12-14,16,17. The current model 
suggests that DNA demethylation through this pathway occurs in a stepwise manner via TET 
catalyzed oxidation of 5mC to 5fC and 5caC that are then excised by TDG dependent BER to restore 
an unmethylated sequence. Despite the general acceptance of this pathway, experimental evidence 
that directly links TET activity to TDG and BER is missing and fundamental mechanistic questions 
have not been addressed. The data presented here provide proof of a successful coupling of 5mC 
oxidation and TDG-initiated BER in a cascade of enzymatic reactions that productively demethylates 
DNA. In vitro reconstitution of the active demethylation of symmetrically modified CpGs revealed a 
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mechanism that is intrinsically coordinated to operate sequentially on both strands. While this prevents 
the formation of DNA DSBs, and hence genomic instability, the process can be mutagenic if 5mC 
deamination and oxidative demethylation events coincide on opposite strands in a CpG dinucleotide. 
In line with co-localization evidence reported previously39 our biochemical work provides strong 
evidence for a direct physical interaction of TET1 with TDG, linking 5mC oxidation to base excision. 
This interaction, which involves structures within the N-terminus and the catalytic domain of TET1, 
allowed us to enrich a functional TET1/TDG complex from E.coli lysates that was highly active and 
capable of removing 5mC from a synthetic DNA substrate. In contrast to previous studies, showing 
5mC conversion by TET and base excision by TDG in separate assays12,13,16, our data demonstrate 
the functionality of a complex of both enzymes in couple 5mC oxidation and excision. 
The relative high abundance of 5hmC in cells compared to 5fC and 5caC13,40 suggests that 5mC 
oxidation by TET enzymes is tightly regulated. One way of explanation is that the rate of the initial 
oxidation of 5mC to 5hmC by TET enzymes is higher than that of the subsequent oxidations of 5hmC 
or 5fC. The latter oxidation steps may depend on or be stimulated by the presence of additional 
factors, such as the TDG13,41 and/or Gadd4542,43. We examined this possibility but did not measure a 
stimulatory effect of TDG on TET1CD catalysis at any step of oxidation, neither did we observe such an 
effect for Gadd45a added to the TET1CD/TDG complex (Supplementary Fig. S3). These experiments 
were done with TET1CD, however, leaving the possibility that the missing N-terminus with its zinc finger 
CXXC domain may play an allosteric regulatory role. Additional work is needed to address the 
important question of TET1 regulation; i.e. to identify the factors and mechanisms determining the 
patterning of genomic 5hmC, 5fC and 5caC generation. The reconstituted demethylation assay 
presented here will be instrumental in this endeavor. 
The engagement of a DNA glycosylase in active DNA demethylation inevitably generates a need for 
repair of AP-sites. Evidence supporting an involvement of the BER pathway has been reported for 
PGCs, where an increase of DNA SSBs and BER activity was linked to active global DNA 
demethylation44, and in a recent study, demonstrating that various BER proteins co-precipitate with 
TET1, when overexpressed in HEK293T cells39. With the successful in vitro reconstitution of 
TET1/TDG-BER-mediated DNA demethylation, we provide the first direct evidence for a physical and 
functional coupling of these factors in the oxidation and excision of 5mC and the re-synthesis of an 
unmethylated CpG. While, from a mechanistic point of view, BER-mediated DNA demethylation seems 
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a straightforward process, it raises concerns regarding potential adverse effects on genome stability, 
particularly where the density of CpGs undergoing demethylation is high and excessive formation of 
DNA strand-breaks might occur. It is therefore fair to assume that active demethylation in cells is a 
highly orchestrated process, controlled through regulatory mechanisms also involving posttranslational 
modifications18,32,36. Our in vitro DNA demethylation system does not recapitulate regulatory actions of 
this kind but it does inform on intrinsic features of the mechanism regarding the potential of DNA DSB 
formation and the handling of complex substrates. 
A distributive mode of action of TET proteins, for instance, would produce a variety of demethylation 
intermediates with 5caC placed opposite from 5mC, 5hmC or an unmodified C within CpG 
dinucleotides, the precise configuration of which may then determine the efficiency of initiation of BER. 
This, however, seems an unlikely regulatory concept as TDG processed 5caC with high efficiency 
irrespective of the opposite C modification. Yet, our experiments also indicate that while the TET/TDG 
demethylase is capable of acting on both strands at symmetrically modified CpGs, it does so in a 
sequential manner without producing DNA DSBs. Even with substrates containing the efficiently 
processed 5caC in both strands, TDG-mediated BER did not generate detectable DNA DSBs, and this 
was not due to a preferential action of TDG on one strand only. Owing to its high affinity to AP-sites, 
TDG will not easily turnover in these reactions30,35. In the specific case of the occurrence of 
symmetrical lesions within CpG dinucleotides, such as during symmetrical DNA demethylation, this 
feature of TDG constitutes an important protective mechanism; not only will it provide an opportunity to 
coordinate AP-site repair but also protect the substrate in the opposite strand from being repaired at 
the same time. Biochemical evidence suggests that TDG will dissociate only in the presence of 
downstream BER factors, which then allows for efficient repair of the AP-site, restoration of the DNA 
strand with an unmodified C, and ultimately initiation of repair at the opposite strand. The importance 
of this coupling of 5caC excision to the BER process in this delicate situation is highlighted by the 
observation that in absence of POLβ and XRCC1/LIG3, TDG and APE1 generated an appreciable 
amount of DSBs in symmetrically modified substrates (Supplementary Fig. S4). We therefore argue 
that BER in the context of active DNA demethylation occurs in a processive manner, where the initially 
attacked strand is fully repaired prior to processing of the opposite strand (Fig. 6d). This may explain 




Another complex situation that may arise is the coincident deamination and oxidation of symmetrically 
opposed 5mCs in CpG dinucleotides. Methylated CpGs are well known for their increased mutability, 
which is to a large extent due to the higher rate of hydrolytic deamination of methylated cytosines 
compared unmethylated cytosines45. Such deamination events occur with an appreciable frequency in 
the genome and will generate G•T mispairs within methylated CpG dinucleotides37. This observation 
alone, however, does not explain the relatively high C to T mutation rates as cells have efficient 
mechanisms in place to repair the pre-mutagenic G•T mismatch, e.g. TDG or MBD4 mediated BER18. 
Our data on G•T versus 5caC repair in CpG dinucleotides provide a plausible biochemical explanation 
of how G•T mismatches might occasionally escape correction and turn into mutations. While, 
consistent with previous observations16, TDG processed the G•T mismatch with higher efficiency than 
5caC when the two lesions were analyzed separately, 5caC was processed with a striking preference 
when both substrates were present within the same CpG, reflecting a situation where spontaneous 
deamination occurs at a site that is being actively demethylated (Fig. 6d). Evidently, TDG has a high 
affinity for 5caC, even when base-paired with a G, consistent with the uniquely specific active site 
contacts it establishes with this substrate46,47. The sequential repair of both lesions, which, as argued 
above, helps to avoid the formation of DNA DSBs, turns into a disadvantage in this particular situation. 
The initial 5caC processing in the context of DNA demethylation would mask a nearby G•T mismatch 
for repair and fix the C to T mutation within the CpG dinucleotide whenever the re-synthesis step of 
BER incorporates more than just one nucleotide (Fig. 6d). 
In conclusion, our data provide proof of functionality of an active DNA demethylation pathway based 
on the coupled oxidation and excision repair of 5mC, they provide insight into how intrinsic features of 
the mechanism allow demethylation of symmetrically methylated CpGs without the formation of DNA 
DSBs and how it may contribute to C to T mutagenesis within methylated CpG dinucleotides. Having a 
fully reconstituted DNA demethylation process established will allow future investigations into the 
detailed mechanism of the process, including the important aspect of regulation. 
 
MATERIALS AND METHODS 
Bacterial expression vectors: The plasmids for the expression of TDG (GI: 37589917) (pTG-mTDGa.0, 
pET28-mTDGa.0, pET28-mTDGa.1), TET1 (GI: 568968019) (pCDF-mTET1), TET1 catalytic domain 
15 
 
(aa 1367 – 2057) (pCDF-His-mTET1CD, pCDF-His-mTET1CD∆cat), TET1 N-terminus (aa 301 - 1366) 
(pACYC-mTET1-N),  APE1 (GI:18375501) (pPRS125, pEThis-APE1.0), POLβ (GI:4505931) 
(pPRS112, pQE30-6HIS-Polβ), XRCC1 (GI:190684675) (pET-XRCC1) and LIG3 (GI:73747829) 
(pGEX4T-Lig3) were assembled by standard cloning methods based on PCR amplification with 
adaptor-oligonucleotides providing suitable restriction sites. 
Antibodies: TDG, rabbit polyclonal ab 141, 1:20’000; TET1CD, rabbit polyclonal α-TET1 ab (Millipore), 
1:5‘000; TET1-N, rabbit polyclonal α-TET1 ab (Genetex), 1:10‘000; 5mC,  mouse monoclonal α-5mC 
ab (Diagenode), 1:250; 5hmC, rabbit polyclonal α-5hmC (Active motif), 1:20‘000, 5fC rabbit polyclonal 
α-5fC (Active motif), 1:2‘500; 5caC, rabbit polyclonal α-5caC (Active motif), 1:2‘000. 
5-carboxyethyl-N4-benzoyl-dC CE phosphoramidite: The 5caC phosphoramidite (5-carboxyethyl-N4-
benzoyl-dC CE) was synthesized in collaboration with Glen Research (USA). 
Oligonucleotides: 60mer (Substrate 1 and 3) or 59mer (Substrate 2) double-stranded oligonucleotide 
substrates containing different modifications were prepared by annealing of two complementary 
oligonucleotides synthesized by Adam Robertson or Microsynth (Switzerland). The upper strand was 
either unlabeled or carried a 5’-TexasRed label, the lower strand was unlabeled or carried a 5’-
fluorescein label. Substrate 1 (standard) upper strand 5’- 
TAGACATTGCCCTCGAGGTACCATGGATCCGATGTXGACCTCAAACCTAGACGAATTCCG -3’ 
where X = C, T, 5mC, 5hmC, 5caC. Substrate 1 lower strand strand 5’-
CGGAATTCGTCTAGGTTTGAGGTXGACATCGGATCCATGGTACCTCGAGGGCAATGTCTA-3’, 
where X = T, 5mC, 5hmC or 5caC. Substrate 2 upper strand 5’- 
TAGACATTGCCCTCGACGACCCGCCGCCGCGCXGGCCACCCGCACCTAGACGAATTCCG -3’ 
where X = C, T, 5mC, 5hmC, 5caC. Substrate 2 lower strand 5’- 
CGGAATTCGTCTAGGTGCGGGTGGCXGGCGCGGCGGCGGGTCGTCGAGGGCAATGTCTA -3’ 
where X = 5mC, 5hmC, 5caC. Substrate 3 upper strand 5’- 
TAGACATTGCCCTCGACGGTGCCCTCXGGGCCGCGCGTCGCGCTCCCTAGACGAATTCCG -3’ 
where X = C. Substrate 3 lower strand 5’- 
CGGAATTCGTCTAGGGAGCGCGACGCGCGGCCXGGAGGGCACCGTCGAGGGCAATGTCTA -3’ 




Recombinant protein expression 
The expression vectors were introduced into E.coli BL21(DE3) cells by electroporation. Overnight pre-
cultures were diluted with fresh pre-warmed LB medium and grown at 30°C to an OD600 level of 0.6 - 
0.8. Cultures were grown under selective pressure using respective antibiotics at concentrations of 
either 100 mg/L of (Ampicillin) or 50 mg/L (Kanamycin, Streptomycin) for single plasmid expressions 
and half the concentration of each antibiotic when co-expressing two plasmids. Protein expression 
was induced using following conditions: TET1 (250 µM IPTG, 25°C for 3 h), TET1/TDG (250 µM IPTG, 
25°C for 3 h), TDG (250 µM IPTG, 15°C for 16 h), APE1 (500 µM IPTG, 25°C for 6 h), POLβ (500 µM 
IPTG, 25°C for 3 h), LIG3 and XRCC1 were co-expressed (250 µM IPTG, 25°C for 4 h). Finally, cells 
were harvested by centrifugation and soluble protein fractions were extracted by sonication (Bioruptor, 
Diagenode) or homogenization (Emulsiflex C-3, Avestin) in lysis buffer (50 mM Na-phosphate buffer 
pH 7.5, 300 mM NaCl, 20% glycerol, 0.1% Tween-20, 1 mM DTT, 1 mM PMSF), if not stated 
otherwise. Crude lysates were then cleared by centrifugation with >30’000 g at 4°C for 60 min. 
 
Protein purification 
For TET1CD purification, the cleared lysate was loaded onto a 1 mL HisTrap FF crude column (GE 
Healthcare), bound protein was eluted with 400 mM imidazole and relevant fractions dialyzed against 
CIEX buffer (50 mM HEPES pH 7.2, 25 mM NaCl, 20% glycerol, 5 mM DTT and 0.1 mM PMSF). 
Dialyzed fractions were then loaded onto a 1 mL Resource S column (GE Healthcare) and bound 
protein was eluted with a linear salt gradient of 25 mM – 1 M NaCl and purest fractions finally dialyzed 
against storage buffer  (50 mM HEPES pH 7.2, 100 mM NaCl, 20% glycerol, 5 mM DTT), frozen on 
dry-ice and stored at -80 °C. 
The BER proteins were purified as followed; in brief, APE1 and POLβ were purified with Ni-NTA 
affinity and ion exchange chromatography as described before34,48. TDG was purified by Ni-NTA 
affinity, heparin affinity and ion exchange chromatography as described before49. LIG3 and XRCC1 
were purified as complex by Ni-NTA, GST and Ni-NTA affinity chromatography according to the 
manufacturer’s instructions. Highly pure fractions were dialyzed against storage buffer (10 mM Tris-
HCl pH8, 50 mM NaCl, 10% glycerol), snap frozen and stored at -80°C. 
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Gel filtration: Gel filtration was performed using a Superdex 200 10/300GL column (GE Healthcare) 
and an ÄKTA Purifier 10 (GE Healthcare) according to the manufacturer’s instructions. Ni-NTA 
enriched fractions were prepared as described above. Ni-NTA elution fractions were pooled, 
concentrated to 8 mg/mL using Amicon Ultra Centrifugal Filters (Millipore) and buffer was changed to 
gel filtration running buffer (50 mM Na-phosphate pH 7.5, 500 mM NaCl, 20% glycerol). 4 mg of the 
enriched fraction was then loaded onto the gel filtration column. Column washing, loading and 
sampling of the fractions was done according to the manufacturer’s instructions. 0.5 mL fractions were 
collected and 20 µL of each fraction was used for SDS-PAGE and Western blot analysis. 
Batch Ni-NTA and GST affinity purification: To study the interaction of TDG and TET1, Ni-NTA and 
GST pull-down assays were performed. TDG-GST was co-expressed with a TET1 N-terminal 
fragment (His6-TET1-N aa 301 - 1366) or the TET1 catalytic domain (His6-TET1CD aa 1367 - 2057) in 
E.coli as described above. 5 mg of cleared E.coli lysate was then incubated with 25 μL of Glutathione 
Magnetic Beads (Thermo Scientific) or Ni-NTA Sepharose beads (Roche) in binding buffer (50 mM 
Na-phosphate pH 7.5, 300 mM NaCl, 20% glycerol, 0.1% Tween-20, 1 mM DTT, 1 mM PMSF) in a 
total volume of 1 mL at room temperature for 2 h. The beads were rinsed 3 times with 500 μL binding 
buffer and bound proteins were analyzed by SDS-PAGE and Western blotting. 
Partial purification of the TET1CD/TDG complex for activity assays was done via Ni-NTA affinity 
purification as described above. As catalytic mutants, His6-TET1CD∆cat (H1652Y; D1654A) and 
TDG∆cat-GST (N151A) were used. 
 
Analytical gel electrophoresis and western blotting 
Protein fractions were analyzed by standard SDS-polyacrylamide gel electrophoresis (SDS-PAGE) 
followed by Coomassie blue staining or by immunoblotting using chemiluminescence (WesternBright 
ECL, Advansta) according to the provider’s protocol. Antibodies were diluted in 5% non-fat dry milk 
TBS (100 mM Tris-HCl pH 8, 150 mM NaCl) supplemented with 0.2% Tween-20. 
 
Yeast Two Hybrid assay 
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To confirm the interaction between TET1 and TDG yeast two hybrid was performed using he 
Matchmaker yeast-two hybrid system (Clontech). TET1 was divided into 4 overlapping fragments 
(TET1-1 aa 1-491; TET1-2 aa 397-931; TET1-3 aa 870-1403; TET1-4 aa 1367-2057) that were cloned 
into the BD (pAS2.1 BD FLAG) of the Gal4 protein, TDG was cloned into the AD (pACT2 AD) of the 
Gal4 protein. The Saccharomyces cerevisiae strain AH109 was co-transformed with 50-500 ng of bait 
and prey plasmids according to the Clontech manual. Interactions were assessed by spotting serial 
dilutions of cells on selective medium (SC-LEU-TRP-ADE-HIS) supplemented with 2.5 mM 3AT (3-
Amino-1,2,4-triazole), a competitive inhibitor of the HIS3 gene product. Cells were incubated at 30°C 
for 6 to 7 days. 
 
Base release assay 
The catalytic activity of the TET1/TDG complex was monitored by means of a standardized nicking 
assay 30. The reactions were carried out in a reaction volume of either 40 µL when using partially 
purified TET1/TDG complex from Ni-NTA affinity purification fractions or 20 µL when using purified 
recombinant protein containing TET reaction buffer (50 mM HEPES pH 8, 50 mM NaCl, 1 mM Di-
Sodium-Ketoglutarate, 2 mM Ascorbic acid, 75 µM Fe(II), 1 mM ATP), 0.5 pmol of substrate and 10 uL 
of Ni-NTA pulldown or 2 pmol purified TET1CD and 1 pmol purified TDG (preincubated together on ice 
for 5’) respectively. Reactions were incubated at 37°C for 1 h and stopped by addition of 1 M NaOH to 
a final concentration of 100 mM and heating for 10 min at 99°C. After EtOH precipitation at -20°C 
overnight, the products were separated in a 15% denaturing polyacrylamide gel and labeled DNA was 
detected using the red or blue fluorescence mode of the Typhoon 9400 (GE Healthcare) and analyzed 
quantitatively by ImageQuant TL software (v7.0, GE Healthcare). 
TDG time course reactions were carried out in 200 µL reaction volume containing nicking buffer (50 
mM Tris-HCl pH 8, 1 mM DTT, 0.1 mg/mL BSA, 1 mM EDTA), 5 pmol of labeled substrate DNA and 5 
pmol of purified TDG. After the indicated times of incubation at 37°C, 20 µL aliquots were withdrawn 
and the reactions were stopped by the addition of 1 M NaOH to an end concentration of 100 mM and 
heating for 10 min at 99°C. Reaction products were analyzed by denaturing polyacrylamide gel 




In vitro methylation and oxidation of plasmid DNA and slot blot analysis 
In vitro methylation of pUC19 plasmid DNA was performed using M.SssI CpG methyltransferase (New 
England Biolabs) according to the manufacturer’s instructions. 
For the in vitro oxidation 200 ng of methylated plasmid was incubated with 500 ng purified His6-
TET1CD from E.coli (see above). The reaction was carried out in TET reaction buffer (50 mM HEPES 
pH 8, 50 mM NaCl, 1 mM Di-Sodium-Ketoglutarate, 2 mM Ascorbic acid, 75 µM Fe(II), 1 mM ATP) 
and incubated at 37°C for 1 h. Reaction was stopped with the addition of NaOH and EDTA to a final 
concentration of  400 mM and 10 mM respectively and heating at 99°C for 10 min. The denatured 
DNA was blotted using the Bio-Rad slot blot system according to the manufacturer’s instruction. 
Hybond-N+ nylon membranes (Amersham) were UV-crosslinked, blocked with 5% milk and 
immunostaining against 5mC, 5hmC, 5fC and 5caC was performed using chemiluminescence 
(WesternBright ECL, Advansta) according to the provider’s protocol. Antibodies were diluted in 5% 
non-fat dry milk TBS (100 mM Tris-HCl pH 8, 150 mM NaCl) supplemented with 0.2% Tween-20. 
 
LC/MS/MS analysis 
Plasmid DNA samples were enzymatically hydrolyzed to deoxyribonucleosides by incubation at 45ºC 
for 40 min in 10 mM ammonium acetate buffer pH 5.3 containing 5 mM magnesium chloride and 0.2 U 
nuclease P1 from Penicillium citrinum (Sigma, N8630). The samples were then buffered in ammonium 
bicarbonate to a final concentration of 100 mM and incubated at 37ºC for 30 min with 0.0002 U 
phosphodiesterase I from Crotalus adamanteus venom (Sigma, P3243) and 0.3 U alkaline 
phosphatase from E.coli (Sigma, P5931). The reactions were stopped and contaminants, that could 
potentially clog the HPLC column, were precipitated by adding three volume equivalents of ice-cold 
acetonitrile and centrifugation at 16,000 g for 30 min. The supernatants were collected in new tubes 
and vacuum centrifuged at room temperature until dry. Salt residues, originating from buffers, were 
partially evaporated by re-dissolving the samples in 100 µL of water and vacuum-drying one more 
time. The standards for 5-me(dC), 5-hm(dC), 5-ca(dC) and 5-f(dC) were prepared to contain the same 
amount of salts as the samples and followed the same desalting procedure. The samples were then 
finally dissolved in 50 µL of water for LC/MS/MS analysis of 5-me(dC), 5-hm(dC), 5-ca(dC) and 5-
f(dC). For quantification of unmodified nucleosides (dA, dC, dG and dT) samples were diluted 1:10 
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with water. For some of the samples 1:10 dilution was also used during quantification of 5-me(dC). 
Quantification was performed with the use of an LC-20AD HPLC system (Shimadzu) coupled to an 
API 5000 triple quadrupole (ABSciex) operating in positive electrospray ionization mode. The 
chromatographic separation was performed at 40ºC with the use of an Ascentis Express C18 2.7 µm 
150 x 2.1 mm i.d. column protected with an Ascentis Express Cartridge Guard Column (Supelco 
Analytical) with an Exp Titanium Hybrid Ferrule (Optimize Technologies Inc.). The mobile phase 
consisted of A (water, 0.1% formic acid) and B (methanol, 0.1% formic acid) solutions. Following 
conditions were employed during chromatography: for unmodified nucleosides – 0.13 mL/min flow, 
starting at 10% B for 0.1 min, ramping to 60% B over 2.4 min and re-equilibrating with 10% B for 4.5 
min; for 5-me(dC), 5-hm(dC), 5-ca(dC), and 5-f(dC) -  0.14 mL/min flow, starting at 5% B for 0.5 min, 
ramping to 45% B over 8 min and re-equilibrating with 5% B for 5 min. For mass spectrometry 
detection the multiple reaction monitoring (MRM) was implemented using the following mass 
transitions: 252.2/136.1 (dA), 228.2/112.1 (dC), 268.2/152.1 (dG), 243.2/127.0 (dT), 242.1/126.0 [5-
me(dC)], 258.1/142.0 [5-hm(dC)], 256.1/140.0 [5-f(dC)], 272.1/156.0 [5-ca(dC)]. 
 
BER reconstitution 
The BER reconstitution reaction was carried out stepwise to analyze individual stages of the process. 
The reaction mixture containing 1 pmol labeled 60 bp or 59 bp DNA, 5 pmol His6-TET1CD and 2 pmol 
His6-TDG were incubated at 37°C for 30 min in TET reaction buffer (50 mM HEPES pH 8, 50 mM 
NaCl, 1 mM Di-Sodium-Ketoglutarate, 2 mM Ascorbic acid, 75 µM Fe(II), 1 mM ATP) to generate an 
AP-site. The reaction mixture was then supplemented with 70 mM KCl, 7 mM MgCl2, 200 µM dCTP or 
dNTP, 2 mM ATP, 500 µg/mL BSA, 1 mM DTT and 10 pmol APE1 and incubated at 37°C for 5 min. 
0.5 pmol DNA polymerase β was then added and the reaction mixture incubated for a further 5 min. 
Finally 2 pmol XRCC1/DNA ligase III complex was added for a 10 min incubation. Reactions were 
terminated by the addition of stop buffer (50 mM Tris-Cl pH 8, 0.5% SDS, 100 mM NaBH4) and 
incubation on ice for 20 min. The reaction products were analyzed by denaturing polyacrylamide gel 
electrophoresis and analyzed as described above. 
For the analysis of the endproduct with HpaII or MscI endonuclease digest, the reconstitution reaction 
was carried out by adding all the factors at the same time and incubation at 37°C for 1 h followed by 
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EtOH precipitation of the labeled DNA at -20°C overnight. The recovered DNA was then treated with a 
total of 5 U HpaII or MscI endonuclease (New England Biolabs) at 37°C for 60 min, fragments were 
separated in 8% native polyacrylamide gels and detected as described above. 
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Figure 1: TET1 physically interacts with TDG. (a) Size fractionation by gel filtration at high ionic 
strength (500 mM NaCl) of Ni-NTA enriched lysates of E.coli cells co-expressing TET1-His6 and TDG-
GST from constructs indicated. Fractions were analyzed by SDS-PAGE and TET1 and TDG detected 
by immunoblotting. Shown is the SDS-PAGE stained with Coomassie Blue (left panel) and an 
immunoblot (right panel); molecular weights of gel filtration standards are indicated. (b) Yeast two 
hybrid analysis of the TET1 TDG interaction. TET1 domains cloned into the GAL4 activation domain 
(AD), TET1-1 (aa 1 - 491), TET1-2 (aa 397 - 931), TET1-3 (aa 870 - 1403), TET1-4 (aa 1367 - 2057) 
are indicated at the top. Shown is the growth reactions of serial dilutions of strains co-expressing TET1 
domains fused to the AD and the TDG fused to the GAL4 binding domain (BD) and respective 
negative controls (TET1 domains or TDG co-expressed with the vector control (V)) on permissive and 
selective media as indicated. The large T antigen (lTAg) and p53 fused to the AD and BD, 
respectively, served as a positive control. (c) Immunoblot analysis of fractions obtained from Ni-NTA 
and GST purifications using E.coli extracts co-expressing His6-TET1N and TDG-GST (left panel), or 
co-expressing His6-TET1CD and TDG-GST (right panel). Expression constructs used are indicated; 
TET1N (aa 301-1366), TET1CD (aa 1367-2057). 
Figure 2: Combined TET1 and TDG activity releases 5mC through oxidized intermediates. (a) Base 
excision activity of a Ni-NTA enriched His6-TET1CD/TDG-GST complex on synthetic DNA substrates 
as indicated. The ability to generate alkaline sensitive AP-sites in two different substrates containing 
either single G•5mC or G•5hmC base pairs was assayed with enriched His6-TET1CD/TDG-GST 
complexes consisting of wildtype proteins or respective mutant variants (His6-TET1CD∆cat/TDG-GST, 
His6-TET1CD/TDG∆cat-GST). Products were separated by denaturing gel electrophoresis, visualized 
with fluorescent scanning and quantified; positions of the 60mer substrate DNA and product fragment 
are indicated. (b) Slot blot analysis of plasmid oxidation by purified His6-TET1CD. In vitro methylated 
pUC19 plasmid DNA (800 nM) was treated with His6-TET1CD (125 nM) and cytosine modifications 
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were detected by immunblotting with specific antibodies against 5mC, 5hmC, 5fC and 5caC. (c) 
Reconstitution of 5mC/5hmC base release with purified His6-TET1CD and His6-TDG proteins. DNA 
substrates (25 nM) containing either G•5mC, G•5hmC or G•5caC base pairs were reacted with a 
preassembled His6-TET1CD/His6-TDG complex (50 nM), reaction products separated by denaturing 
gel electrophoresis, visualized and quantified. Positions of the 60mer substrate DNA and product 
fragments are indicated. Shown are mean values with standard deviations (n = 3). 
Figure 3: TET1CD stabilizes TDG activity. (a) Stimulatory effect of His6-TDG∆cat on His6-TET1CD 
analyzed by base release assay. His6-TET1CD (50 nM) or His6-TET1CD/His6-TDG∆cat (25 nM) 
complex were incubated with DNA substrate (25 nM) containing a G•5mC base pair for the indicated 
times. Recovered DNA was then assayed by a base release assay using His6-TDG (250 nM) to 
monitor presence of oxidized 5mC species. Shown is a typical gel-scan (top panel) with mean values 
and standard deviations of 3 independent experiments (bottom panel). (b) LC/MS/MS analysis of 
plasmid oxidation assays using His6-TET1CD or TET1CD/His6-TDG∆cat. In vitro methylated pUC19 
plasmid DNA (660 nM) was treated with either TET1CD (100 nM) or a preassembled TET1CD/TDG∆cat 
complex for the indicated time to determine the stimulatory effect of TDG on TET1 catalysis. DNA was 
analyzed by LC/MS/MS; shown are mean values (modif. nts/106 unmodif. nts) with standard deviations 
of 3 independent experiments. (c) The effect of His6-TET1CD on His6-TDG∆cat catalysis assessed in 
base release assays. The time-dependent generation of AP-sites was measured after reaction of a 
60mer substrate containing either a single G•5caC or G•T base pair with a preassembled His6-
TDG/His6-TET1CD complex or His6-TDG/BSA. Equimolar concentrations of G•5caC substrate (25 nM) 
and TDG protein (25 nM) (upper pannel) or a 5-fold molar excess of G•T substrate (125 nM) over TDG 
protein (25 nM) (lower panel) were incubated at 37°C and reactions stopped by the addition of NaOH 
after the indicated times. Product formation was monitored and quantified using denaturing gel 
electrophoresis and fluorescent scanning. Shown are mean values with standard deviations (n = 1 
(G•T), n = 3 (G•5caC). 
Figure 4: Full reconstitution of TET-TDG-BER mediated DNA demethylation. (a) Intermediate steps of 
the oxidative DNA demethylation reaction were reconstituted and visualized by denaturing gel 
electrophoresis. Labeled 60mer substrate DNA containing one G•5mC base pair was incubated 
sequentially with TET/TDG-BER enzymes at concentrations indicated. Reaction products were 
separated by denaturing gel electrophoresis and visualized by fluorescent scanning; sizes of the 
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60mer substrate DNA and reaction products are indicated. (b) Complete DNA demethylation by the 
reconstituted TET/TDG-BER system analyzed by the generation of a HpaII sensitive restriction site. 
Reconstituted DNA demethylation was done with a 5'-labeled 59 bp substrate containing one G•5mC 
base pair within a HpaII recognition site (CCGG). Recovered DNA was digested with methylation 
sensitive HpaII endonuclease and analyzed by native polyacrylamide gel electrophoresis; positions of 
the 59 bp substrate DNA and product fragment are indicated. 
Figure 5: Processing of differentially modified CpGs by TET1CD/TDG or TDG. (a) Base release from 
fully methylated CpGs by His6-TET1CD/His6-TDG. His6-TET1CD/His6-TDG complex preformed from 
purified proteins was incubated with labeled 60mer substrates containing a single 5mC modification on 
either the fluorescent labeled top (5'-TexasRed, TR) or bottom strand (5'-fluorescein, FAM) or 
containing a fully methylated CpG with labeles on both strands as illustrated. Product formation was 
monitored and quantified using denaturing gel electrophoresis and fluorescent scanning (Texas Red, 
R-channel; fluorescein, F-channel); positions of the 60mer substrate DNA and the resulting base 
incision products of both strands are indicated. (*) unlabeled DNA strand. (b) Release of 5caC from 
differentially modified CpGs by His6-TDG monitored over time. 60mer DNA substrates containing 
5caC opposite C, 5mC or 5hmC in a CpG dinucleotide or 5caC in single-stranded (ss) DNA were 
incubated with His6-TDG for the indicated times. Products were separated by denaturing gel 
electrophoresis, visualized by fluorescent scanning and quantified. Shown are mean percentages of 
product formation with standard deviations (n = 3). (c) 5caC release from a symmetrically modified 
CpG dinucleotide by His6-TDG. A substrate containing 5caC on both strands within a CpG 
dinucleotide and labels of both strand was incubated with His6-TDG for indicated times. Reactions 
were analyzed by denaturing gel electrophoresis and both strands visualized by fluorescent scanning 
adjusted to detect either of the two labels. Shown are mean percentages of product formation with 
standard deviation (n = 3). (d) Full reconstitution of TDG-BER on a symmetrically modified 5caC 
substrate. A labeled 59 bp substrate containing a symmetrically 5caC modified base pair within a 
HpaII recognition site (CCGG) was incubated with TDG and BER factors. Recovered DNA was 
digested with HpaII endonuclease and analyzed by native polyacrylamide gel electrophoresis, 
visualized and quantified by fluorescent scanning. Unmodified (CG/CG) and hemi-modified 
(CG/5caCG) substrates were used as controls for the HpaII digest. Positions of the 59 bp substrate 
DNA and product fragments are indicated; ssDNA, free single-stranded DNA. 
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Figure 6: DNA demethylation blocks G•T repair and can induce mutations. (a) Enzymatic activity of 
TDG on G•5caC and G•T containing substrates. Release of 5caC and T by His6-TDG (25 nM) was 
monitored over time on 5'-labeled 60 bp substrates (25 nM) containing either a G•5caC or G•T base 
pair. Reactions were stopped at indicated times, separated by denaturing gel electrophoresis, 
visualized with fluorescent scanning and quantified. Shown are mean percentages of product 
formation with standard deviations (n = 3) (b) Base release from a substrate containing a G•5caC next 
to a G•T mismatch. Substrate preference of TDG (25 nM) was evaluated on a 59 bp DNA fragment 
(25 nM) containing 5caC on the labeled top strand (5’, TexasRed) and T on the labeled bottom strand 
(5’, fluorescein) within the same CpG context as illustrated. Reactions were stopped after indicated 
times, separated by denaturing gel electrophoresis, and both strands visualized by fluorescent 
scanning and quantified. Shown are mean percentages of product formation with standard deviations 
(n = 3). (c) Full reconstitution of TDG-BER on a G•5caC/G•T containing substrate. A labeled 59 bp 
substrate containing a G•5caC next to a G•T mismatch was incubated with His6-TDG and BER 
factors. Correct repair of the 5caC as well as the introduction of an A opposite of T was monitored by 
MscI digestion and analyzed by native polyacrylamide gel electrophoresis and fluorescent scanning. 
Unmodified (CG/CG) substrate DNA digested with HpaII was used as size marker; positions of the 
substrate DNA and product fragments are indicated. ssDNA indicates free single-stranded DNA. (d) 
Mechanistic model of TET/TDG-BER-mediated DNA demethylation. In presence of all the necessary 
factors, DNA demethylation at fully methylated CpGs occurs in a coordinated and sequential manner 
to correctly reestablish the unmodified state (regular BER). Lack of coordination, e.g. in the absence of 
downstream BER factors, repair-mediated DNA demethylation can lead to the induction of DNA DSBs 
(uncoupled BER). Coincident oxidation and hydrolytic deamination at fully methylated CpG sites can 
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Double-strand break assay 
Double-strand break assays were carried out in 20 µL reaction volumes containing incision buffer (50 
mM HEPES pH 8, 70 mM KCl, 7 mM MgCl2, 500 µg/mL BSA, 1 mM DTT), 0.5 pmol of labeled 
substrate, 1 pmol APE1 and 1 pmol TDG. After incubation at 37°C for 30 min proteinase K was added 
to a final concentration of 100 µg/mL and the reaction was incubated at 37°C for another 30 min. 




Figure S1: Ni-NTA affinity purification of E.coli lysates co-expressing His6-TET1CD and TDG-GST. 
After co-expression of His6-TET1CD and TDG-GST (250 µM IPTG, 25°C for 3 h) cells were lysed and 
Ni-NTA affinity purification was carried out using Ni-NTA Sepharose beads according to the 
manufacturer’s instructions. Fractions were analyzed by SDS-PAGE followed by (A) Coomassie 
staining or (B) immunoblotting using anti TET1 antibody (Millipore). An immunoblot of TDG from Ni-
NTA co-affinity purification can be found in Fig. 1. in = input, f = flow, w = wash, e = elution. 
Figure S2: Purified His6-TET1CD and BER proteins used in biochemical assays. Purified His6-TET1CD, 
His6-TDG, APE1-His6, His6-POLβ, LIG3/XRCC1-His6 used in the biochemical assays were analyzed 
by SDS-PAGE followed by Coomassie staining. Purification procedures are described in materials and 
methods section. Except for LIG3 the affinity tags were not cleaved off. * catalytically inactive C-
terminal TET1CD fragment. 
Figure S3: Gadd45a has no stimulatory effect on TET1CD when in complex with TDG∆cat. In vitro 
methylated pUC19 plasmid was treated with a preassembled His6-TET1CD/His6-TDG∆cat or His6-
TET1CD/His6-TDG∆cat/His6-Gadd45a complex and resulting cytosine modifications were analyzed by 
LC/MS/MS according to materials and methods. (n = 3, mean values with standard deviations). 
Figure S4: TDG/APE1 induce DNA DSBs at symmetrically modified CpGs. Base release assay using 
TDG and APE1 on a labeled 59 bp substrate containing either a single 5caC or a symmetrically 5caC 
modified base pair within a HpaII recognition site (CCGG). Reactions were directly analyzed with 
native polyacrylamide gel electrophoresis to monitor the appearance of DSBs. The positions of the 59 
bp substrate DNA and product fragment are indicated. 
Figure S5: Processing of differentially modified CpGs by TDG. Base release assay with His6-TDG on 
labeled 60 bp substrates containing T on the labeled top strand (5’ TexasRed, TR) and 5caC or C on 
the labeled bottom strand (5’ fluorescein, FAM) within the CpG context, illustrated at the top. 
Reactions were carried out at 37°C for 15 min with the indicated enzyme/substrate ratio, stopped by 
the addition of NaOH and separated by denaturing gel electrophoresis. Both strands were then 
visualized by fluorescent scanning and quantified. 
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Versatile Recombinant SUMOylation System for the
Production of SUMO-Modified Protein
Alain R. Weber, David Schuermann*, Primo Scha¨r*
Department of Biomedicine, University of Basel, Basel, Switzerland
Abstract
Posttranslational modification by small ubiquitin-like modifiers (SUMO) is being associated with a growing number of
regulatory functions in diverse cellular processes. The biochemical investigation into the underlying molecular mechanisms,
however, has been lagging behind due to the difficulty to generate sufficient amounts of recombinant SUMOylated
proteins. Here, we present two newly designed two-component vector systems for the expression and purification of
SUMO-modified target proteins in Escherichia coli. One system consists of a vector for SUMO conjugation, expressing human
SUMO-activating (SAE1/SAE2) and conjugating (Ubc9) enzymes together with His6-tagged SUMO1, 2 or 3, that can be
combined with commonly used expression constructs for any gene of interest. To facilitate SUMOylation of targets normally
requiring a SUMO-E3 ligase for efficient modification, a second system is designed to express the target protein as a fusion
with the human SUMO-conjugating enzyme Ubc9, thus compensating the absence of a potential SUMO ligase. We
demonstrate the proficiency of these systems by SUMOylation of two DNA repair proteins, the thymine DNA glycosylase
(TDG) and XRCC1, and describe purification schemes for SUMOylated proteins in native and active form. This SUMO toolbox
facilitates ‘‘in-cell’’ and ‘‘in-extract’’ production and purification of recombinant SUMO-modified target proteins for
functional and structural analysis.
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Introduction
Posttranslational modification by ubiquitin-like polypeptides, so-
called UBLs, affects a large number of proteins, thereby regulating
a variety of cellular processes [1,2]. The SUMO (small ubiquitin-
like modifier) peptides represent a prominent subfamily of the
UBLs and exist in four different isoforms (SUMO1, SUMO2,
SUMO3 and SUMO4) in mammalian cells, each encoded by a
different gene. Although these SUMOs differ to some extent in
their amino acid sequences – SUMO2 and SUMO3 share
sequence identity of 97% with each other and about 50% with
SUMO1 – they all show high 3D-structural resemblance [3–6].
SUMOs, as all UBLs, are attached to their target proteins by a
sequence of enzymatic reactions resembling those of ubiquitin
conjugation [7,8], involving a heterodimeric activating enzyme E1
(SAE1/SAE2), a single conjugating enzyme E2 (Ubc9) and, in
some cases, an E3 protein ligase (Figure 1A). SUMO itself is first
synthesized as a precursor peptide that is then trimmed by a
SUMO-specific isopeptidase (sentrin-specific proteases; SenPs) to
expose an internal glycine-glycine (GG) motif at the C-terminus.
The carboxyl group of this mature SUMO peptide is then linked
via a thioester to a cysteine residue in SAE2 in an ATP-dependent
manner [9]. Subsequently, the activated SUMO is transferred to a
cysteine residue of the SUMO-conjugating enzyme Ubc9 [10].
Ubc9 can recognize substrate proteins directly [11] and catalyze
the formation of a peptide bond involving the C-terminal carboxyl
group of SUMO and an e-amino group of a target lysine within
the SUMOylation consensus motif YKxE (Y, hydrophobic
residue; x, any residue) of the substrate protein [12]. Often,
however, SUMO conjugation is additionally promoted by
SUMO-E3 ligases, which act as substrate-specific adapters
(Figure 1A).
SUMO modification concerns a wide spectrum of target
proteins, implicating functions in a variety of vital biological
processes such as the cellular response to DNA replication stress,
the repair of DNA damage, the regulation of gene expression and
epigenetic DNA and histone modifications [2,5,13]. Although
research into protein SUMOylation has identified a large number
of targets over recent years, there is limited insight into the
functional consequences of the modification. Investigations into
the immediate biochemical and structural impact of SUMO
modification have been a challenge due to difficulties in producing
SUMO-modified proteins in sufficient amounts and homogeneity.
Enrichment of native endogenous SUMOylated proteins by cell
fractionation is generally limited by the low abundance of such
proteins and the action of efficient SUMO proteases [14]. In vitro
modification of enriched target proteins with recombinant
SUMOylation enzymes is a more promising approach, typically
yielding mixtures of modified and unmodified target proteins
contaminated with the SUMOylation enzymes, hence requiring
subsequent purification steps [15,16]. Also, co-expression of
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SUMO targets with SUMO1 and SUMO-activating and -
conjugating enzymes of different origin (human, mouse, Xenopus
laevis) in E.coli was shown to produce SUMO-modified protein
[17–19], but in our experience, the yields of specifically modified
proteins were often poor, impeding efficient purification and
subsequent biochemical analysis.
To streamline the production of homogeneously SUMOylated
recombinant proteins for biochemical and structural studies, we set
out to establish an optimized and versatile SUMOylation system,
coupling efficient SUMO-conjugation with affinity purification of
modified target proteins. We designed and experimentally
validated two alternative two-component vector systems for
simultaneous expression of mature SUMO1, 2 or 3 polypeptides,
SUMO-E1, SUMO-E2 and a target protein of interest in E.coli. In
contrast to previous approaches [18–20], we used SUMOylation
enzymes of human origin only, physically separated the SAE1 and
SAE2 E1 subunits and added a protease-cleavable His6-tag to the
SUMOs to facilitate purification of modified protein. To
overcome a possible rate limitation by the absence of an
appropriate SUMO-E3 ligase in the E.coli system, one system is
designed to express the target protein as fusion to the SUMO-
conjugating enzyme Ubc9, a strategy that was successfully applied
for SUMOylation of ectopically expressed p53 and STAT1 in
HEK293, HeLa, COS-7 and CHO cells [21,22]. We evaluated
these newly developed vector systems with the DNA base excision
repair (BER) enzymes thymine DNA glycosylase (TDG) and
XRCC1. TDG is a well-studied SUMO target [23]; SUMO
modification of TDG was shown to effect conformational changes
that promote enzymatic turnover [24] and may also regulate the
subcellular localization [25]. XRCC1 acts as central scaffold factor
in BER [26] and was identified as a putative SUMO target in an in
vitro screening approach. It was found SUMOylated in HeLa cells
Figure 1. The pSUMO-based SUMOylation system modifies proteins in E.coli. (A) Scheme of the in vivo SUMO maturation, SUMO
conjugation and deconjugation process (for detailed description, see ‘‘Introduction’’). (B) pSUMO vectors containing the humanized SUMOylation
system consisting of N-terminally His6-tagged SUMO1, 2 or 3, the SUMO-conjugating enzyme E2 (Ubc9) and both subunits of the SUMO-activating
enzyme (SAE1 and SAE2) as a cistronic expression unit with an internal ribosomal binding site (rbs). Expression of the respective cDNAs is under the
control of a lac-repressor (LacI) regulated T7 promoter. (C) Scheme of the experimental setup of the pSUMO-based in-cell SUMO conjugation. E.coli
BL21 cells were used containing pSUMO1 in combination with pTG-mTDG or pGEX-hXRCC1 plasmids were used for the co-expression of the
complete SUMO system with C- and N-terminally GST-tagged mTDG and hXRCC1, respectively. Immunoblot analyses of mTDG (D) and hXRCC1 (E)
SUMOylation in E.coli cells, expressing the SUMO target and the SUMO system from either the pSUMO1 or the pT-E1E2S1 plasmid (250 mM IPTG at
25uC for 2 h). Co-expression of target proteins mutated in the SUMO acceptor sites of mTDG (K341R) and hXRCC1 (K176R) were included to assess the
specificity of the SUMOylation system.
doi:10.1371/journal.pone.0102157.g001
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following heat shock treatment [27,28], but the function of this
modification remains to be elucidated. We assessed the efficiency
and specificity of SUMO modification of these proteins in our
recombinant systems as well as the proficiency of the purification
procedure to generate biologically active SUMO proteins. Finally,
we provide guidance to optimize the experimental setup and
conditions for the SUMOylation of any target protein in bacteria,
discussing the use of the different SUMOylation vectors and
expression strategies for ‘‘in-cell’’ or ‘‘in-extract’’ SUMOylation.
Materials and Methods
Vector construction
The plasmids with the complete SUMO system (pSUMO1-3),
the SUMO-activating (pSA1-3) and the SUMO-conjugating (pSC-
PreE2/IntE2) plasmids were assembled by standard cloning
methods based on PCR amplification with adaptor oligonucleo-
tides providing suitable restriction sites. The plasmid DNA, vector
sequences and maps are available from Addgene (http://www.
addgene.org), plasmid ID 52258-52284. The cDNAs of the human
SUMOylation components SAE1, SAE2, Ubc9 and SUMO1-3
were amplified from pGEX-based bacterial expression vectors
kindly provided by R. Hay and M. Hottiger. pSUMO1-3, pSA1-3
and pSC-PreE2/IntE2 vectors are based on pCDFDuet-1
(Novagen) and pTXB3 (New England BioLabs), respectively.
The cDNAs of the SUMO target proteins were amplified by
adaptor PCR and introduced into the NcoI and EcoRI site
(hXRCC1, hTDG) or NcoI and XhoI (mTDG) of the pSC-IntE2/
PreE2 vectors. The consensus SUMOylation motif (VKEE) was
deleted by site-directed mutagenesis in hTDG (K330A), mTDG
(K341R), hXRCC1 (K176R).
Recombinant protein expression, in-cell SUMOylation
and cell lysis
The expression vectors were introduced into E.coli BL21(DE3)
cells by electroporation. Overnight pre-cultures were diluted with
fresh pre-warmed LB medium and grown at 30uC to OD600 levels
as indicated. Cultures were grown under selective pressure using
either 100 mg/L of Ampicillin or 50 mg/L of Streptomycin for
single plasmid expressions and half the concentration of each
antibiotic when co-expressing two plasmids. Protein expression
was induced by the addition of the isopropyl-b-D-thiogalactose
(IPTG) to the final concentrations as specified in the results and
cultures were further incubated as indicated. Finally, cells were
harvested by centrifugation and soluble protein fractions were
extracted by sonication in lysis buffer (50 mM Na-phosphate
buffer pH 7.5, 300 mM NaCl, 10% glycerol, 0.1% Tween-20,
1 mM DTT, 1 mM PMSF), if not stated otherwise. Crude lysates
were then cleared by centrifugation with .20’000 g at 4uC for
30 min.
Purification of SUMOylated protein
Small-scale protein preparations were performed with Gluta-
thione sepharose HP (GE Healthcare) or cOmplete His-tag
purification (Roche Applied Science) resins. Cleared lysates were
incubated with 100 mL resin in lysis buffer at 4uC for 3 h, prior to
loading onto gravity flow columns (BioRad). Unbound proteins
were washed out with 20 and 10 bed volumes of lysis buffer with
0.3 and 1 M NaCl, respectively. After a final wash step with 10 bed
volumes of lysis buffer, bound proteins were eluted by the addition
of 250 mM imidazole or 10 mM reduced glutathione to the lysis
buffer. Large-scale protein purification was carried out on an
A¨KTA purifier 10 system using pre-packed columns (GE
Healthcare). To enrich for SUMOylated proteins, cell lysates
were loaded onto a 5 mL HisTrap crude FF column (GE
Healthcare), washed with an imidazole gradient from 0 to
40 mM over 2 column volumes (CV) and bound proteins were
eluted with 10 CV lysis buffer containing 400 mM imidazole. Peak
fractions were pooled and dialyzed 3 times for 30 min against
300 mL GST loading buffer (50 mM Na-phosphate buffer
pH 7.5, 500 mM NaCl, 15% glycerol, 0.1% Tween-20, 1 mM
DTT, 0.5 mM PMSF) and loaded on a 1 mL GSTrap HP column
(GE Healthcare). Unbound protein was washed out by a NaCl
gradient from 0.5 to 1 M over 10 CV. Subsequently, bound target
protein was released from the GST-Ubc9 moiety either by
induced self-splicing at 4uC in cleavage buffer (50 mM Tris-HCl
pH 8, 500 mM NaCl, 15% glycerol, 0.1% Tween-20, 0.1 mM
PMSF, 50 mM DTT) for 16 h or by the application of 80 U of
PreScission protease (GE Healthcare) according to the manufac-
turer’s instructions. Cleaved protein was eluted, dialyzed 3 times
for 30 min against 300 mL storage buffer (20 mM Tris-HCl pH 8,
50 mM NaCl, 10% glycerol, 1 mM DTT), snap-frozen and stored
at 280uC.
Analytical gel electrophoresis, western blotting and
protein detection
Protein fractions were analyzed by standard SDS-polyacryl-
amide gel electrophoresis (SDS-PAGE) followed by Coomassie
blue staining or by immunoblotting using the Odyssey imaging
system (LI-COR Biosciences) or chemiluminescence (Wester-
nBright ECL, Advansta) according to the provider’s protocol.
Antibodies were diluted in 5% non-fat dry milk TBS (100 mM
Tris-HCl pH 8, 150 mM NaCl) supplemented with 0.2% Tween-
20: human TDG, rabbit polyclonal ab 141 (raised against
recombinant full-length hTDG), 1:5’000; mouse TDG, rabbit
polyclonal ab L58 (raised against recombinant full-length mTDG),
1:5’000; XRCC1, rabbit polyclonal ab (Sigma-Aldrich X0629),
1:2’000 and mouse monoclonal ab (33-2-5; Abcam ab1838),
1:1’000; SUMO1, mouse monoclonal a-GMP1 ab (21C7; Life
Technologies 33-2400), 1:1’000 and rabbit polyclonal a-SUMO1
ab (Sigma-Aldrich S8070) 1:1’000.
Base release assay
A 60 bp heteroduplex DNA containing a G?U mismatch was
prepared by annealing an unlabeled oligonucleotide (59-TAGA-
CATTGC CCTCGAGGTA CCATGGATCC GATGTCGACC
TCAAACCTAG ACGAATTCCG-39) to a 59-fluorescein-labeled
uracil-containing oligonucleotide (59-ATCTGTAACG
GGAGCTCCAT GGTACCTAGG CTACAGUTGG
AGTTTGGATC TGCTTAAGGC-39) by heating to 95uC for
5 min and gradual cooling to 25uC with a rate of 0.02uC/s.
Reactions were carried out in 20 mL nicking buffer (50 mM
Tris-HCl pH 8, 1 mM EDTA, 1 mM DTT, 0.1 mg/mL BSA)
containing 5 pmol of substrate DNA and 0.5 pmol of TDG
protein, unless stated otherwise, at 37uC for the indicated time
periods. AP-sites were then chemically cleaved by the addition of
2 mL of 1 M NaOH and boiling at 99uC for 10 min. DNA was
precipitated overnight at 220uC after adding 2.2 mL of 3 M Na
acetate pH 5.2, 0.5 mL yeast tRNA (10 mg/mL) and 67.5 mL
ethanol. Subsequently, DNA was pelleted by centrifugation,
washed with 70% ethanol, air-dried for 10 min, resuspended in
10 mL gel loading buffer (16TBE, 90% formamide), heated at
99uC for 5 min and loaded on a 15% denaturing polyacrylamide
gel (8 M urea, 16TBE) for analysis. Gels were run at 13 V/cm for
30 min and labelled DNA was detected using the blue fluores-
cence mode of the Typhoon 9400 (GE Healthcare) and analyzed
quantitatively by ImageQuant TL software (v7.0, GE Healthcare).
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SUMOylation and de-SUMOylation assays
In vitro SUMOylation with purified recombinant protein was
carried out in 50 mL SUMOylation buffer (50 mM Tris-HCl
pH 8, 50 mM NaCl, 10% glycerol, 0.5 mM DTT, 5 mM MgCl2,
5 mM ATP), containing 80 pmol SUMO1, 16 pmol Ubc9,
4 pmol SAE1/SAE2 and 16 pmol target protein. Reactions were
incubated at 30uC for 30 min. De-SUMOylation was carried out
in SenP2 buffer (25 mM Tris-HCl pH 8, 150 mM NaCl, 2 mM
DTT, 0.1% Tween-20) using an excess amount of SenP2 protease.
The reaction mixture was incubated at RT for 30 min.
For in-extract SUMOylation, cells expressing pSUMO1, pSA1
and target vectors were lysed in SUMOylation buffer without ATP
and mixed at indicated volume ratios. SUMOylation was triggered
by the addition of ATP to a final concentration of 5 mM and
reaction mixtures were incubated at 30uC for 1 h.
Results
Recombinant human SUMOylation system modifies
target proteins in E.coli
To provide a humanized SUMO-E1/E2 conjugation system for
modification of target proteins in a recombinant bacterial
expression setup, we constructed a series of CDFori-based vectors
(pSUMO1-3), expressing the SUMO-E1 and -E2 enzymes as well
as the mature SUMO1, 2 or 3 polypeptides (C-terminal GG motif)
under the control of the phage T7 promoter (Figure 1B). Unique
to this system is that it bases on human proteins only, expresses the
heterodimeric SAE1-SAE2 complex (SUMO-E1) from a bi-
cistronic unit and provides SUMO polypeptides with an N-
terminal His6-tag separated by a thrombin cleavage site,
facilitating the enrichment of modified proteins by affinity
chromatography and the removal of the affinity tag.
We validated the functionality of the system by co-expression
with an established and a postulated SUMOylation target of the
BER pathway, TDG and XRCC1. To ensure a stable mainte-
nance of the pSUMO1 and the target expression constructs in
E.coli, we chose pMB1ori-based plasmids for the expression of the
mouse TDG (mTDG) and the human XRCC1 (hXRCC1)
(Figure 1C). First, we compared our pSUMO1 with the previously
published pT-E1E2S1 vector [18] for the efficiency to produce
SUMO1-conjugated C-terminally GST-tagged mTDG (pTG-
mTDG) and N-terminally GST-tagged hXRCC1 (pGEX-
hXRCC1) when co-expressed with the recombinant SUMO
system in E.coli BL21(DE3) cells. Under the applied experimental
conditions, we observed a significantly higher efficiency of
SUMO1 modification with the newly designed pSUMO1 vector
for both substrates, yielding nearly 100% SUMOylated mTDG
and about 20% SUMOylated hXRCC1 (Figure 1D and E,
compare lanes 2 and 4). The highly efficient modification in the
presence of pSUMO1 may generate some unspecific SUMO
conjugation as evidenced by the low amount of mis-targeted
modification notable with an mTDG mutated in the major
SUMO acceptor lysine (mTDG-K341R) (Figure 1D, lane 3).
hXRCC1 mutated in its predicted SUMO acceptor lysine
(hXRCC1-K176R; unpublished information kindly provided by
Roland Steinacher), however, showed no detectable SUMOyla-
tion (Figure 1E, lane 3), thus demonstrating the selectivity of
pSUMO1-mediated SUMO modification.
The SUMO conjugation system presented here generates
SUMOylated products with GST- and His6-tags fused to the
target protein and the SUMO polypeptide, respectively. Purifica-
tion of the modified target can thus be achieved through successive
GST and Ni-NTA affinity chromatography steps (Figure 2A) as
shown here for mTDG and hXRCC1. Modification of the target
proteins was obtained by induced in-cell SUMOylation in E.coli at
25uC for 2 hours, co-transformed with pSUMO1 and pTG-
mTDG or pGEX-hXRCC1. Yields of SUMO-modified mTDG
and hXRCC1 proteins were estimated by stained analytic SDS-
PAGE and found to be around 5 and 1.5 mg per liter bacterial
culture, respectively. Thus, substantial amounts of recombinant
proteins are expected to be purifiable from the in-cell SUMOyla-
tion system.
SUMOylated proteins were enriched by fractionation of the
E.coli lysates using either sequential GST and Ni-NTA affinity
chromatography (work flow 1) or vice versa (work flow 2)
(Figure 2A). Following purification work flow 1, both, unmodified
and modified mTDG and hXRCC1 were enriched in the elution
fractions of the GST affinity column as detected by SDS-PAGE
analysis followed by Coomassie staining (Figure 2B and F, GST
lanes e1 and e2) and immunoblotting with anti-mTDG and anti-
hXRCC1 antibodies (Figure 2E and G). Applying the pooled GST
elutions to a Ni-NTA affinity column led to a further enrichment
of the SUMOylated protein fractions. mTDG eluted from the
column as homogeneously SUMOylated protein fraction
(Figure 2B and E, Ni-NTA lanes e1 and e2). A prominent protein,
however, migrating at about 20 kDa co-eluted in the main fraction
and turned out to be free SUMO1 (Figure 2C). The Ni-NTA step
also enriched the proportion of SUMO1-modified hXRCC1 but
did not separate it entirely from unmodified hXRCC1 (Figure 2F
and G, Ni-NTA lanes e1 and e2). This may be due to the
propensity of hXRCC1 to dimerize through its BRCT domain
under purification conditions [29], SUMO-mediated protein-
protein interactions or a possible dimerization of the GST-tag,
thus forming hXRCC1-SUMO1/hXRCC1 heterodimers. Fol-
lowing work flow 2, we observed an efficient enrichment of
SUMO1-modified mTDG but also of free SUMO1 and probably
some E.coli proteins on the Ni-NTA column (Figure 2D, Ni-NTA
lanes e1 and e2). These impurities could then be separated from
the SUMO1-modified target protein by GST affinity purification,
which yielded homogeneously SUMOylated mTDG (Figure 2D,
GST lanes e1 and e2).
A SUMO-E2-fusion system to facilitate SUMOylation of
suboptimal targets
Having confirmed the functionality of the humanized SUMOy-
lation system in E.coli, we aimed to optimize its robustness for
targets, requiring a SUMO-E3 ligase for efficient modification, by
expressing the target protein as a fusion with the SUMO-
conjugating enzyme [21]. To this end, we split the expression units
for SUMOylation into two compatible vectors, one for SUMO
activation (SA) and the other for SUMO conjugation (SC). The
SUMO-activating vector (pSA1, pSA2, or pSA3) contains
expression cassettes encoding mature human SUMO proteins
(SUMO1-3), N-terminally fused to a His6-tag separated by a
thrombin cleavage site, as well as both subunits of the human
SUMO-activating enzyme E1 (SAE1 and SAE2) as a bi-cistronic
unit (Figure 3A). The SUMO-conjugating vectors pSC-PreE2
(Figure 3E) and pSC-IntE2 (Figure 3C) were designed to express
the target protein with a C-terminal fusion to the SUMO-E2
enzyme Ubc9 and the GST-tag. The inclusion of the PreScission
cleavage site in pSC-PreE2 facilitates the specific release of the
target proteins from the Ubc9-GST fusion by a protease digestion.
The linker in pSC-IntE2 separates the SUMO target from the
SUMO-E2 portion through the Mycobacterium xenopi GyrA intein
sequence (Figure 3C) and facilitates the release of the modified
target protein by self-splicing in a reducing environment [30], i.e.
without protease treatment. The two constructs also provide
alternative TARGET-Ubc9 configurations, should one or the
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other fusion cause structural constraints that compromise
SUMOylation efficiency and specificity.
We first tested the functionality of the SUMO-E2-fusion system
in in-cell SUMO conjugation (Figure 3B), using as targets the
human TDG (hTDG), which SUMOylates in vitro with interme-
diate efficiency, its mouse ortholog mTDG as a control for high
efficient SUMOylation, and hXRCC1 as an inefficiently modified
substrate. We thus introduced the SUMO1-activating (pSA1) and
respective SUMO TARGET-E2 vectors (pSC-hTDG-IntE2,
pSC-hTDG-PreE2, pSC-mTDG-IntE2, pSC-hXRCC1-IntE2,
pSC-hXRCC1-PreE2) into E.coli BL21(DE3). Protein expression
was then induced with 250 mM and 1 mM IPTG at 15uC for 3
and 6 hours and 37uC for 1 hour, respectively. In the control
reactions without SUMO activation, the non-modified full-length
Figure 2. Purification of SUMO1-modified mTDG and hXRCC1 produced by in-cell SUMOylation. (A) Purification scheme for in-cell
SUMO-modified protein. Cell lysates are subjected to subsequent GST- and Ni-NTA-affinity purification (work flow 1) or vice versa (work flow 2). Boxed
letters indicate the corresponding sub-panels. Fractions of the purification of SUMO1-modified mTDG from purification work flow 1 (B) and 2 (D) and
hXRCC1 from work flow 1 (F) were analyzed by SDS-PAGE and subsequent Coomassie blue staining and immunoblotting using monoclonal anti-
GMP1 (C), polyclonal anti-mTDG (E) and anti-hXRCC1 (G) antibodies, respectively. in, input (cleared lysate or dialyzed elution fractions); f, flow
through; w, wash steps; e, elution fractions; *, SUMO1-modified truncated mTDG.
doi:10.1371/journal.pone.0102157.g002
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hTDG-IntE2 and hTDG-PreE2 fusion proteins appeared as a
prominent bands migrating just below 150 kDa and around
100 kDa, respectively (Figure 3D and F, lanes 3, 6 and 9). After
3 hours of co-expression at 15uC, prominent slower migrating
polypeptides appeared in cells expressing hTDG-IntE2 or hTDG-
PreE2, corresponding to the SUMO1-modified hTDG fusion
proteins (Figure 3D and F, lane 1). Similarly efficient and specific
modification of hTDG-IntE2 or -PreE2 occurred when co-
expression was done for 1 hour at 37uC under strong IPTG
induction (Figure 3D and F, lanes 7 and 8). After prolonged
expression for 6 hours at 15uC, additional high molecular weight
SUMO modification products became apparent (Figure 3D and F,
lane 4). We interpret these to represent hTDG isoforms with
multiple SUMO chains or poly-SUMO chains attached, most of
which do not form at the major acceptor site and are not normally
seen with endogenous hTDG. The majority of these SUMO
conjugates also appeared for the hTDG-K330A variant, which is
mutated in the major SUMO-acceptor site (Figure 3D and F, lanes
5), hence reflecting mis-targeted modifications at either the hTDG
or the fused (intein-)Ubc9-GST polypeptides, which are known
Figure 3. In-cell SUMOylation of TDG with the SUMO-E2-fusion system. Scheme of the SUMO-activating vectors pSA1-3, which are identical
to the pSUMO1-3 vectors but lack the Ubc9 expression unit (A) and the Ubc9-fusion SUMO-conjugating vectors pSC-PreE2 (E) and pSC-IntE2 (C) for
expression of target protein fused to a GST-tagged Ubc9 under the control of the T7 promoter. A PreScission protease cleavage site or a
Mycobacterium xenopi GyrA intein sequence in the linker region allows for the release of the modified target from the Ubc9-GST fusion. (B)
Experimental setup of in-cell SUMO conjugation with the SUMO-E2-fusion system. pSA1 is co-expressed with target proteins either from pSC-IntE2 or
pSC-PreE2 vectors in E.coli BL21. Boxed letters indicate the corresponding sub-panels. Immunoblot analysis of lysates of E.coli cells expressing the
SUMO-activating proteins (pSA1) and wild-type (wt) or SUMO acceptor site-mutated (K330A) human TDG (hTDG) from the SUMO-conjugating vectors
pSC-IntE2 (D) or pSC-PreE2 (F). Expression was induced with 250 mM IPTG at 15uC for 3 and 6 h or with 1 mM IPTG at 37uC for 1 h. (G) SUMOylation
of mouse TDG (mTDG) expressed from the pSC-IntE2 vector was followed over time by immunoblot analysis. Expression was induced with 500 mM
IPTG and cells were incubated at 20uC.
doi:10.1371/journal.pone.0102157.g003
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and predicted SUMOylation targets. The generation of SUMO
conjugates also appears to be influenced by the configuration of
the TARGET-Ubc9 construct as, generally, the hTDG-IntE2
fusion generated more heterogeneity in modification products
than the hTDG-PreE2 fusion, most likely because of various
modifications in the intein-Ubc9-GST moiety. As with the
pSUMO system (Figure 1), in-cell modification of mTDG
expressed from the pSC-IntE2 vector was highly efficient, with
close to 100% yields of SUMOylated mTDG (Figure 3G, lanes 1–
5). At early time-points of induced protein expression (500 mM
IPTG, 20uC), this setup produced a single prominent SUMOy-
lated form of mTDG-IntE2. Only upon prolonged expression, we
observe slower migrating multi-SUMOylated mTDG. As only
little non-specific SUMOylation occurred with an mTDG mutated
in the SUMO acceptor site (K341R) (Figure 3G, lane 7), we
interpret the slower migrating mTDG-SUMO1 products to
predominantly represent SUMO chain formation.
In-extract SUMOylation increases efficiency and flexibility
of the SUMO-E2-fusion system
While in-cell SUMOylation with the SUMO-E2-fusion system
was highly efficient for both TDGs, the outcome was not
satisfactory for hXRCC1 (data not shown), due to inefficient
expression of the fusion protein. To work around such constraints,
we resorted to a strategy of expressing pSA1 and pSC-IntE2/-
PreE2 vectors separately in E.coli cells and performing SUMO
modification of target proteins in crude E.coli extracts without
prior purification of the necessary SUMOylation factors
(Figure 4A).
To assess the potential of in-extract SUMOylation, we
expressed hXRCC1 from pSC-PreE2 or pSC-IntE2 and the
SUMO activating factors from pSA1 in separate E.coli cultures at
25uC and 30uC, respectively, for 3 hours. The crude lysates of
these cultures were then mixed at variable volume ratios and
incubated at 30uC in the presence of 5 mM ATP for 1 hour. We
then compared the efficiency of in-extract SUMOylation of
hXRCC1 by the SUMO-E2-fusion system with that of extracts
from cells expressing GST-tagged hXRCC1 (pGEX-hXRCC1)
and the pSUMO1 system (Figure 4B and C). The SUMO-E2-
fusion system produced a substantial amount of SUMO1-modified
hXRCC1-PreE2 protein, which was fully dependent on an intact
SUMO acceptor site (Figure 4B). By contrast, when hXRCC1 was
provided without the Ubc9 fusion, in-extract SUMOylation was
not detectable, even in the presence of an excess of extract
providing the complete SUMOylation components (Figure 4C).
Although this can be explained partly by a reduced SUMOylation
capacity of the pSUMO1 lysate compared to the pSA1 lysate
(Figure 4D, compare lane 2 and 3), these results show that the
SUMO-E2-fusion system facilitates efficient in-extract SUMOyla-
tion of a suboptimal SUMO target like hXRCC1 (Figure 4D,
compare lane 1 and 2).
To assess the impact of the configuration of the TARGET-
Ubc9 fusion, we also performed in-extract SUMOylation with
hXRCC1 and hTDG expressed from the pSC-IntE2 plasmid. We
thus prepared crude lysates from E.coli expressing the pSA1
components (30uC, 3 hours induction) and the TARGET-IntE2
fusion (25uC, 3 hours induction) and incubated mixed extracts at
different volume ratios at 30uC for 1 hour. This produced an
appreciable amount of SUMO1-modified hXRCC1-IntE2 fusion
protein (Figure 4E), largely in an ATP-dependent manner. The
residual SUMO conjugation, notable without addition of ATP, at
a 5-fold excess of activating over conjugating lysates (Figure 4E,
lane 5) most likely reflects the pre-existence of a small amount of
activated SUMO1 in the extracts. Compared to the hXRCC1-
PreE2 fusion, however, the in-extract SUMOylation of hXRCC1-
IntE2 fusion appeared to be less efficient; the maximum yield of
SUMOylated product was generally lower for hXRCC1-IntE2
than for the hXRCC1-PreE2 fusion. Consistent with the
observations from in-cell modification, in-extract SUMOylation
of the TARGET-IntE2 fusions may also be less specific than that
of the TARGET-PreE2 fusions, as some residual SUMO
modification of hXRCC1 and hTDG mutated in the main
SUMO acceptor sites appeared in the presence of an excess of
SUMO-activating lysate (Figure 4E, lane 6; and Figure 4F, lane 5).
These results indicate that a fusion of the SUMO-E2 enzyme to
the target protein can substantially enhance in-extract SUMOyla-
tion efficiency and may be useful to compensate rate limitations
due to the lack of a proper SUMO-E3 ligase in the recombinant
system. Notably, the stimulatory effect of the Ubc9 fusion was less
pronounced for hTDG (Figure 4F and G); in-extract SUMOyla-
tion with either IntE2-fused or non-fused hTDG generated
approximately 50% modified hTDG protein with some tendency
to mis-targeted modification. This is consistent with TDG’s high
propensity of SUMO modification in the absence of an E3 ligase
and may reflect a high affinity of hTDG for SUMO1-loaded
Ubc9.
Altogether, these results show that efficient SUMOylation of
hTDG and hXRCC1 can be achieved with the pSA- and pSC-
based SUMO-E2-fusion system. In-cell modification experiments
resulted in high SUMOylation efficiency for either of the hTDG-
Ubc9 fusions, but also generated considerable amounts of mis-
targeted modification, either in the target protein itself or in the
SUMO-E2-fusion-tag. For this particular target, stronger induc-
tion of expression at higher temperature for shorter times
markedly improved the SUMOylation specificity without affecting
overall protein levels. Hence, induction conditions have a strong
influence on in-cell SUMOylation efficiency and specificity and
thus provide opportunities for target-specific fine-tuning of the
system. Overall, the PreE2 fusions seem to SUMOylate more
efficiently than the IntE2 fusions. Attempts to do in-cell
SUMOylation of hXRCC1 indicated that the co-expression of
larger Ubc9 fusions with all SUMO components in E.coli may not
yield satisfactory results. In such cases, SUMO modification in
mixed extracts provides a valuable alternative.
In-cell modified mTDG is biochemically active
To demonstrate that the SUMO-E2-fusion system produces
authentically modified target protein, we performed in-cell
modification with mTDG expressed from the pSC-IntE2 plasmid
and purified the modified protein through consecutive enrichment
over GST and Ni-NTA affinity columns. To test the suitability of
the intein linker sequence for on-column release of the Ubc9-GST
moiety, we eluted the SUMO-conjugated mTDG from the GST
matrix by induced intein self-splicing in presence of 50 mM DTT.
We then compared the eluted mTDG-SUMO1 with purified
recombinant mTDG, either unmodified or SUMO1-modified in a
defined in vitro SUMOylation system by immunoblot analysis using
anti-mTDG (Figure 5A) and anti-SUMO1 antibodies (Figure 5B).
Both antibodies detected in-cell modified mTDG as a prominent
protein band migrating at around 80 kDa (Figure 5A and B, lane 3
and 5). A few higher molecular weight mTDG-SUMO1 species
were also apparent, as expected for the very efficiently modified
mTDG, while unmodified mTDG was hardly detectable
(Figure 5A, lane 3). Upon treatment with the recombinant SUMO
protease SenP2, SUMO1 was cleaved from the in-cell as well as
from the in vitro SUMOylated mTDG (Figure 5A and B, lane 4
and 6) to generate the unmodified isoform, indicating that the
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Figure 4. The SUMO-E2-fusion system allows SUMOylation of targets in crude cell extracts. (A) In-extract SUMOylation procedure using
lysate from pSUMO1- or pSA1-expressing bacteria. Boxed letters indicate the corresponding sub-panels. In-extract SUMOylation efficiency with or
without the addition ATP to a final concentration of 5 mM (30uC for 1 h) was assessed by immunoblot analysis. Extracts from E.coli BL21(DE3) cells
expressing the SA1 (B) or the SUMO1 (C) system (250 mM IPTG at 30uC for 3 h) were mixed with extracts from cells expressing the fusion of Ubc9 to
wild-type hXRCC1 (wt) or hXRCC1-K176R from the pSC-PreE2 plasmid (250 mM IPTG at 25uC for 3 h) with the indicated volume (V) ratio. (D) Direct
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detected high molecular bands are indeed SUMO1-modified
mTDG protein.
To confirm that the enriched SUMO1-modified mTDG shows
previously described modification-induced enzymatic features
[31], we analyzed purified recombinant mTDG (Figure 5A and
comparison of the SUMOylation efficiency of hXRCC1-PreE2 and hXRCC1 not fused to Ubc9 with either the SA1 or SUMO1 extracts. (E) Crude E.coli
BL21(DE3) cell extracts expressing wild-type (wt) or SUMO acceptor site-mutated hXRCC1 (K176R) (250 mM IPTG at 25uC for 3 h) from the pSC-IntE2
plasmids were mixed with extracts with the SA system (250 mM IPTG at 30uC for 3 h) at the indicated volume (V) ratio. Applying the same
experimental conditions as above, the SUMOylation of wild-type (wt) and the SUMOylation-deficient (K330A) hTDG mutant was analyzed comparing
co-incubation of extracts from E.coli BL21(DE3) cells expressing pSA1 and the TARGET-IntE2-fusion (F) or pSUMO1 and the non-Ubc9 fusion (G).
doi:10.1371/journal.pone.0102157.g004
Figure 5. In-cell SUMOylated TDG is active and shows enzymatic turnover. 200 ng of purified mouse TDG (mTDG), purified in-cell
SUMOylated mTDG and in vitro SUMOylated samples were analyzed by immunoblot analysis using anti-mTDG (A) as well as anti-SUMO1 (B)
antibodies. Conjugated SUMO1 was cleaved with the recombinant SUMO protease SenP2 at RT for 30 min (lanes 2, 4, 6) and compared to untreated
samples (lanes 1, 3, 5). (C) Enzymatic activity and turnover of unmodified TDG (mTDG), in vitro (mTDG-SUMO1 i.v.) and purified in-cell SUMOylated
TDG (mTDG-SUMO1) were assessed by the base release assay with a 10-fold molar excess of G?U mismatched oligonucleotides over enzyme. Samples
were taken at the indicated time-points and the relative amounts of processed 23 nucleotide product (23 nt) versus unprocessed 60 nucleotide
substrate (60 nt) was quantified and depicted in (D). Error bars, SEM of 2 experiments.
doi:10.1371/journal.pone.0102157.g005
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B, lane 1), purified in-cell SUMOylated mTDG (Figure 5A and B,
lane 3) and in vitro SUMOylated mTDG (Figure 5A and B, lane 5)
for their capacity to release uracil from G?U mismatched DNA
substrates in a base release assay (Figure 5C and D). A 10-fold
excess of DNA substrate over enzyme was provided in all reactions
to allow an assessment of enzymatic turnover induced by mTDG
SUMOylation. For unmodified mTDG, substrate processing
plateaued at a product-enzyme ratio of about 2, in agreement
with previous reports, showing that unmodified TDG has a strong
affinity to the product AP-site and, therefore, shows the kinetics of
product inhibition [24,32]. By contrast, in-cell SUMOylated
mTDG processed up to an 8-fold excess of substrate without
reaching a plateau after 30 min, even more efficiently than in vitro
SUMOylated mTDG. These findings are in line with the
previously established effect of mTDG SUMOylation on the
turnover rate of mTDG in a base release assay with of G?U
mismatched DNA substrate. We therefore conclude that the
purification of SUMO1-modified mTDG generated from the
enhanced SUMO-E2-fusion system, using vectors pSA1 and pSC-
mTDG-IntE2, yields functionally intact protein with the expected
biochemical properties.
Discussion
Over the past decade, posttranslational protein modification by
SUMO polypeptides has emerged as a key regulatory mechanism
of important cellular processes [2,5,8,33,34]. The number of
known and suspected SUMO targets is increasing rapidly, many of
which being identified by large-scale proteomic or by bioinfor-
matic approaches. However, insight into mechanisms underlying
SUMO-regulated biological transactions is lagging behind due to
the difficulty to produce recombinant SUMO-modified proteins of
sufficient homogeneity and quality for biochemical analyses. To
this end, we developed humanized SUMOylation systems and
strategies for simple purification of modified proteins from E.coli
(Figure 6). The pSUMO-based system expresses all essential
components for SUMO modification from a single plasmid
(pSUMO1-3), which is compatible with the commonly used
bacterial expression vectors carrying a target protein of interest
with a suitable affinity tag for purification. The SUMO-E2-fusion
system is composed of a SUMO-activating vector (pSA1-3) and a
SUMO-conjugating vector (pSC), containing a TARGET-Ubc9-
GST fusion expression cassette. This system is suitable for both, in-
cell and in-extract SUMOylation, depending on the requirements
of a target protein and, the latter offering useful combinatorial
options.
Unlike previously introduced SUMOylation systems [17–
19,35], the ones presented here consist of human components
only and combine two different affinity-tags on the SUMO
polypeptide and the target protein to facilitate separation of
modified and unmodified target protein. The expression of the
SUMO-activating enzyme E1 (SAE1 and SAE2) as separate
subunits from a cistronic expression cassette avoids the SAE1-
SAE2 fusion, which was shown to reduce E1 activity [20].
Consistently, SUMOylated mTDG and hXRCC1 protein ap-
peared faster and at higher levels with our E.coli SUMOylation
setup when compared to the system by Saitoh and colleagues [20].
SUMO-E3 ligases strongly enhance the SUMOylation efficien-
cy and specificity in the in vivo situation by promoting proximity
between the substrate and the SUMO-loaded Ubc9. Accordingly,
more efficient and specific SUMOylation of target proteins were
reported for an E.coli SUMOylation system when the respective
E3 ligases were co-expressed [35]. However, SUMO-E3 ligases for
many proteins are not known and the additional expression of
such a component is likely to reduce the overall production of
recombinant proteins, and is thus not suitable as a universal
strategy. Fusion of Ubc9 with SUMO1 or target proteins provides
an alternative [36] and has been successfully applied in
mammalian cells to compensate rate limiting SUMO-E3 activity
[21]. The engineered proximity makes the SUMOylation inde-
pendent of the affinity between target protein and activated
SUMO-E2, which is a determinant for modification efficiency
[25,37]. This TARGET-Ubc9 fusion approach is part of our E.coli
SUMO-E2-fusion system for in-cell and in-extract modification.
Using this system, we observed a fast and efficient SUMOylation
of recalcitrant targets such as hXRCC1, which was only
inefficiently modified without the Ubc9 fusion. Notably, canonical
SUMOylation of Ubc9 itself was suggested to have a regulatory
function in target discrimination, in particular for target proteins
with a high affinity to SUMO [38,39], and to stimulate the
formation of SUMO chains [40]. This might explain the multiple
SUMOylation events observed with the SUMO-E2-fusion system,
particularly pronounced upon prolonged time of induction. The
Ubc9-fusion might not only facilitate the modification of targets
but could also enhance SUMOylation of the fusion-tag itself,
especially when the SUMOylation site in the target is not
available, i.e. mutated. However, the specificity and efficiency of
target protein SUMOylation appears to be little affected by these
unscheduled SUMOylation events and they will be eliminated in
the course of protein purification by cleaving off the target from
the fusion-tag. As authentic regulatory mechanisms are lacking
and, hence, target site selection may be biased to some extent in
recombinant E.coli SUMOylation systems, caution should be
applied if the SUMO-E2-fusion is used for the validation of
SUMO acceptor sites (Figure 6). In any case, the conditions for in-
cell and in-extract SUMOylation with our vector systems need to
be carefully evaluated and controlled so that off-target SUMOyla-
tion or non-canonical SUMO-chain formation not observed in the
authentic host system can be avoided.
Based on our experience with the SUMO targets TDG and
XRCC1, we can provide some basic guidelines for how to purify
SUMOylated targets, although optimal conditions can vary and,
thus, have to be evaluated individually. We recommend starting
with the pSUMO-based system, i.e. the co-expression of a gene of
interest fused to a suitable affinity tag with the SUMOylation
factors provided by plasmids pSUMO1-3. The efficiency as well as
the specificity of target SUMOylation is difficult to predict and
likely to depend on the abundance of soluble recombinant proteins
and on the affinity of the target protein with the SUMO
components. For instance, SUMO modification of minor acceptor
sites or the formation of poly-SUMO chains as observed with
heterologous SUMOylation systems [17–19] may be favored when
the cellular concentration of activated Ubc9 is high. It is therefore
crucial to initially determine optimal induction conditions that
ensure an optimal balance between expression and specificity, i.e.
produce predominantly mono-SUMOylated protein, carrying the
SUMO at the authentic acceptor site. In the case of TDG, which
has a well-defined SUMOylation site, either a strong and fast
(1 mM IPTG) induction at a high temperature (37uC) or a mild
induction (250 mM IPTG) at a lower temperature (15uC) for 3 to
4 hours gave the best results with respect to SUMOylation
efficiency and specificity. Applying prolonged induction times
yielded more protein but also produced unwanted multi-
SUMOylation at unspecific sites.
If the pSUMO-based system does not yield satisfactory
SUMOylation, the SUMO-E2-fusion system, expressing the target
protein from either the pSC-IntE2 or pSC-PreE2 vector, provides
an alternative strategy (Figure 6). Although the intein self-cleavage
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mechanism used in the pSC-IntE2 vector has the advantage that
no additional protease is required to remove the Ubc9 and the
affinity-tag, the rather large fusion product may negatively affect
the protein yields and the complex intein structure might also have
an adverse effect on SUMOylation specificity. If so, the pSC-
PreE2 vector with a conventional protease cleavage site offers a
valuable alternative. In our experiments, we usually observed
higher expression levels, increased modification efficiencies and
better site specificity with targets expressed from pSC-PreE2. We
recommend applying the SUMO-E2-fusion system for in-cell
SUMOylation of small and easy to express proteins that
SUMOylate poorly with the pSUMO-based system because of
limited affinity to the activated Ubc9 or the requirement of a
SUMO-E3 ligase.
For SUMO targets that are difficult to be produced and
modified by co-expression, we evaluated an alternative procedure
to obtain large quantities of SUMOylated proteins by in-extract
conjugation, which does not require the prior purification of the
SUMOylation factors. We independently expressed the TAR-
GET-Ubc9 fusion protein and the SA system in E.coli BL(21) cells
and prepared cleared lysate under in vitro SUMOylation-proficient
buffer conditions. Co-incubation of these lysates resulted in a
satisfactory SUMOylation of hXRCC1. Also, our data show that
the Ubc9 fusion enhances SUMOylation of hXRCC1 in mixed
lysates, suggesting a successful mimicking of a SUMO-E3 ligase
function missing in this context. A significant advantage of this in-
extract procedure is that expression conditions of the SA
components and the TARGET-Ubc9 fusion constructs can be
fine-tuned individually. In the case of hXRCC1, for instance, the
SA system expressed most efficiently following induction with
250 mM IPTG, 30uC for 3 hours, whereas the optimal conditions
for hXRCC-Ubc9 were induction with 250 mM IPTG, 25uC for
3 hours. Hence, the possibility to fine-tune these conditions will
impact on the yields and quality of SUMO-modified protein. In-
extract modification may also produce good yields with the
pSUMO-based SUMOylation system, although in this case a
prerequisite is that the target protein has a high intrinsic affinity to
SUMO1-loaded Ubc9, such as TDG. This strategy offers even
higher combinatorial flexibility as existing expression vectors for
potential SUMO targets can be used without having to consider
plasmid replication incompatibility or selection markers (Figure 6).
Purification of GST- and His6-tagged protein can be carried out
by applying the cell extracts onto GST and Ni-NTA affinity
columns irrespective of whether SUMOylation was performed in-
cell or in-extract. The sequence of affinity column purification has
to be evaluated individually but should only have a minor effect on
the final purity. First enriching the targets on the GST affinity
column gives the advantage that protein can directly be eluted
from the column via release from the GST-fusion-tag. Doing so,
possible modifications of the fusion-tag are eliminated and the
separation of modified and unmodified target by the subsequent
Ni-NTA column is not affected by a possible GST dimerization.
Yet, our experience from purifying TDG and XRCC1 was that
yields were better when extracts were first fractionated on the Ni-
NTA column and then on the GST column. In addition, this work
flow resulted in less co-purification of free SUMO1 polypeptides;
an issue that will apply to all targets harboring an intrinsic SUMO
interaction domain. Also, non-covalent interaction with free
Figure 6. Summarizing table. Overview on our newly introduced SUMOylation systems indicating advantages, disadvantages and putative
applications in comparison to host in vivo and purely in vitro systems.
doi:10.1371/journal.pone.0102157.g006
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SUMO but also SUMO-conjugated target protein results in the
co-purification of unmodified target and may require further
purification steps such as size exclusion or ion-exchange chroma-
tography or adaptation of buffer conditions (salt concentration,
detergents).
In conclusion, we present tools and strategies to generate
SUMOylated proteins using versatile binary expression vector
systems in protease-deficient E.coli. They are designed to be
applied for SUMOylation-related experimentation, complemen-
tary to classical investigation in the native host or in vitro (see
Summary Figure 6). We provide purification work flows to enrich
for SUMOylated protein that retains the expected biochemical
properties. Owing to its high SUMOylation efficiency, the system
will be suitable for screening and testing of predicted SUMOyla-
tion targets, but also for large scale purifications of modified
proteins as required for biochemical and structural studies.
Depending on the target, some degree of fine-tuning of expression
and modification conditions will be needed to limit non-specific
SUMO-conjugation. As the vector systems are available for
SUMO1, SUMO2 and SUMO3, modified proteins with the
variant forms can be produced to analyze and compare SUMO-
specific functional properties and consequences.
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ABSTRACT
Growth arrest and DNA-damage-inducible protein 45
(Gadd45) family members have been implicated in
DNA demethylation in vertebrates. However, it re-
mained unclear how they contribute to the demethy-
lation process. Here, we demonstrate that Gadd45a
promotes active DNA demethylation through thymine
DNA glycosylase (TDG) which has recently been
shown to excise 5-formylcytosine (5fC) and 5-
carboxylcytosine (5caC) generated in Ten-eleven-
translocation (Tet)––initiated oxidative demethyla-
tion. The connection of Gadd45a with oxidative
demethylation is evidenced by the enhanced acti-
vation of a methylated reporter gene in HEK293T
cells expressing Gadd45a in combination with cat-
alytically active TDG and Tet. Gadd45a interacts with
TDG physically and increases the removal of 5fC and
5caC from genomic and transfected plasmid DNA by
TDG. Knockout of both Gadd45a and Gadd45b from
mouse ES cells leads to hypermethylation of spe-
cific genomic loci most of which are also targets of
TDG and show 5fC enrichment in TDG-deficient cells.
These observations indicate that the demethylation
effect of Gadd45a is mediated by TDG activity. This
finding thus unites Gadd45a with the recently defined
Tet-initiated demethylation pathway.
INTRODUCTION
Methylation at position 5 of cytosine (5-methylcytosine,
5mC) in DNA is a major epigenetic modification that regu-
lates gene transcription and other functions of the genome
(1,2). Cytosine methylation in CpG-rich regulatory gene
promoters and enhancers inversely correlates with tran-
scriptional activity of associated genes as it causes chro-
matin condensation and thus gene silencing. Since pat-
terns of 5mC are subject to mitotic inheritance through
maintenance methylation during DNA replication, active
demethylation is required for a rapid and efficient erasure of
5mC (3). Both locus-specific and genome-wide demethyla-
tion have been documented (4). For instance, the promoter
of the estrogen receptor target gene pS2 undergoes active
demethylation in the cyclic activation of transcription (5).
Genome-wide demethylation in primordial germ cells is be-
lieved to be important for erasing the parental methylation
patterns (6). Demethylation of the zygotic genome is associ-
ated with remodeling of the parental epigenomes, presum-
ably to establish developmental competence for the early
embryo (7–10). Multiple mechanisms have been proposed
to achieve active demethylation, which include direct re-
moval of the exocyclic methyl group from the cytosine via
C–C bond cleavage, replacement of the methylated cytosine
base and nucleotide respectively through DNA base exci-
sion repair (BER) and nucleotide excision repair pathways
(11). However, most of the proposed mechanisms have not
been validated biochemically and genetically (12,13).
Compelling biochemical and genetic evidence has sug-
gested that members of the Ten-eleven-translocation (Tet)
family of DNA dioxygenases function to reverse DNA
methylation (4,14). Tet enzymes catalyze the oxida-
tion of 5mC to 5-hydroxymethylcytosine (5hmC), 5-
formylcytosine (5fC) and 5-carboxylcytosine (5caC) (15–
17). ThymineDNAglycosylase (TDG), originally identified
as a DNA glycosylase for the excision of thymine and uracil
mispaired with guanine, is able to recognize and excise the
Tet-generated oxidation products 5fC and 5caC, leading to
the incorporation of unmethylated cytosine via the BER
pathway (15,18–20). The functional relevance of TDG in
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the regulation of DNA methylation is well-established by
gene inactivation experiments at both animal (21,22) and
ES cell levels (15,23,24). Given the importance of DNA
methylation in stem cell biology and cancer, the study of
Tet/TDG-mediated demethylation has become a major fo-
cus over the recent years. However, it is still unclear how the
oxidative demethylation process is regulated.
Gadd45 (growth arrest and DNA-damage-inducible pro-
tein 45) family proteins aremulti-faceted nuclear factors im-
plicated in active DNA demethylation, apart from mainte-
nance of genomic stability, DNA repair and suppression of
cell growth (25,26). Overexpression of Gadd45a activates
methylation-silenced reporter genes and promotes global
DNA demethylation (27). However, despite the connec-
tion of Gadd45 proteins with DNA demethylation in sev-
eral contexts, including neuronal activity-induced demethy-
lation in the mouse brain (28) and deaminase-related
demethylation in Xenopus laevis embryos (29), if and how
they exactly promoteDNAdemethylation has remained un-
resolved and controversial (26,30).
In this study, we investigate the role of Gadd45a in active
demethylation and activation of silenced genes.We find that
Gadd45a interacts physically and functionally with TDG
and contributes to DNA demethylation and gene activation
in a TDG-dependent manner. In mouse ES cells, inactiva-
tion ofGadd45a/b leads to hypermethylation at loci most of
which overlap with those depending on TDG for demethy-
lation. These findings connect Gadd45 proteins with the




Primary antibodies used for western blotting assays were
as follows: anti-Flag (Sigma, F7425), anti-HA (Sigma,
H6908), anti-GAPDH (Sigma, 9545). Anti-Tet2 and anti-
TDG antibodies were as described previously (31). The Tdg
knockout ES cell line was described (32).
Luciferase reporter assay
The reporter plasmid pCpGL-CMV-firefly luciferase was
generated by subcloning the Cytomegalovirus (CMV) pro-
moter from pcDNA3.1 (Invitrogen) into the CpG-free
pCpGL-basic vector (33). By replacing the firefly luciferase
gene with the renilla luciferase gene, an analogous control
reporter plasmid pCpGL-CMV-renilla luciferase was con-
structed. The firefly plasmid was in vitro methylated with
CpG methylase M.SssI (NEB) and the complete methyla-
tion was verified by digestion with methylation sensitive en-
zymes TaiI (Fermentas). HEK293T cells were transiently
transfected in 12-well plate with 500 ng expression con-
structs (Tet2/TDG/Gadd45a) each, 20 ng methylated fire-
fly luciferase reporter and 0.2 ng unmethylated renilla lu-
ciferase reporter as an internal control for normalization.
Forty-six hours after transfection, luciferase activities were
measured using the dual-luciferase reporter assay system
(Promega) according to the manufacturer’s instructions.
Each experiment was repeated at least three times.
HPLC analysis of nucleosides
The nucleosides were analyzed by HPLC according to He
et al. (15). Briefly, 200 g of genomic DNA extracted from
HEK293T cells were heat-denatured and hydrolyzed into
mononucleotides with 0.5 U of nuclease P1 (Sigma) at 37◦C
overnight (the reaction buffer containing 20 mMNaAc, pH
5.3, 0.2 mM ZnSO4). The nucleotides were then dephos-
phorized by incubation with calf intestinal alkaline phos-
phatase (CIAP, TaKaRa) for at least 2 h at 37◦C. The re-
actions were then concentrated into 35 l and analyzed on
an Agilent 1260 HPLC machine with an AQ-C18 column
of 5-m particle size, 25 cm × 4.6 mm. The mobile phase
was 10 mM KH2PO4, pH 3.7, running at 0.6 ml per min
and the detector was set at 280 nm. 5hmC and 5caC nu-
cleoside standards were prepared by dephosphorylation of
5-Hydroxymethyl-dCTP and 5-Carboxy-dCTP (TriLink),
and 2′-deoxycytidine (C) and 5-methyl 2′-deoxycytidine
(5mC) were bought from Sigma.
UHPLC- MS/MS analysis of mononucleosides
UHPLC-MS/MS analysis of modified mononucleosides
was carried out according to Yin et al. (34). It was per-
formed on an Agilent 1290 UHPLC system coupled with
a G6410B triple quadrupole mass spectrometer (Agilent
Technologies, Palo Alto, CA, USA). An isocratic elution
with 5.0% methanol, 95% water and 0.1% formic acid run-
ning at 0.25 ml/min was used for UHPLC separation of
mononucleosides. The eluate from the column was injected
into electrospray ionization-triple quadrupole mass spec-
trometry. Positive multiple reaction monitoring modes were
used: m/z 242→126 for 5mC (collision energy, 5eV); m/z
258→142 for 5hmC (5eV); m/z 256→140 for 5fC (5eV);
m/z 272→156 for 5caC (5eV). 2′-deoxyguanosine (dG) in
all samples was also measured to normalize the amount of
DNA on column. Each sample was analyzed at least three
times. The frequency of modified mononucleosides was cal-
culated by corresponding standard curves.
Establishment of TDG KO HEK293T cell lines
Targeting of TDG in HEK293T cells was carried out
by using TALEN mediated homologous recombination.
TALENs against TDG were designed by online soft-
ware TAL Effector Nucleotide Targeter 2.0 (35) to tar-
get the exon 2 of TDG. The TALENs were com-
posed of domains targeting to the left arm sequence:
5′-TCAGCTATTCCCTTCAGCA-3′ and the right arm
sequence: 5′-TCAGTTGTTGAAATGGAAA-3′. TALEN
constructs were assembled using FastTALE TALEN As-
sembly Kit (SiDanSai). The TALENs plasmids and target-
ing vectors (PGK-hygromycin and PGK-puromycin) were
transfected into HEK293T cells using Lipofectamine 2000.
Selective medium with 200 g/ml hygromycin and 1.5
g/ml puromycin was applied 48 h after transfection and
replaced every two days. Individual positive colonies were
picked and expanded, which were further characterized by
genotyping polymerase chain reaction (PCR) and western
blotting using antibody against TDG.
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Generation of Gadd45a/Gadd45b double-knockout mouse
ES cell lines
Gene targeting of Gadd45a/b was accomplished by using
CRISPR/Cas9 system according to Ran et al. (36). The tar-
get sequences were designed on the website (http://crispr.
genome-engineering.org/) to disrupt the first exon contain-
ing the start codon of the Gadd45a or Gadd45b genes. Ex-
pression vector px330 containing the Cas9 and mCherry
genes was digested with BbsI and the linearized plasmid
purified using QIAquick PCR Purification Kit (Qiagen).
Paired oligonucleotides for sgRNA at each targeted site
(Supplementary Table S1) were annealed and ligated to the
linearized vector. The plasmids were confirmed by sequenc-
ing.
V6.5 ES cells were cultured on feeder cells with stan-
dard ES cell culture conditions. Cells were transfected with
px330-sgRNA plasmids using Lipofectamine 2000. After
48 h, mCherry-positive cells were sorted by flow cytometry
using BD FACS Aria II (BD) and cultured on feeder lay-
ers. After recovering for 4–6 days, individual colonies were
picked and genotyped by PCR genotyping and sequencing.
Reduced representation bisulfite sequencing (RRBS)
Reduced representation bisulfite sequencing (RRBS) was
performed as described in Guo et al. (32) with slight modi-
fication. Briefly, genomic DNA was digested by MspI (Fer-
mentas) and the 200–500 bp DNA fragments were se-
lected to undergo bisulfite conversion. Analysis of RRBS
data was performed according to Guo et al. (32), the
adaptor-trimmed reads were mapped to the mouse genome
(mm9) using Bismark (v. 0.76, http://www.bioinformatics.
babraham.ac.uk/projects/bismark/). The methylation level
of each single CpG site was calculated using the number of
RRBS-measuredC (methylated) divided by the sumofmea-
sured C (methylated) and T (unmethylated). CpG sites with
at least five uniquely mapped reads were chosen for further
analysis.
The differentially methylated CpG sites were identified
if the absolute methylation level difference was >25% be-
tween wild-type (WT) and Gadd45 DKO ES cells (one-
tailed Fisher’s exact test with P < 0.05, with Benjamini–
Hochberg false discovery rate <0.05). The neighboring hy-
permethylated (or hypomethylated) CpG sites were merged
to form a differentially methylated region if there was at
most one CpG site between these two hypermethylated (or
hypomethylated) CpG sites and the distance between them
was <100 bp.
Preparation of the 5fC/5caC-containing plasmid (oxi-5mC
plasmid)
For the preparation of oxi-5mC plasmid DNA, 100 ng of
M.SssI-methylated pCpGL-CMV-firefly plasmids were ox-
idized by using 2g of the TET2 protein (37) in the reaction
buffer (50 mMHEPES, pH 8.0, 50 mMNaCl, 2 mM ascor-
bic acid, 1mM 2-oxoglutarate, 100 M Fe(NH4)2(SO4)2, 1
mM adenosine triphosphate (ATP) and 1 mM Dithiothre-
itol (DTT)) for 1 h at 37◦C. The reaction was then added
with 1 g of the TET2 protein for further incubation of 1
h. The plasmid DNA was recovered by phenol–chloroform
Figure 1. Gadd45a synergizes with Tet and TDG in activation of a methy-
lated reporter gene in a dual luciferase reporter assay. A methylated
(A) or unmethylated (B) pCpGL-CMV-firefly luciferase reporter was co-
transfected into HEK293T cells with Gadd45a, Tet2CD and TDG in var-
ious combinations indicated. Shown is the firefly luciferase activity nor-
malized to the level of control pCpGL-CMV-renilla luciferase relative to
that of cells without Tet, TDG and Gadd45 expression, which is set to 1.
‘m’ denotes catalytically inactive mutants of Tet2CD and TDG. Data are
represented as the mean ± SEM of three independent experiments.
extraction and the oxidative level of the DNAwas tested by
M.SssI-assisted bisulfite sequencing (MAB-seq) (32).
Isolation of transfected plasmid
Forty-eight hours after transfection, nuclei were extracted
from the transfected HEK293T cells using the Wizard Ge-
nomic DNA Purification Kit (Promega) according to the
manufacturer’s instructions. The plasmid DNA was then
isolated using phenol–chloroform extraction.
Bisulfite sequencing
A total of 200 ng of genomic DNA were treated with the
EZ DNA Methylation-Direct Kit (Zymo Research). Spe-
cific genomic regions were PCR-amplified using TaqHS en-
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Figure 2. Ectopic expression of Gadd45a reduces genomic 5fC and 5caC
generated by Tet2 in transfected HEK293T cells. (A) HPLC analysis of
5caC in the genomicDNAof cells overexpressing full-length Tet2 with and
without Gadd45a. The y-axis indicates OD280nm of nucleoside prepara-
tions from genomic DNA. Defined nucleosides were used as standards (C,
5mC, 5hmC and 5caC). Dashed lines indicate the elution position of 5caC.
(B) Mass spectrometric quantification of modified cytosines (5mC, 5hmC,
5fC and 5caC) in the genomic DNA of cells ectopically expressing Tet2
alone or with Gadd45a. Data are represented as the mean ± SEM from
two independent experiments, and are analyzed by two-tailed t-test, P <
0.05 (*).
zyme (Takara). The PCR products were gel-purified by us-
ing Gel Extraction Kit (Qiagen) and cloned into pMD 19-
T (Takara) for sequencing. Data were analyzed by an on-
line called BISMA (38) (http://services.ibc.uni-stuttgart.de/
BDPC/BISMA/) and duplicated clones were deleted by this
software.
M.SssI-assisted bisulfite sequencing (MAB-seq)
MAB-seq was performed to map sequence-specific 5fC and
5caC distribution as described (31,32). A total of 100 ng of
genomic DNAwere methylated byM.SssI (NEB) following
the vendor’s instructions. The methylated DNA sample was
then purified by phenol–chloroform extraction. Bisulfite
conversion, sequencing and data analysis were performed
as described above.
Recombinant protein expression and purification
For purification of Flag-tagged proteins, coding sequences
were cloned into a modified pcDNA4 (Invitrogen) vector.
The expression plasmids were transfected into HEK293T
cells using polyethylenimine (PEI, Sigma). After culturing
for 48 h, the cells were harvested and lysed in lysis buffer (50
mMTris, pH 7.5, 500mMNaCl, 1%NP-40, 1× protease in-
hibitors without ethylenediaminetetraacetic acid (EDTA)).
The recombinant proteins were purified by using the FLAG
M2 affinity gel (Sigma) according to the manufacturer’s in-
structions. The eluted proteins were dialyzed against stor-
age buffer (20 mMHEPES, pH 7.4, 50 mMNaCl and 50%
glycerol) for 4 h at 4◦C and then stored at −80◦C.
For purification of Glutathione S-transferase (GST) fu-
sion proteins, GST-tagged proteins were overexpressed
in Escherichia coli strain BL21 (DE3) Codon-Plus-RIL
(Stratagene). Cells were grown at 37◦C in LB medium to an
optical density of 0.6–0.8 at 600 nm and then induced with
0.2 mM Isopropyl -D-1-thiogalactopyranoside (IPTG) at
20◦C overnight. Purification was performed using Glu-
tathione Sepharose 4B (GE Healthcare) according to the
manufacturer’s instructions.
Purification of TDG used in the in vitro glycosylase assay
was described before (39).
GST-pull down assay
To confirm the interaction of TDG and Gadd45a, GST
pull-down assay was performed essentially as described
(40). A total of 4 g of the GST–TDG fusion protein pu-
rified from E. coli were incubated with 20 l Glutathione
Sepharose 4B beads in the binding buffer [20 mM Tris–
HCl (pH 7.9), 0.1 M NaCl, 1 mM EDTA, 5 mM MgCl2,
0.1% NP-40, 1 mM DTT, 0.2 mM phenylmethanesulfonyl
fluoride (PMSF) ] in a total volume of 200 l at 4◦C for
2 h. Then 1 g of Flag-Gadd45a was added to the slurry
and incubated at 4◦C for another 2 h. The Sepharose beads
were washed three times with the washing buffer [20 mM
Tris–HCl (pH 7.9), 0.15 M NaCl, 1 mM EDTA, 5 mM
MgCl2, 0.1% NP-40, 1 mM DTT, 0.2 mM PMSF] and
bound proteins were analyzed by sodium dodecyl sulphate-
polyacrylamide gel electrophoresis and visualized by west-
ern blotting.
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The interaction of Flag-TDG andGST-Gadd45a was de-
termined using the same protocol.
Yeast two-hybrid assay
To confirm the interaction between Gadd45a and TDG,
Gadd45a was cloned in-frame with GAL4 DNA binding
domain (GAL4DBD) in the bait vector pGBKT7 (Clon-
tech) and TDG fragments were fused with the GAL4 ac-
tivation domain (GAL4AD) in the prey vector pGADT7.
Yeast was co-transformed with pGBKT7-Gadd45a and
pGADT7-TDG. Colonies were selected on the SD medium
lacking His, Leu, Trp and adenine according to the recom-
mended protocol (Clontech).
Base release assay
The 60-mer double-stranded oligonucleotide substrates
containing different modifications were prepared by
annealing of an unlabeled upper strand oligonucleotide
5′-TAGACATTGCCCTCGAGGTACCATGGATCC
GATGTCGACCTCAAACCTAGACGAATTCCG-3′
to a 5′-fluorescein-labeled lower oligonucleotide strand
5′-F-CGGAATTCGTCTAGGTTTGAGGTXGACATC
GGATCCATGGTACCTCGAGGGCAATGTCTA-3′,
where X = T or 5caC.
Multiple turnover base release assays were carried out
in a total volume of 200 l containing 25 nM of the la-
beled DNA substrate (G•T), 100 nM of unlabeled DNA
substrate, 25 nM of recombinant TDG and 1 MGadd45a
(or BSA) in 1× reaction buffer [50 mM Tris–HCl (pH 8.0),
1 mM EDTA, 1 mMDTT] at 37◦C and 20 l samples were
taken at indicated time points. Generated AP-sites were
cleaved by the addition of NaOH to a final concentration
of 100 mM and heating to 99◦C for 10 min. Subsequently,
DNAwas ethanol precipitated overnight at−20◦C in 0.3M
Na-acetate (pH 5.2) and in the presence of 0.4 mg/ml car-
rier tRNA. The DNA was collected by centrifugation (20
min, 20 000 g, 4◦C) and washed in 70% ethanol. Air-dried
pellets were resuspended in loading buffer (1× Tris-Borate-
EDTA (TBE) buffer, 90% formamide), heated at 99◦C for 5
min and then immediately chilled on ice. Reaction products
were separated on 15% denaturing polyacrylamide gels in
1× TBE. The fluorescein-labeled DNA was visualized with
a Typhoon 9400 (GE Healthcare) and quantified using the
ImageQuant TL software (GE Healthcare).
Single turnover base release assays were carried out as de-
scribed above in a total volume of 200 l containing 25 nM
of the labeled DNA substrate (G•5caC), 250 nM recombi-
nant TDG and 1 M Gadd45a in 1× reaction buffer [50
mMTris–HCl (pH 8.0), 1 mMEDTA, 1 mMDTT] at 30◦C
and 20 l samples were taken at indicated time points.
RESULTS
Gadd45a activates the expression of a methylated reporter
gene in cooperation with Tet and TDG
Active DNA demethylation can be achieved by a concerted
action of Tet and TDG (41). We reasoned that other factors
previously proposed to contribute to demethylation might
exert their effects by modulating the Tet-TDG axis. To test
this possibility, we used a cell-based firefly luciferase re-
porter assay to test anti-gene silencing effects of factors of
interest (Supplementary Table S2). The luciferase-reporter
plasmids were free of CpGs except for the 0.6-kb CMV pro-
moter (33) regions, which contained 37 CpGs that we fully
methylated in vitro by reaction with the CpG-specific bacte-
rial methyltransferase M.SssI prior to transfection. Methy-
lation of the CMV promoter conferred 100-fold repres-
sion of the firefly luciferase activity but co-transfection of
the methylated reporter plasmid with Tet2 catalytic domain
(Tet2CD) together with TDG, increased the activity by 13-
fold, thus partially alleviating the repression (Figure 1A).
Gadd45a, which we tested as a candidate for a modulatory
factor, was able to stimulate the silenced reporter expression
by 35-fold, but only when co-transfected with Tet2CD and
TDG (Figure 1A). Expression of Gadd45a did not affect
the protein levels of Tet2CD and TDG in transfected cells
(Supplementary Figure S1). Moreover, its effect was depen-
dent on the enzymatic activities of Tet and TDG because
no stimulation effect was observed in co-transfection with
the catalytically inactive mutants. By contrast, Gadd45a in
combination with Tet and TDG had only a two-fold stimu-
latory effect on expression of the reporter gene on an un-
methylated plasmid (Figure 1B). These observations sug-
gest that Gadd45a cooperates with Tet and TDG in the ac-
tivation of a methylation-silenced reporter gene.
Reduction of 5fC and 5caC by Gadd45a in HEK293T cells
overexpressing Tet2
Since the effect of Gadd45a on methylated reporter activa-
tion depends on catalytically active Tet and TDG, we next
investigated whether Gadd45a might impact on the func-
tions of Tet and TDG in transfected cells. The occurrence
of 5caC in the genomic DNA of HEK293T cells trans-
fected with a Tet enzyme could be detected by HPLC anal-
ysis (15). We took advantage of this system to examine
whether Gadd45a can regulate the level of 5caC generated
in transfected cells. As reported previously (15), 5caC could
be detected in Tet2-transfected cells (Figure 2A). However,
the 5caC level was reduced to 30% by co-transfection of
Gadd45a with Tet2, while the 5mC and 5hmC levels were
unchanged. Gadd45a expression did not influence the pro-
tein expression of transfected Tet2 and endogenous TDG
(Supplementary Figure S2A and B). Drastic reduction in
5fC and 5caC levels was confirmed by triple quadruplemass
spectrometry quantification (Figure 2B). The selective re-
moval of 5fC and 5caC but not 5mC and 5hmC could sug-
gest that Gadd45a might not affect the oxidation function
of Tet2 but promote the function of the endogenous TDG
which is likely rate-limiting in removing genomic 5fC and
5caC from HEK293T cells.
Gadd45a interacts with TDG
Having demonstrated the functional relationship between
Gadd45a and TDG in reporter gene reactivation and the
regulatory effect of Gadd45a on the 5caC and 5fC lev-
els in transfected cells, we wondered whether there is a di-
rect protein–protein interaction between them. As shown in
Figure 3A, purified Flag-TDG from HEK293T cells could
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Figure 3. Gadd45a interacts with TDG in vitro. (A) GST and Flag pull-down assay. Western blot analysis of Flag-TDG in fractions obtained from a GST
pull-down assay using GST-Gadd45a (lane 1) or GST (lane 2) (upper panel) and viceversa (lower panel). Mock is the control without GST or its fusion.
Ten percent of the input was loaded. (B) Co-immunoprecipitation (Co-IP) assay. Immunoprecipitates of lysates of HEK293T cells transfected with HA-
Gadd45a and Flag-TDG alone or in combination were resolved by SDS-PAGE and detected by western blotting with the indicated antibodies. (C) Yeast
two-hybrid assay. Appearance of colonies in the SD-L-T-A-H selective medium indicates that the reporter genes have been activated due to the interaction
between the bait (GAL4DBD-Gadd45a) and prey (TDG-GAL4AD) hybrid proteins. Yeast strains harboring the Gadd45a bait construct and an empty
prey vector were used as negative controls. (D) Mapping of Gadd45a-TDG interaction domains. The protein regions tested in yeast two-hybrid assays are
indicated above.
bind with bacterial recombinant protein GST-Gadd45a.
The protein association could also be shown with co-
immunoprecipitation (Co-IP) assay using extracts from
HEK293T cells transfected with epitope-tagged TDG and
Gadd45a (Figure 3B). To further confirm and characterize
the interaction, we performed yeast two-hybrid assay. As ex-
pected, yeasts harboring both a Gadd45a bait and a TDG
prey construct could grow on the selective medium lacking
His, Leu, Trp and adenine because of the activation of re-
porter genes due to the interaction between Gadd45a and
TDG (Figure 3C). To map the interacting domains, dele-
tion analysis was performed with the bait and prey con-
structs. We found that the N-terminal domain of Gadd45a
(amino acids1–137) mediates the interaction with TDG via
a N (amino acids 1–132) and a C-terminal (amino acids
178–397) domain of TDG (Figure 3D). These data provide
a confirmation of the physical interaction betweenGadd45a
and TDG.
The effect of Gadd45a on 5caC removal is exclusively medi-
ated by TDG
TDG is the only known enzyme capable of specifically ex-
cise 5fC and 5caC from DNA (15). To determine whether
Gadd45a affects the reduction of 5caC in genomic DNA
through the endogenous TDG, we generatedHEK293T cell
lines deficient in TDG. The TDG gene was disrupted by us-
ing TALEN technology (Supplementary Figure S3). Exon 2
was replaced in the two alleles, by the hygromycin-resistance
gene in one gene copy and by the puromycin-resistance gene
in the other. Deletion of this exon would lead to a frame-
shift behind the first seven N-terminal codons. Genomic
PCR confirmed that the exon 2 sequences had been deleted,
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Figure 4. Reduction of genomic 5caC by Gadd45a depends on TDG in transfected HEK293T cells. (A) Confirmation of the TDG gene knockout (KO)
in HEK293T cells by PCR genotyping of genomic DNA. The two TDG alleles present in wild-type (WT) cells were replaced by puromycin (Puro) and
hygromycin (Hygro) drug selection markers in KO cells (Supplementary Figure S3). (B) Loss of the endogenous TDG protein in the established knockout
cell line confirmed by western analysis using anti-TDG antibody. Detection with anti-GAPDH served as a loading control. (C) HPLC analysis of genomic
5caC in TDG-knockout cells expressing ectopic full-length Tet2 alone and together with Gadd45a. Transfection of the TDG control eliminates 5caC
generated by Tet2, as previously reported (15). (D) Mass spectrometry quantification of modified cytosines in the genomic DNA of TDG knockout cells
ectopically expressing Tet2 alone or Tet2 together with and Gadd45a. Data are represented as the mean ± SEM from two independent experiments.
with the acquisition of drug selection markers in the estab-
lished knockout cell line (Figure 4A). Loss of TDG protein
expression was confirmed by western blot analysis using an
anti-TDG antibody (Figure 4B). As shown in the HPLC
analysis of genomic DNA from transfected cells, expression
of Gadd45a in TDG-deficient cells did not change the level
of 5caC generated by Tet2 (Figure 4C). Mass spectrome-
try analyses of the genomic DNA samples confirmed that
levels of 5fC and 5caC were not changed by Gadd45a ex-
pression in TDG-knockout cells (Figure 4D). The possibil-
ity that Gadd45a may increase the expression level of Tet2
thus masking its effect by generating higher level of 5caC
was ruled out (Supplementary Figure S2C). Additionally,
the complete removal of 5caC upon re-expression of ec-
topic TDG in the knockout cells validated the cellular com-
petence for TDG function. These results indicate that the
function of Gadd45a in DNA demethylation is realized ex-
clusively through its effect on TDG.
Gadd45a promotes conversion of 5fC and 5caC to unmodified
cytosine in a TDG-dependent manner
As shown above, Gadd45a reduces the buildup of genomic
5fC and 5caC formed by ectopic Tet2 in transfected cells.
To directly demonstrate the role of Gadd45a, we prepared
in vitro a 5fC/5caC-containing reporter plasmid and trans-
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Figure 5. Gadd45a promotes conversion of 5fC and 5caC into unmodified cytosine in a TDG-dependent manner in transfected cells. (A) Characterization
of oxidized pCpGL-CMV reporter plasmid DNA (oxi-5mC plasmid). Plasmid DNAwas methylated in vitro with CpGmethyltransferase M.SssI and then
oxidized using human TET2 enzyme to obtain oxi-5mC DNA. BS-seq and MAB-seq profiles show occurrence of expected modifications at CpGs in the
CMV promoter region. There was about 10% 5mC or 5hmC remaining in the oxi-5mC DNA due to incomplete oxidization with TET2. The white circles
denote unmodified C or higher oxidized forms of 5mC (5fC and 5caC) and the black circles denote 5mC or 5hmC in BS analysis. The blue circles in the
MAB-seq profile represent C, 5mC or 5hmC. The orange circles represent higher oxidized forms (5fC or 5caC). (B) MAB-seq analysis of oxidized reporter
plasmid DNA recovered from transfected HEK293T cells. The oxi-5mC plasmid DNA was transfected into WT or TDG knockout cells with Gadd45a,
TDG or vector control. Percentages of the oxi-5mC bases (5fC and 5caC) are indicated.
fected the plasmid with the Gadd45a expression plasmid
into HEK293T cells. The recovered reporter plasmid DNA
was then analyzed by M.SssI-assisted bisulfite sequenc-
ing (MAB-seq) which allows to distinguish unmodified cy-
tosines from 5fC/5caC in a specific sequence at single-base
resolution (31,32). We first confirmed the efficient methy-
lation (5mC 99.2%) and oxidation (5fC + 5caC; 89.2%)
of the CpG sites in the CMV promoter region of the pre-
pared plasmid (oxi-5mC) using bisulfite-seq and MAB-seq
(Figure 5A; Supplementary Figure S4). Interestingly, in
the recovered plasmid upon co-transfection with Gadd45a,
the combined level of 5fC and 5caC was reduced to 58%
while the DNA without Gadd45a co-transfection retained
the majority of 5fC/5caC (84.3 versus 89.2%, Figure 5B).
Consistent with the idea of TDG activity mediating the
Gadd45a effect, overexpression of TDG also reduced the
5fC/5caC level to 51%. Moreover, Gadd45a had no effect
on the 5fC/5caC level in TDGKO cells (89.5 versus 89.2%,
Figure 5B), indicating that the endogenous TDG is essen-
tial to mediate the function of Gadd45a in HEK293T cells.
Taken together, Gadd45a promotes demethylation by pos-
itively impacting TDG for the conversion of 5fC and 5caC
into C.
Gadd45a/b knockout causes locus-specific hypermethylation
in mouse ES cells
If Gadd45a positively regulates Tet/TDG-mediated DNA
demethylation in ES cells, Gadd45a deficiency would lead
to hypermethylation in genomic regions known to be the
target loci of active demethylation. To eliminate the effect
of potential functional redundancy with Gadd45b that has
55% protein sequence identity and has a similar mRNA
expression level with Gadd45a in ES cells, we generated
Gadd45a/Gadd45b double-knockout (DKO) mouse ES cell
lines using the CRISPR/Cas9 system. Nucleotide inser-
tions and deletions at the targeted sites were identified
which would lead to frame shift mutation or early termina-
tion, thus gene inactivation (Supplementary Figure S5). To
compare genomic methylation between DKO and the WT
ES cells, we performed genome-scale single-base-resolution
analysis using RRBS. In the DKO cells, no obvious methy-
lation difference was observed at the genome scale (Sup-
plementary Figure S6). Both the mutant and WT ES cells
have a CpG methylation frequency of around 33% in the
RRBS-covered genome part and a similar overall gene dis-
tribution pattern. However, 68 specific regions were found
hypermethylated which contained more than 4 CpG sites of
significantly increased methylation (Supplementary Table
S3), as exemplified by the genomic loci from the Plagl1 and
Cilp2 genes (Figure 6A). In sharp contrast, no hypomethy-
lated regions could be identified in these DKO ES cells.
Primer-based conventional bisulfite sequencing confirmed
significantly elevated methylation in the corresponding re-
gions of Plagl1 and Cilp2 (Figure 6B). Interestingly, these
two regions also gained hypermethylation in control ES
cells deficient in TDG (Figure 6B). Since 5mC and 5hmC
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Figure 6. Locus-specific hypermethylation in Gadd45a/b DKO mouse ES cells. (A) Representative loci of hypermethylation in Gadd45a/b DKO ES cells
mapped by RRBS analysis. Vertical bars indicate the methylation level (0–1) at individual CpGs in the genomic regions indicated. (B) Confirmation of
increased methylation at the selected loci by bisulfite sequencing in WT, Gadd45a/bDKO and TdgKO ES cells. Black and white circles denote methylated
and unmethylated CpG sites respectively. Percentages of the CpGs sites resistant to bisulfite conversion are indicated below. (C) Comparison of the 68
hypermethylated regions identified in Gadd45a/b DKO ES cells (top pie charts) or 68 randomly chosen RRBS covered regions (bottom) with the pool of
5hmC-rich regions (24,42) (left) and the pool of 5fC-rich regions (24) (right) previously identified in Tdg KO ES cells.
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are not distinguishable in conventional bisulfite sequenc-
ing, we performed Tet-assisted bisulfite sequencing (TAB-
seq) to determine 5hmC in the Plagl1 and Cilp2 regions.
We found 5hmC very rare and no increase in both cell lines
deficient in Gadd45 or TDG (Supplementary Figure S7).
This indicates that the hypermethylation was actually com-
posed of 5mC rather than 5hmC. Further inspection of
the Gadd45 deficiency–caused hypermethylated regions re-
vealed that most of them were overlapped with 5hmC and
5fC-enriched regions previously mapped in ES cells (24,42).
Among the 68 hypermethylated regions, 50 are overlapped
with 174 655 regions reported to be enriched in 5hmC and
48 are overlappedwith 120 052 regions enriched in 5fC (Fig-
ure 6C). By comparison, much fewer regions randomly cho-
sen from the RRBS-covered sequences are overlapped with
5hmCor 5fC regions. Overall, these results support the con-
clusion that Gadd45 proteins functionally cooperate with
the Tet and TDG enzymes in demethylation of genomic tar-
gets in mouse ES cells.
DISCUSSION
Mechanisms of DNA demethylation have been intensively
studied but remain elusive. There exist a wide variety of fac-
tors that belong to different pathways but appear to regu-
late DNA methylation negatively (13). As biochemical ev-
idence revealing their participation in the demethylation
process is lacking in most cases, it is plausible that the role
of these factors in DNA methylation control may be indi-
rect. In the presented work, we have examined the role of
Gadd45a in the context of the recently proposed Tet-TDG
mediated demethylation pathway (41). Our data indicate
that Gadd45a is involved in oxidative demethylation by reg-
ulating the activity of TDG in cells.
The Tet family of proteins, or DNA dioxygenases by na-
ture, have emerged as the most plausible enzymes for initi-
ation of active demethylation, owing to their ability to oxi-
dize the methyl group of 5mC (14,43). While the simple ox-
idation of 5mC to 5hmC will demethylate DNA passively
through replicative dilution, further oxidation to 5fC and
5caC generates substrates for TDG,which will remove these
bases, triggering their replacement by unmethylated cyto-
sine, potentially via a conventional BER process (19,41).
As demethylation is a highly regulated process, we reasoned
that auxiliary factors including those previously implicated
in demethylation may function to modulate the activity of
the Tet-TDG system. Among such factors is the multifunc-
tional Gadd45a initially identified to antagonize methyla-
tion by its activation effect on methylated reporter genes
(27). Gadd45a was proposed to promote demethylation
potentially through XPG-dependent DNA repair (27,44)
or BER of AID-based deamination products (22,29). Our
finding that Gadd45a serves as a regulator in the Tet-TDG
pathway is supported by several lines of evidence. First,
Gadd45a synergizes with Tet and TDG to activate methy-
lated reporter gene in transfected cells (Figure 1), and over-
expression of Gadd45a alone cannot reactive the methy-
lated reporter gene, consistent with the previous report by
Jin et al. (30). Second, Gadd45a interacts with TDG phys-
ically in vitro (Figure 3). Third, Gadd45a potentiates TDG
glycosylase to remove 5fC and 5caC from genomic DNA of
transfected HEK293T cells (Figure 2). Forth, endogenous
TDG is required to mediate the effect of ectopic Gadd45a
in decreasing Tet2-generated 5caC (Figures 4 and 5). Lastly,
deletion of Gadd45a/b in mouse ES cells leads to hyperme-
thylation at specific genomic loci which also gain increased
methylation in Tdg-deficient cells and are enriched in 5fC
(Figure 6). Since the molecular functions of Gadd45a ap-
pear to be diverse (26), it is noteworthy that Gadd45a pro-
motes demethylation specifically through TDG in our stud-
ies. However, since the Gadd45 deficiency-caused hyperme-
thylated regions aremuch fewer than the previouslymapped
5hmC and 5fC enriched regions in ES cells (24,42) (68 ver-
sus 174 655 and 120 052), Gadd45 may only contribute to
the control of a small fraction of Tet-TDG regulated ge-
nomic targets.
It is curious how Gadd45a exactly regulates TDG activ-
ity in cells. In light of the direct interaction between the
two proteins and the stimulation of TDG-dependent DNA
demethylation by Gadd45a in cells, we examined the possi-
bility that Gadd45a might impact on the enzymatic activ-
ity of TDG in vitro using purified proteins. Under multiple-
turnover conditions, addition of an excess ofGadd45a stim-
ulated initial processing by as well as overall efficiency
of TDG but it didn’t improve its rate limiting turnover
(Supplementary Figure S8A and B). The stimulation by
Gadd45a, however, was in a similar range as observed when
a molar equivalent of BSA was added to the reaction, indi-
cating a non-specific effect of the protein on the structural
integrity of TDG. Likewise, under single-turnover condi-
tions, the addition of Gadd45a had no measurable effect
on TDG activity, suggesting that Gadd45a does not modu-
late TDG substrate recognition potential (Supplementary
Figure S8C and D). Taken together, Gadd45a does not
appear to stimulate TDG in substrate binding, process-
ing or turnover in a specific manner. We therefore favor
a model whereby Gadd45a promotes Tet-TDG-mediated
demethylation by coordinating the recruitment of TDG
into demethylation complexes. Gadd45a (and Gadd45b)
could act as a scaffold protein which interacts with other
epigenetic regulators (26) and directs TDG to the target
loci in the context of chromatin to efficiently excise 5fC and
5caC. This is consistent with the recently proposed model
in which recruitment of both Gadd45a and TDG is impli-
cated in demethylation of the tumor suppressor geneTCF21
targeted by a long non-codingRNA (45). Further investiga-
tion will be needed to elucidate the exact molecular mecha-
nism by which Gadd45 proteins regulate the function of the
TDG enzyme in specific chromatin contexts.
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Figure S6. Related to Figure 6


Supplementary Figure Legends 
 
Figure S1. Western blotting assay to confirm the expression of proteins co-transfected with 
the luciferase reporter plasmids. Anti-Tet2, -Flag and -HA antibodies were used to detect the 
respective proteins expressed in transfected HEK293T cells in the luciferase assay (Figure 1). 
Detection with anti-GAPDH served as a loading control. 
 
Figure S2. Western blotting assays to confirm the unaltered expression of ectopic Flag-Tet2 
and endogenous TDG in transfected HEK293T cells. 
(A) Flag-Tet2 expression was not altered in wild-type cells when co-transfected with Gadd45a. 
Western blotting analysis was performed with anti-Flag. The GAPDH detection served as a 
loading control of the protein extracts. 
(B) Endogenous TDG level was not affected by transfection with Tet2 alone or with Gadd45a. 
Western analysis was performed with anti-TDG. 
(C) Flag-Tet2 expression was not altered when co-transfected with Gadd45a or TDG in TDG 
knockout HEK293T cells. Western analysis was performed with anti-Flag. 
 
Figure S3. Gene targeting strategy of TDG in HEK293T cells. The two alleles of exon 2 were 
replaced by the puromycin or hygromycin resistance genes using TALEN technology. 
 
Figure S4. Characterization of the oxi-pCpGL-CMV luciferase reporter plasmid and analysis of 
recovered oxi-plasmid after transfection with other expression constructs.  
(A) COBRA analysis of C, 5mC, oxi-, or M.SssI-incubated oxi- plasmids prepared in vitro. The 
5mC plasmid was generated from C plasmid by M.SssI methylation, and oxi-plasmid from the 
5mC plasmid by Tet2 oxidation.  
(B) Restriction assay for 5fC and 5caC analysis of oxi-plasmid recovered from nuclei of 
HEK293T cells transfected with empty vector, Gadd45a, TDG or Gadd45a and TDG 
expression constructs. The recovered plasmid DNA was treated with M.SssI and bisulfite 
conversion. PCR products amplified from the CMV region were digested with TaiI. The 
appearance of shorter fragments from TaiI digestion indicates 5fC/5caC removal and cytosine 
restoration at the TaiI CpG sites in the CMV promoter. Unmodified plasmid (C-CMV) was used 
as a control to monitor the in vitro M.SssI methylation efficiency.  
 
Figure S5. Targeting of the Gadd45a and Gadd45b genes in mouse ES cells.  
(A) Schematic of the Cas9/sgRNA-targeting sites in Gadd45a and Gadd45b. The 
sgRNA-targeting sequence is underlined, and the protospacer adjacent motif (PAM) sequence 
is labeled in green. The nucleotides at the target regions used for restriction analysis are bold.  
(B) Genotyping of DKO ES cell lines #2 and #6 by restriction analysis. Gadd45a PCR products 
amplified from the exon 1 region were digested with EcoRI. Expected fragment sizes: WT = 
180 + 369 bp, Mutant = 549 bp. Gadd45b PCR products were digested with BstUI. Expected 
fragment sizes: WT = 182 + 118 + 113 + 56 + 24 bp, Mutant = 300 + 113 + 56 + 24 bp.  
(C) The sequences of mutated alleles in double-knockout ES cell lines #2 and #6. The start 
codon is labeled in red. 
 
Figure S6. Global DNA methylation was unaltered in Gadd45a/b knockout mouse ES cells.  
(A) DNA methylation levels of wild-type (WT) and Gadd45a/b DKO (DKO) ES cells. The y-axis 
indicates the proportion of methylated CpG sites in the RRBS-covered genome part, 
calculated based on the RRBS data. # denotes independent ES cell lines. 
(B) Averaged DNA methylation levels along the gene bodies and 25-kb regions upstream and 
downstream of the gene body. TSS, transcription start site. TES, transcription end site. 
 
Figure S7. 5hmC profiles of the selected two regions (Plagl1 and Cilp) in Gadd45a/b double 
knockout (DKO), Tdg knockout (KO) and wild-type (WT) ES cells. 5hmC was determined by 
Tet-assisted bisulfite sequencing (TAB-seq). 
 
Figure S8. Gadd45 does not stimulate the activity of TDG in vitro.  
(A) Quantitation of base release activities of TDG with or without Gadd45a (or BSA) under 
multiple-turnover conditions. A 60-bp double-strand oligonucleotide duplex (125 nM) 
containing a G•T mismatch end-labeled with fluorescein was incubated with purified TDG (25 
nM) and Gadd45a or BSA (1 µM) at 37°C. The 60-mer substrate band and a 23-mer product 
band separated on a denaturing gel were quantified using the ImageQuant TL software. The y 
axis indicates the percentage of 23-mer product bands to the initial 60-mer substrate. The x 
axis indicates different reaction time points.  
(B) Quantitation of base release activities of TDG in the initial phase of the reaction (A). Data 
are presented as means ± SD from three independent experiments.  
(C) Quantitation of base release activities of TDG with BSA or Gadd45a under single-turnover 
condition. G•5caC-DNA (25 nM) was used as substrate and incubated with 250 nM TDG and 1 
µM Gadd45a or BSA.  
(D) shows the activity of TDG in the initial phase of (C). 
  
Supplementary Materials and Methods 
 
Tet-assisted bisulfite sequencing (TAB-seq) 
Genomic DNA extracted from mouse ES cells were treated as described (1). Briefly, 200 ng of 
genomic DNA were sonicated into fragments in average size of 500 bp and then glucosylated 
with T4 Phage β-glucosyltransferase (T4-BGT) (NEB) according to the manufacturer’s 
instructions. The glucosylated DNA was recovered by phenol-chloroform extraction and 
oxidized with recombinant TET2 protein twice, followed by bisulfite treatment. PCR primers 




1. Yu, M., Hon, G.C., Szulwach, K.E., Song, C.X., Zhang, L., Kim, A., Li, X., Dai, Q., Shen, Y., Park, B. 
et al. (2012) Base-resolution analysis of 5-hydroxymethylcytosine in the mammalian genome. 
Cell, 149, 1368-1380. 
 
Table S1. List of oligonucleotides and PCR primers used in the this study.  
TDG genotyping PCR primers (5’-3’): 
hTDG-exon2-F2 GGCTGACTTGACAGGACTGA 
hTDG-exon2-R2 GGCTGGAACTTCTTCTGGCA 
hTDG geno.puro-F CGACCACCAGGGCAAGG 
hTDG geno.hygro-F GTCCGAGGGCAAAGGAATGA 
hTDG geno.R TACCCAACAGGAAGCCCTGA 



















Table S2．Luciferase assay in 293T cells expressing ectopic candidate genes in the presence 
of Tet2 or Tet2 and TDG. Renilla luciferase activity was used for the normalization of firefly 
luciferase activity. Luciferase signals were normalized to the signal (arbitrarily set at 1) from 
cells transfected with empty vector and methylated reporter gene. 
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Elp3 3.4 7.1 
MBD2  3.2  8.2 
 
 
#Chr CpG site start at CpG site end at
No. of hypermethylated CpG
sites (methylation level DKO-
WT >= 25%)
chr10 12810629 12811034 25
chr17 29989346 29989629 12
chr8 124497875 124498055 11
chr7 114353723 114354069 10
chr11 11926195 11926386 9
chr11 116464994 116465161 9
chr2 156846689 156846869 9
chr1 63247019 63247224 8
chr10 28916824 28917000 8
chr17 39985424 39985567 8
chr6 47974857 47974999 8
chr10 94778414 94778594 7
chrX 160374376 160374599 7
chr1 173939752 173939942 6
chr12 11444962 11445130 6
chr13 96374092 96374300 6
chr14 52360659 52360837 6
chr14 55262846 55263070 6
chr14 80061327 80061490 6
chr19 61302514 61302645 6
chr6 117821502 117821665 6
chr7 30578032 30578263 6
chr7 117146779 117146919 6
chr8 29640647 29640801 6
chr1 108016012 108016241 5
chr15 51859452 51859578 5
chr18 61225434 61225598 5
chr2 156846988 156847212 5
chr2 165611147 165611298 5
chr2 174110204 174110339 5
chr5 120904875 120905074 5
chr5 143006075 143006216 5
chr7 4959731 4959983 5
chr7 19478584 19478731 5
chr7 50931969 50932121 5
chr7 52632486 52632699 5
chr8 72406508 72406672 5
chr8 86192449 86192618 5
chr9 43915985 43916108 5
chr10 10675791 10675963 4
chr11 11926800 11926959 4
chr11 96573894 96574066 4
chr11 114333878 114334019 4
chr15 79447772 79447944 4
chr15 102009414 102009586 4
chr17 32497199 32497327 4
chr17 48088489 48088609 4
chr17 88349236 88349388 4
chr18 20760061 20760222 4
chr18 86377421 86377559 4
Table S3. Hypermethylated loci identified in Gadd45a/b  DKO ES cells.
chr2 154162024 154162158 4
chr3 90077809 90077940 4
chr4 145427159 145427298 4
chr5 110497981 110498132 4
chr6 100432791 100432929 4
chr7 4960086 4960227 4
chr7 80664446 80664603 4
chr7 125633325 125633465 4
chr7 134379244 134379386 4
chr8 3994244 3994402 4
chr8 74225409 74225552 4
chr8 87396661 87396811 4
chr8 97852302 97852476 4
chr8 107898587 107898755 4
chr9 43916469 43916643 4
chr9 57606552 57606685 4
chrX 91225968 91226103 4
chrX 133464204 133464373 4
